Sentence,class,file
Proc Natl Acad Sci U S A 2010; 107:8328-33;  PMID:20404142 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/04/43/onci-3-e28964.PMC4108456.pdf
Cancer Res 2014; 74:2412-21; PMID:24556719 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/43/onci-3-e28964.PMC4108456.pdf
Clin Cancer Res 2013; 19:1035-43;  PMID:23460534 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/43/onci-3-e28964.PMC4108456.pdf
Nature 2006; 442:461-5; PMID:16688182 ;  http://dx.doi.org/10.1038/nature0480 9.,Non-OADS,/arxiv_data1/oa_pdf/04/43/onci-3-e28964.PMC4108456.pdf
J Cell Biochem 2012; 113:2122-5; PMID:22298331 ; http://dx.doi.org/10.1002/ jcb.2408 10.,Non-OADS,/arxiv_data1/oa_pdf/04/43/onci-3-e28964.PMC4108456.pdf
OncoImmunology 2014; 3:e29312; http://dx.doi.org/10.4161/onci.29312Hormesis in cancer immunology Does the quantity of an immune reactant matter?,Non-OADS,/arxiv_data1/oa_pdf/9a/05/onci-3-e29312.PMC4108457.pdf
Nature 2011; 480:480- 9; PMID:22193102 ; http://dx.doi.org/10.1038/ nature10673 2.,Non-OADS,/arxiv_data1/oa_pdf/9a/05/onci-3-e29312.PMC4108457.pdf
J Cell Sci 2012; 125:5591-6;  PMID:23420197 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9a/05/onci-3-e29312.PMC4108457.pdf
Cancer Cell 2010; 17:121-34;  PMID:20138013 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/05/onci-3-e29312.PMC4108457.pdf
Clin Cancer Res 2013; 19:4728-39; PMID:23833306 ; http://dx.doi.org/10.1158/1078- 0432.CCR-13-0088Figure 1.  th e immune response curve to antibody-based anticancer therapeutics.,Non-OADS,/arxiv_data1/oa_pdf/9a/05/onci-3-e29312.PMC4108457.pdf
Clin Dev Immunol 2010; 2010: http://dx.doi.org/10.1155/2010/851728 ;  PMID:20811480 7.,OADS,/arxiv_data1/oa_pdf/9a/05/onci-3-e29312.PMC4108457.pdf
Curr Opin Immunol 2007; 19:203-8;  PMID:17292599 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9a/05/onci-3-e29312.PMC4108457.pdf
Semin Cancer Biol 2008; 18:349-55; PMID:18467122 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/9a/05/onci-3-e29312.PMC4108457.pdf
"OncoImmunology 2014; 3:e29181; http://dx.doi.org/10.4161/onci.29181LTX-315 (Oncopore™) A short synthetic anticancer peptide and novel  immunotherapeutic agent Ketil André Camilio1,2, Øystein  re kdal1, and Baldur  sv einbjörnsson1,2,* 1Lytix Biopharma A s;  tr omsø, Norway; 2Department of Medical Biology; Faculty of he alth sc iences; un iversity of tr omsø; tr omsø, Norway Keywords:  anticancer peptides, B16 melanoma, intralesional treatment, inflammation, immunogenic cell death, DAMPs Abbreviations:  CAP, cationic antimicrobial peptide; LfcinB, bovine lactoferricin; DAMP, danger-associated molecular pattern  molecule; HMGB1, high mobility group box protein 1; ICD, immunogenic cell death; IL, interleukin; TIL, tumor-infiltrating  lymphocyte.",Non-OADS,/arxiv_data1/oa_pdf/7a/fa/onci-3-e29181.PMC4108458.pdf
Nature 2002; 415:389- 95; PMID:11807545 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7a/fa/onci-3-e29181.PMC4108458.pdf
Eur J Pharmacol 2009; 625:190-4; PMID:19835863 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7a/fa/onci-3-e29181.PMC4108458.pdf
Mol Cancer Ther 2005; 4:612-24; PMID:15827335 ;  http://dx.doi.org/10.1158/1535-7163.MCT-04-0077 5.,Non-OADS,/arxiv_data1/oa_pdf/7a/fa/onci-3-e29181.PMC4108458.pdf
Breast Cancer Res Treat 2003; 82:199-206;  PMID:14703067 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7a/fa/onci-3-e29181.PMC4108458.pdf
Int J Cancer 2006; 119:493-500; PMID:16572423 ;  http://dx.doi.org/10.1002/ijc.21886 7.,Non-OADS,/arxiv_data1/oa_pdf/7a/fa/onci-3-e29181.PMC4108458.pdf
Cancer Immunol Immunother 2014; 63:601-13; PMID:24676901 ;  http://dx.doi.org/10.1007/s00262-014-1540-0 9.,Non-OADS,/arxiv_data1/oa_pdf/7a/fa/onci-3-e29181.PMC4108458.pdf
Annu Rev Immunol 2013; 31:51-72; PMID :23157435 ; http://dx.doi.org/10.1146/ annurev-immunol-032712-100008 10.,Non-OADS,/arxiv_data1/oa_pdf/7a/fa/onci-3-e29181.PMC4108458.pdf
Cancer Immunol Immunother 2010; 59:1285-94;  PMID:20422410 ;  http://dx.doi.org/10.1007/s00262-010-0857-6 ©2014 Landes Bioscience.,Non-OADS,/arxiv_data1/oa_pdf/7a/fa/onci-3-e29181.PMC4108458.pdf
"OncoImmunology 2014; 3:e29258; http://dx.doi.org/10.4161/onci.29258A novel preclinical murine model   of immune-mediated metastatic dormancy ir ene  rom ero1, Federico Garrido1,2, and Angel M Garcia-Lora1,* 1se rvicio de Analisis Clinicos e in munologia; uG C Laboratorio Clínico; in stituto de in vestigación Biosanitaria ibs.G rA NADA; ho spital un iversitario Virgen de las Nieves;  Granada,  sp ain; 2Departamento de Bioquímica; Biología Molecular e in munología iii; un iversidad de Granada; Granada, sp ain Keywords:  MHC class I, T lymphocytes, animal model, dormancy, immunosurveillance, metastases th e mechanisms underlying cancer dormancy are poorly understood.",Non-OADS,/arxiv_data1/oa_pdf/31/45/onci-3-e29258.PMC4108459.pdf
Nat Rev Cancer  2007; 7:834-46;  PMID:17957189 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/31/45/onci-3-e29258.PMC4108459.pdf
Cancer Immunol Immunother 2011; 60:1257-68; PMID :21553283 ;  http://dx.doi.org/10.1007/s00262-011-1027-1 6.,Non-OADS,/arxiv_data1/oa_pdf/31/45/onci-3-e29258.PMC4108459.pdf
Immunity 2003; 19:561-9;  PMID:14563320 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/31/45/onci-3-e29258.PMC4108459.pdf
Cancer Cell 2012; 22:373-88; PMID:22975379 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/31/45/onci-3-e29258.PMC4108459.pdf
Carcinogenesis 2012; 33:687-93;  PMID:22219178 ;  http://dx.doi.org/10.1093/carcin/bgr318 10.,Non-OADS,/arxiv_data1/oa_pdf/31/45/onci-3-e29258.PMC4108459.pdf
J Pathol 2012; 227:367-79; PMID:22451343 ; http://dx.doi.org/10.1002/ path.4029 ©2014 Landes Bioscience.,Non-OADS,/arxiv_data1/oa_pdf/31/45/onci-3-e29258.PMC4108459.pdf
"OncoImmunology 2014; 3:e29194; http://dx.doi.org/10.4161/onci.29194Pancreatic cancer Hurdles in the engineering of CAR-based immunotherapies Daniel Abate-Daga1,*, st even A ro senberg1, and  ri chard A Morgan2 1su rgery Branch; Center for Cancer re search; National Cancer in stitute; Bethesda, MD usA ; 2bluebird bio; Cambridge, MA usA Keywords:  adoptive immunotherapy, PSCA, pancreatic cancer, chimeric antigen receptors (CAR), synthetic biology Abbreviations:  CAR, chimeric antigen receptor; FAP, fibroblast-activating protein; PSCA, prostate stem cell antigen Pancreatic cancer remains largely an incurable disease necessitating the development of novel therapeutic  approaches.",Non-OADS,/arxiv_data1/oa_pdf/51/a8/onci-3-e29194.PMC4108460.pdf
Blood 2010; 116:4099-102;  PMID:20668228 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/51/a8/onci-3-e29194.PMC4108460.pdf
N Engl J Med 2011; 365:725-33; PMID:21830940 ; http://dx.doi.org/10.1056/ NEJMoa1103849 3.,OADS,/arxiv_data1/oa_pdf/51/a8/onci-3-e29194.PMC4108460.pdf
Sci Transl Med 2013; 5:77ra38; PMID :23515080 ;  http://dx.doi.org/10.1126/scitranslmed.3005930 4.,Non-OADS,/arxiv_data1/oa_pdf/51/a8/onci-3-e29194.PMC4108460.pdf
Nat Med 2008; 14:1264-70;  PMID:18978797 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/51/a8/onci-3-e29194.PMC4108460.pdf
Cancer Immunol Res 2014; 2:112-20; PMID:24579088 ;  http://dx.doi.org/10.1158/2326-6066.CIR-13-0170 6.,Non-OADS,/arxiv_data1/oa_pdf/51/a8/onci-3-e29194.PMC4108460.pdf
Cancer Immunol Res 2013; 1:26-31; http://dx.doi.org/10.1158/2326-6066.CIR-13-0006 7.,Non-OADS,/arxiv_data1/oa_pdf/51/a8/onci-3-e29194.PMC4108460.pdf
Hum Gene Ther 2014; (Forthcoming); http://dx.doi.org/10.1089/ hum.2013.209 8.,Non-OADS,/arxiv_data1/oa_pdf/51/a8/onci-3-e29194.PMC4108460.pdf
Sci Transl Med 2013; 5:ra172; PMID:24337479 ;  http://dx.doi.org/10.1126/scitranslmed.3006597 9.,Non-OADS,/arxiv_data1/oa_pdf/51/a8/onci-3-e29194.PMC4108460.pdf
N Engl J Med 2011; 365:1673-83;  PMID:22047558 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/51/a8/onci-3-e29194.PMC4108460.pdf
Sci Transl Med 2013; 5:ps7; PMID:23552369 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/51/a8/onci-3-e29194.PMC4108460.pdf
"OncoImmunology 2014; 3:e29195; http://dx.doi.org/10.4161/onci.29195Monoclonal antibody targeting of mononuclear  cell chemokines driving malignant pleural effusion Antonia Marazioti and Georgios  t st athopoulos* Laboratory for Molecular re spiratory Carcinogenesis; Department of Physiology; Faculty of Medicine; un iversity of Patras; ri o, Greece Keywords:  malignant pleural effusion; CCL2; CCL12; inflammation; neutralizing antibodies ; adenocarcinoma; angiogenesis;  vascular permeability Abbreviations:  BRAF, v-raf murine sarcoma viral oncogene homolog B; CCL, C-C-motif chemokine ligand; EGFR, epidermal  growth factor receptor; KRAS, Kirsten rat sarcoma viral oncogene homolog; MPE, malignant pleural effusion; NF, nuclear factor;  TNF, tumor necrosis factor; VEGF, vascular endothelial growth factor re cent evidence suggests that host immune cells contribute to the development of malignant pleural effusion (MP e) ,  a common manifestation of metastatic cancer.",Non-OADS,/arxiv_data1/oa_pdf/60/9f/onci-3-e29195.PMC4108461.pdf
J Clin Oncol 2014; 32:960-7; PMID:24550423 ; http://dx.doi.org/10.1200/ JCO.2013.50.5453 2.,Non-OADS,/arxiv_data1/oa_pdf/60/9f/onci-3-e29195.PMC4108461.pdf
JAMA 2012; 307:2432-3;  PMID:22609878 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/60/9f/onci-3-e29195.PMC4108461.pdf
Am J Respir Crit Care Med 2014; 189:626-7;  PMID:24628311 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/9f/onci-3-e29195.PMC4108461.pdf
Am J Respir Crit Care Med 2012; 186:487-92; PMID:22652027 ; http://dx.doi.org/10.1164/ rccm.201203-0465PP 6.,Non-OADS,/arxiv_data1/oa_pdf/60/9f/onci-3-e29195.PMC4108461.pdf
Cancer Res 2007; 67:9825-34;  PMID:17942913 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/9f/onci-3-e29195.PMC4108461.pdf
Am J Respir Cell Mol Biol 2006; 34:142-50;  PMID:16210694 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/60/9f/onci-3-e29195.PMC4108461.pdf
J Natl Cancer Inst 2008; 100:1464-76;  PMID:18840818 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/9f/onci-3-e29195.PMC4108461.pdf
"OncoImmunology 2014; 3:e29081; http://dx.doi.org/10.4161/onci.29081Antibody-based depletion of Foxp3+ T cells  potentiates antitumor immune memory  stimulated by mTOR inhibition hy ung L Kim* Department of su rgery; Division of ur ology; Cedars- si nai Medical Center; Los Angeles, CA usA Keywords:  CD4, regulatory T cells, mTOR, memory T cell, tumor immunology in hibition of m t or  signaling enhances antitumor memory t  lymphocytes while increasing the frequency of immuno - suppressive regulatory  t  cells ( tr egs).",Non-OADS,/arxiv_data1/oa_pdf/40/04/onci-3-e29081.PMC4108462.pdf
Nature 2009; 460:108-12;  PMID:19543266 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/04/onci-3-e29081.PMC4108462.pdf
Br J Cancer 2011; 104:643-52; PMID:21285988 ;  http://dx.doi.org/10.1038/bjc.2011.15 4.,Non-OADS,/arxiv_data1/oa_pdf/40/04/onci-3-e29081.PMC4108462.pdf
J Immunol 2009; 182:4244-54; PMID:19299723 ; http://dx.doi.org/10.4049/ jimmunol.0802041 5.,Non-OADS,/arxiv_data1/oa_pdf/40/04/onci-3-e29081.PMC4108462.pdf
Blood 2011; 117:6952-62;  PMID:21521781 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/04/onci-3-e29081.PMC4108462.pdf
J Exp Med 2013; 210:1695-710; PMID:23897981 ;  http://dx.doi.org/10.1084/jem.20130579 7.,Non-OADS,/arxiv_data1/oa_pdf/40/04/onci-3-e29081.PMC4108462.pdf
PLoS One 2011; 6:e26491; PMID:22046294 ;  http://dx.doi.org/10.1371/journal.pone.0026491 9.,Non-OADS,/arxiv_data1/oa_pdf/40/04/onci-3-e29081.PMC4108462.pdf
J Clin Invest 2005; 115:3623-33; PMID:16308572 ; http://dx.doi.org/10.1172/ JCI2594710.,Non-OADS,/arxiv_data1/oa_pdf/40/04/onci-3-e29081.PMC4108462.pdf
Int J Cancer 2007; 120:2723-33;  PMID :17315189 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/40/04/onci-3-e29081.PMC4108462.pdf
"OncoImmunology 2014; 3:e29257; http://dx.doi.org/10.4161/onci.29257‘Hardcore’ OX40+ immunosuppressive regulatory   T cells in hepatic cirrhosis and cancer si lvia Piconese1,*, ele onora  ti mperi1, and Vincenzo Barnaba1,2,* 1Dipartimento di Medicina in terna e sp ecialità Mediche; “ sa pienza” un iversità di ro ma; ro me, it aly; 2is tituto Pasteur - Fondazione Cenci Bolognetti; ro me, it aly Keywords:  Treg, OX40, chronic hepatitis C, Th1, commitment Abbreviations:  CHC, chronic hepatitis C; CXCR3, chemokine (C-X-C motif) receptor 3; FOXP3, forkhead box P3; HCC,  hepatocellular carcinoma; HCV, hepatitis C virus; Helios (IKZF2), IKAROS family zinc finger 2; IFN γ, interferon gamma; IL-12,  interleukin 12; IL-12R β2, interleukin 12 receptor beta 2; MF, macrophages; OX40 (TNFRSF4), tumor necrosis factor receptor  superfamily member 4; OX40L (TNFSF4), tumor necrosis factor (ligand) superfamily member 4; T-bet (TBX21), T-box   21;  TGFβ, transforming growth factor beta 1; Th1, T helper 1; TNF α, tumor necrosis factor; Treg, regulatory T cell; TSDR,   Treg cells-specific demethylated region hu man regulatory t  cells ( tr egs) comprise an array of distinct subsets displaying diverse functions in response to  microenvironmental signals.",Non-OADS,/arxiv_data1/oa_pdf/11/20/onci-3-e29257.PMC4108463.pdf
J Clin Invest 2009; 119:551-64; PMID:19229109 ; http://dx.doi.org/10.1172/ JCI36604 2.,Non-OADS,/arxiv_data1/oa_pdf/11/20/onci-3-e29257.PMC4108463.pdf
Hepatology 2014; (Forthcoming);  PMID:24756990 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/20/onci-3-e29257.PMC4108463.pdf
Lab Invest 2010; 90:1782-93;  PMID:20680008 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/11/20/onci-3-e29257.PMC4108463.pdf
Cancer Res 2012; 72:4351-60; PMID:22798340 ;  http://dx.doi.org/10.1158/0008-5472.CAN-12-0579 6.,Non-OADS,/arxiv_data1/oa_pdf/11/20/onci-3-e29257.PMC4108463.pdf
Front Immunol 2013; 4:247;  PMID:23986759 ; http://dx.doi.org/10.3389/ fimmu.2013.00247 7.,Non-OADS,/arxiv_data1/oa_pdf/11/20/onci-3-e29257.PMC4108463.pdf
J Exp Med 2011; 208:1571-7;  PMID:21746812 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/11/20/onci-3-e29257.PMC4108463.pdf
Cancer Res 2013; 73:7189-98; PMID:24177180 ; http://dx.doi.org/10.1158/0008- 5472.CAN-12-4174 ©2014 Landes Bioscience.,Non-OADS,/arxiv_data1/oa_pdf/11/20/onci-3-e29257.PMC4108463.pdf
"OncoImmunology 2014; 3:e29381; http://dx.doi.org/10.4161/onci.29381Cellular immunotherapy directed   against human cytomegalovirus as a novel  approach for glioblastoma treatment Andrea  sc huessler1, David G wa lker2, and  ra jiv Khanna1,* 1QiMr C entre for imm unotherapy and Vaccine Development and tum our imm unology Laboratory; Department of imm unology; Q iMr B erghofer Medical re search in stitute;  Brisbane, QLD Australia; 2Newro Foundation; th e we sley ho spital; Brisbane, QLD Australia Keywords:  cytotoxic T cells, adoptive immunotherapy, recurrent glioblastoma multiforme, cytomegalovirus, clinical trial Glioblastoma multiforme (GBM) has a very poor prognosis, despite multimodal therapy including surgery, radiation  and chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/75/a0/onci-3-e29381.PMC4108464.pdf
N Engl J Med 2005; 352:987-96; PMID:15758009 ; http://dx.doi.org/10.1056/ NEJMoa043330 2.,OADS,/arxiv_data1/oa_pdf/75/a0/onci-3-e29381.PMC4108464.pdf
Expert Rev Vaccines 2013 ; 12:597-615;  PMID:23750791 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/a0/onci-3-e29381.PMC4108464.pdf
Virus Res 2011; 157:193-203; PMID:21036194 ;  http://dx.doi.org/10.1016/j.virusres.2010.10.026 5.,OADS,/arxiv_data1/oa_pdf/75/a0/onci-3-e29381.PMC4108464.pdf
Clin Cancer Res 2014; 20:2684-94; PMID :24658154 ; http://dx.doi.org/10.1158/1078- 0432.CCR-13-3268 6.,Non-OADS,/arxiv_data1/oa_pdf/75/a0/onci-3-e29381.PMC4108464.pdf
Cancer Res 2014;In Press; PMID:24795429 ; http://dx.doi.org/10.1158/0008- 5472.CAN-14-0296Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/75/a0/onci-3-e29381.PMC4108464.pdf
"OncoImmunology 2014; 3:e28184; http://dx.doi.org/10.4161/onci.28184Drag  cells in immunity Plasmacytoid DCs dress up as cancer cells Irene Bonaccorsi1,2, Gaetana Pezzino1,2, Barbara Morandi3, and Guido Ferlazzo1,2,* 1Laboratory of Immunology and Biotherapy; Department of hu man Pathology; un iversity of Messina; Messina, Italy; 2Cell Therapy Program; a.O .u.",Non-OADS,/arxiv_data1/oa_pdf/ec/65/onci-3-e28184.PMC4108465.pdf
Immunol Lett 2013; 158:73- 8; PMID:24333339 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ec/65/onci-3-e28184.PMC4108465.pdf
J Exp Med 2004 ; 199:567- 79; PMID:14970182 ; http://dx.doi.org/10.1084/ jem.20031059 3.,Non-OADS,/arxiv_data1/oa_pdf/ec/65/onci-3-e28184.PMC4108465.pdf
Annu Rev Immunol  2005 ; 23:651-82; PMID :15771583 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ec/65/onci-3-e28184.PMC4108465.pdf
J Immunol  2014 ; 192:824-32; PMID:24337377 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ec/65/onci-3-e28184.PMC4108465.pdf
Immunity 2012 ; 36:438-50; PMID:22444632 ;  http://dx.doi.org/10.1016/j.immuni.2012.01.017 7.,OADS,/arxiv_data1/oa_pdf/ec/65/onci-3-e28184.PMC4108465.pdf
Hum Immunol  2002 ; 63:1149 -55; PMID:12480258 ;  http://dx.doi.org/10.1016/S0198-8859(02)00753-X 8.,OADS,/arxiv_data1/oa_pdf/ec/65/onci-3-e28184.PMC4108465.pdf
Clin Cancer Res 2004 ; 10:7466 -74;  PMID:15569976 ; http://dx.doi.org/10.1158/1078- 0432.CCR-04-0684 9.,Non-OADS,/arxiv_data1/oa_pdf/ec/65/onci-3-e28184.PMC4108465.pdf
J Immunol  2013 ; 191:4858 -66; PMID:24078697 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ec/65/onci-3-e28184.PMC4108465.pdf
"OncoImmunology 2014; 3:e29244; http://dx.doi.org/10.4161/onci.29244Distinct immunological mechanisms of CTLA-4  and PD-1 blockade revealed by analyzing TCR  usage in blood lymphocytes Lidia  ro bert1, Christina  har view2, ry an  em erson3,4, Xiaoyan  wa ng1,5, st ephen Mok6, Blanca  ho met1, Begonya Comin-Anduix6,7,  ri chard C Koya6, har lan  ro bins3,4, Paul C tu meh2, and Antoni  ri bas1,6,7,* 1Department of Medicine (Division of he matology- on cology); un iversity of California Los Angeles ( uC LA); Los Angeles, CA usA ; 2Department of Medicine   (Division of Dermatology);  un iversity of California Los Angeles ( uC LA); Los Angeles, CA  usA ; 3Fred hu tchinson Cancer re search Center; se attle, wA usA ;   4Adaptive Biotechnologies; se attle, wA usA ; 5Department of Medicine ( st atistics core); un iversity of California Los Angeles ( uC LA); Los Angeles, CA usA ;   6Department of su rgery (Division of su rgical- on cology); un iversity of California Los Angeles ( uC LA); Los Angeles, CA usA ; 7Jonsson Comprehensive Cancer Center (JCCC);  un iversity of California Los Angeles ( uC LA); Los Angeles, CA  usA Keywords:  CTLA-4, MK-3475, PBMC, PD-1, TCR, Tremelimumab, sequencing ta rgeting immune inhibitory receptors has brought excitement, innovation and hope to cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/70/6f/onci-3-e29244.PMC4108466.pdf
N Engl J Med 2011; 364:2517-26;  PMID:21639810 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/70/6f/onci-3-e29244.PMC4108466.pdf
J Clin Oncol 2013; 31:616-22; PMID:23295794 ;  http://dx.doi.org/10.1200/JCO.2012.44.6112 3.,Non-OADS,/arxiv_data1/oa_pdf/70/6f/onci-3-e29244.PMC4108466.pdf
N Engl J Med 2012; 366:2443-54; PMID:22658127 ;  http://dx.doi.org/10.1056/NEJMoa1200690 4.,OADS,/arxiv_data1/oa_pdf/70/6f/onci-3-e29244.PMC4108466.pdf
N Engl J Med 2013; 369:134-44;  PMID:23724846 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/70/6f/onci-3-e29244.PMC4108466.pdf
Clin Cancer Res 2009; 15: 6267-76 ;  PMID:19789309 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/70/6f/onci-3-e29244.PMC4108466.pdf
Clin Cancer Res 2014; 20:2424-32;  PMID:24583799 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/70/6f/onci-3-e29244.PMC4108466.pdf
Blood 2009; 114:4099-107;  PMID:19706884 ;  http://dx.doi.org/10.1182/blood-2009-04-217604 10.,Non-OADS,/arxiv_data1/oa_pdf/70/6f/onci-3-e29244.PMC4108466.pdf
Clin Cancer Res 2013; 19:5300-9; PMID:24089443 ;  http://dx.doi.org/10.1158/1078-0432.CCR-13-0143 Figure 1.  im munotherapy-specific changes in the absolute number of unique t  cell receptor  sequences in cancer patient blood lymphocytes.,Non-OADS,/arxiv_data1/oa_pdf/70/6f/onci-3-e29244.PMC4108466.pdf
"OncoImmunology 2014; 3:e29125;   http://dx.doi.org/10.4161/onci.29125Immune cells in pancreatic cancer Joining the dark side Yaqing Zhang1, Florencia McAllister2,3, and Marina Pasca di Magliano1,4,5,6,* 1Department of su rgery; un iversity of Michigan; Ann Arbor, M i  usA ; 2Department of on cology; Johns ho pkins un iversity; Baltimore, MD usA ;   3Division of Clinical Pharmacology; Department of Medicine; Johns ho pkins un iversity; Baltimore, MD usA ; 4Program in Cellular and Molecular Biology; Ann Arbor, M i usA ;  5Department of Cell and Developmental Biology; Ann Arbor, M i  usA ; 6Comprehensive Cancer Center; un iversity of Michigan; Ann Arbor, M i  usA Keywords:  pancreatic cancer, Kras, CD4 T cells, regulatory T cells, TH17 cells, CD8 T cells, IL-17, mouse model Abbreviations:  ADM, acinar–ductal metaplasia; GM-CSF, granulocyte macrophage colony stimulating factor; IFN γ, interferon- gamma; IL-6, interleukin 6; IL-17, interleukin 17; IL-17RA, IL-17 receptor A; MDSC, myeloid-derived suppressor cell; PanIN,  pancreatic intraepithelial neoplasia; PDA, pancreatic ductal adenocarcinoma; TH17, T helper 17 cell Pancreatic tumors are rich in immune cell infiltrates that include CD4+ t- cell subsets encompassing both regulatory  t  cells and  th17 cells.",Non-OADS,/arxiv_data1/oa_pdf/3a/a9/onci-3-e29125.PMC4108467.pdf
Available from: http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2014/index 2.,Non-OADS,/arxiv_data1/oa_pdf/3a/a9/onci-3-e29125.PMC4108467.pdf
Cancer Cell 2003; 4:437-50; PMID:14706336 ;  http://dx.doi.org/10.1016/S1535-6108(03)00309-X 3.,Non-OADS,/arxiv_data1/oa_pdf/3a/a9/onci-3-e29125.PMC4108467.pdf
J Clin Invest 2010; 120:508-20; PMID:20071774 ; http://dx.doi.org/10.1172/ JCI40045 4.,Non-OADS,/arxiv_data1/oa_pdf/3a/a9/onci-3-e29125.PMC4108467.pdf
Cancer Res 2007; 67:9518-27; PMID:17909062 ;  http://dx.doi.org/10.1158/0008-5472.CAN-07-0175 5.,Non-OADS,/arxiv_data1/oa_pdf/3a/a9/onci-3-e29125.PMC4108467.pdf
Cancer Cell 2014; 25:621-37; PMID:24823639 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3a/a9/onci-3-e29125.PMC4108467.pdf
J Clin Invest 2012; 122:639-53; PMID:22232209 ; http://dx.doi.org/10.1172/ JCI59227 8.,Non-OADS,/arxiv_data1/oa_pdf/3a/a9/onci-3-e29125.PMC4108467.pdf
Cancer Cell 2011; 19:456-69; PMID:21481788 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/3a/a9/onci-3-e29125.PMC4108467.pdf
Cancer Cell 2012; 21:836-47; PMID:22698407 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/3a/a9/onci-3-e29125.PMC4108467.pdf
Cancer Cell 2012; 21:822-35; PMID:22698406 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/3a/a9/onci-3-e29125.PMC4108467.pdf
"OncoImmunology 2014; 3:e29351; http://dx.doi.org/10.4161/onci.29351Potential utility of the pan-Bcl-2 inhibitor   GX15–070 (obatoclax) in cancer immunotherapy Peter  s Kim and Jeffrey  sc hlom* Laboratory of tu mor im munology and Biology; Center for Cancer re search; National Cancer in stitute; National in stitutes of he alth; Bethesda, MD usA Keywords:  pan-Bcl-2 inhibitor, T lymphocytes, regulatory T cells, combination immunotherapy Abbreviations:  GX15, GX15-070; Tregs, T regulatory cells An exploration of the immunotherapeutic potential of the pan-Bcl-2 inhibitor GX15–070 (GX15) has revealed that  early-activated  t  cells derived from human peripheral blood are more sensitive to GX15 than are prolonged-activated  t  cells.",Non-OADS,/arxiv_data1/oa_pdf/23/79/onci-3-e29351.PMC4108468.pdf
Semin Oncol 2012; 39:323-39;  PMID:22595055 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/23/79/onci-3-e29351.PMC4108468.pdf
Expert Opin Investig Drugs 2012; 21:363-73;  PMID:22324354 ; http://dx.doi.org/10.1 517/13543784.2012.652302 3.,Non-OADS,/arxiv_data1/oa_pdf/23/79/onci-3-e29351.PMC4108468.pdf
Int J Cancer 2010; 127:1603-13;  PMID:20091862 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/23/79/onci-3-e29351.PMC4108468.pdf
J Immunol 2014; 192:2622-33; PMID:24516200 ; http://dx.doi.org/10.4049/ jimmunol.1301369 5.,Non-OADS,/arxiv_data1/oa_pdf/23/79/onci-3-e29351.PMC4108468.pdf
BMC Med Genomics 2008; 1:53;  PMID:18947405 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/79/onci-3-e29351.PMC4108468.pdf
Exp Biol Med (Maywood) 2013; 238:248-56;  PMID:23576806 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/23/79/onci-3-e29351.PMC4108468.pdf
J Immunol 2011; 186:5729-37; PMID:21451108 ; http://dx.doi.org/10.4049/ jimmunol.1100102 8.,Non-OADS,/arxiv_data1/oa_pdf/23/79/onci-3-e29351.PMC4108468.pdf
Cancer Res 2012; 72:3439-44; PMID:22761338 ; http://dx.doi.org/10.1158/0008- 5472.CAN-11-3912 10.,Non-OADS,/arxiv_data1/oa_pdf/23/79/onci-3-e29351.PMC4108468.pdf
"OncoImmunology 2014; 3:e28989;   http://dx.doi.org/10.4161/onci.28989http://dx.doi.org/10.4161/onci.28989Stromal niche communalities underscore   the contribution of the matricellular protein SPARC  to B-cell development and lymphoid malignancies sabina  sangaletti1,†, claudio Tripodo2,†, Paola Portararo1, Matteo Dugo3, caterina Vitali1, laura Botti1, carla  guarnotta2,  Barbara  cappetti1, alessandro  gulino2, ilaria Torselli1, Patrizia c asalini4, claudia  chiodoni1, and Mario P c olombo1,* 1Molecular i mmunology Unit; Department of e xperimental Oncology and Molecular Medicine; Fondazione irccs i stituto n azionale Tumori; Milan, i taly;   2Tumor i mmunology Unit, Department of h ealth s ciences; University of Palermo; Palermo, i taly; 3Functional g enomics c ore Facility; Department of e xperimental Oncology  and Molecular Medicine; Fondazione irccs i stituto n azionale Tumori; Milan, i taly; 4Molecular Therapies Unit; Department of e xperimental Oncology and Molecular Medicine;  Fondazione irccs i stituto n azionale Tumori; Milan, i taly †These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
Immunity  2001; 15:323-34 ;  PMID:11520466 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
Immunity  2010; 32:187-99;  PMID:20171124 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
Proc Natl Acad Sci U S A 2013; 110:E2915- 24; PMID:23847204 ; http://dx.doi.org/10.1073/ pnas.1218131110 7.,OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
J Cell Biol  2012; 196:395-406;  PMID:22351925 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
Blood 2012; 120:3541-54; PMID:22955913 ; http://dx.doi.org/10.1182/ blood-2011-12-398537 9.,Non-OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
J Autoimmun 2011; 37:300-10; PMID:21962567 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
Cancer Discov 2014; 4:110-29;  PMID:24189145 ; http://dx.doi.org/10.1158/2159- 8290.CD-13-0276 11.,Non-OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
Annu Rev Immunol 2001; 19:595-621;  PMID:11244048 ; http://dx.doi.org/10.1146/ annurev.immunol.19.1.595 12.,Non-OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
J Immunol 2001;  166:5567-77;  PMID:11313396 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
J Exp Med 2000; 191:5- 8; PMID:10620600 ; http://dx.doi.org/10.1084/ jem.191.1.5 14.,Non-OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
J Immunol 2003; 170:252- 60; PMID:12496407 ; http://dx.doi.org/10.4049/ jimmunol.170.1.252 15.,Non-OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
J Immunol 2004; 172:5535-43; PMID :15100296 ;  http://dx.doi.org/10.4049/jimmunol.172.9.5535 17.,Non-OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
Am J Pathol 2011; 179:3000-10;  PMID:22001347 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
Cancer Metastasis Rev 2010; 29:295- 307; PMID:20386958 ; http://dx.doi.org/10.1007/ s10555-010-9221-8 20.,Non-OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
Nat Immunol 2012; 13:170-80;  PMID:22197976 ; http://dx.doi.org/10.1038/ni.2194 21.,Non-OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
Blood 2002; 100:246-58; PMID:12070034 ;  http://dx.doi.org/10.1182/blood.V100.1.246 22.,Non-OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
Am J Pathol 1999; 154:805-12; PMID:10079258 ; http://dx.doi.org/10.1016/ S0002-9440(10)65327-8 23.,Non-OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
Blood 2014; 123:1836-49; PMID:24452203 ;  http://dx.doi.org/10.1182/blood-2013-04-497271 24.,Non-OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
Cancer Res 2008;  68:9050-9;  PMID :18974151 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
J Leukoc Biol 2008; 83:799- 803; PMID:18063695 ; http://dx.doi.org/10.1189/ jlb.090760926.,Non-OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
Nat Rev Clin Oncol 2011; 8:456-66;  PMID :21448151 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
Blood 2011; 117:3596-608; PMID:21245480 ; http://dx.doi.org/10.1182/ blood-2010-08-301556 28.,Non-OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
Br J Haematol 2006;  134:467-74;  PMID:16848793 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
Blood 2009; 114:49-59; PMID:19417209 ; http://dx.doi.org/10.1182/ blood-2009-01-197988 30.,Non-OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
Blood 2013; 121:4821- 31; PMID:23589674 ; http://dx.doi.org/10.1182/ blood-2012-12-475483 31.,Non-OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
Curr Cancer Drug Targets  2009; 9:617-25;  PMID:19508173 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
J Immunol 2014; 192:2449-59; PMID:24501201 ;  http://dx.doi.org/10.4049/jimmunol.1301055 33.,Non-OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
Acta Haematol 2007; 117:48-50; PMID:17095859 ;  http://dx.doi.org/10.1159/000096788 35.,Non-OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
Adv Hematol 2012; 2012:138079;  PMID:22400028 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
J Cell Sci 2006; 119:314- 25; PMID:16390867 ; http://dx.doi.org/10.1242/ jcs.02741 37.,OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
Hematology Am Soc Hematol Educ Program 2007;  210-5;  PMID:18024632 ; http://dx.doi.org/10.1182/ asheducation-2007.1.210 40.,Non-OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
J Immunol 2005; 174:1438-45; PMID :15661902 ;  http://dx.doi.org/10.4049/jimmunol.174.3.1438,Non-OADS,/arxiv_data1/oa_pdf/71/6e/onci-3-e28989.PMC4108469.pdf
Cerebellum and GABA system The cerebellum and the thalamus are the main regions involved in the genesis (cerebellum) and propagation (thalamus) of tremor inFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
Theyfound significant reduced levels of parvalbumin (a marker of GABAergic Figure 1.Schematic Representation of the Gamma-aminobutyric Acid Hypothesis in Essential Tremor.Gironell A GABA Hypothesis in Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"36Muscimol, 199140 Louis et al.18Shill et al.23Gabapentin, 199941 Gabapentin, 200043 Topiramate, 200245 Topiramate, 200646 Topiramate, 200848 Pregabaline, 200750 Cons Rajput et al.61Deng et al.29Progabide, 198337 Thier et al.30Progabide, 198738 Shill et al.62Garcı ´a-Martı ´n et al.31Gabapentin, 199942 Symanski et al.63Garcı ´a-Martı ´n et al.32Topiramate, 200647 Tiagabine, 200849 Pregabaline, 200951 Pregabaline, 201252 CSF, Cerebrospinal Fluid; ET, Essential Tremor; GABA, gamma-aminobutyric acid.GABA Hypothesis in Essential Tremor Gironell A Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
We can conclude from these findings that in vivo neuroimaging studies support the role of cerebellar GABAergic dysfunction as the main pathophysiologicalhypothesis of the disease.Gironell A GABA Hypothesis in Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
51performed another controlled study withGABA Hypothesis in Essential Tremor Gironell A Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
Loss of GABA in ET may be amarker of the problem (Purkinje cell loss) but the problem produced by Purkinje cell loss may not simply be fixed by enhancing GABA transmission.Gironell A GABA Hypothesis in Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Lancet Neurol 2011;10:148–161, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Arch Neurol 1999,56:807–808, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Mov Disord 1989;4: 183–187, doi: http://dx.doi.org/10.1002/mds.870040210.",OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"J Neurol Neurosurg Psychiatry 1988;51:591–592, doi: http://dx.doi.org/10.1136/jnnp.51.4.591.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Arch Neurol 2002;59:413–417, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Brain Stimul 2013;6:175–179, doi: http://dx.doi.org/10.1016/j.brs.2012.04.009.",OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Lancet 1990;336:1028–1030, doi: http://dx.doi.org/10.1016/0140-6736(90)92489-5.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"J Neurol Sci 1993;114:45–48, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Neurosci Lett 2002;333: 17–20, doi: http://dx.doi.org/10.1016/S0304-3940(02)00966-7.",OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Mov Disord 2004;19: 672–677, doi: http://dx.doi.org/10.1002/mds.20019.",OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Neurology 2006; 67:1452–1456, doi: http://dx.doi.org/10.1212/01.wnl.0000240130.94408.99.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Brain 2007;130:3297–307, doi: http://dx.doi.org/10.1093/brain/awm266.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Purkinje cell loss is a characteristic of essential tremor: Towards a more mature understanding of pathogenesis.Parkinsonism Relat Disord 2012;18:1003–1004, doi: http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Quantification of cerebellar hemispheric Purkinje cell linear density: 32 ET cases versus 16 controls.Mov Disord 2013;28:1854–9, doi: http://dx.doi.org/10.1002/mds.25629.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Pharmacol Rev 2002;54:247–264, doi: http://dx.doi.org/ 10.1124/pr.54.2.247.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"J Neural Transm 1996; 103;555–560, doi: http://dx.doi.org/10.1007/BF01273153.",OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Mov Disord 2012;27:113–117, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Neuroscience 2008;156:537–549, doi: http://dx.doi.org/10.1016/j.neuroscience.2008.07.060.",OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Science 1988;242:1654– 1664, doi: http://dx.doi.org/10.1126/science.3059497.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Brain Res1992;595:295–300, doi: http://dx.doi.org/10.1016/0006-8993(92)91063-K. 29.Deng H, Xie WJ, Le WD, Huang MS, Jankovic J.",OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Neurosci Lett 2006;401:16–19, doi: http://dx.doi.org/10.1016/j.neulet.2006.02.066.GABA Hypothesis in Essential Tremor Gironell A Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services7",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Eur J Neurol 2011;8:1098–1100, doi: http://dx.doi.org/10.1111/j.1468-1331.2010.03308.x.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Pahrmacogenet Genomics 2011;7:436–439, doi: http://dx.doi.org/10.1097/FPC.0b013e328345bec0.",OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"J Neurol 2011;2:203–211, doi: http://dx.doi.org/10.1007/ s00415-010-5708-z.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Neurology 2014;82:1000–1007, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"J Clin Invest 2005;115:774–779, doi: http://dx.doi.org/10.1172/JCI200523625.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"J Nucl Med 2010;51:1030– 1035, doi: http://dx.doi.org/10.2967/jnumed.109.074120.",OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Parkinsonism Relat Disord 2012;18: 876–880, doi: http://dx.doi.org/10.1016/j.parkreldis.2012.04.024.",OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Acta Neurol Scand 1983;68:248–252, doi: http://dx.doi.org/10.1111/j.1600-0404.1983.tb04833.x.",OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Arch Neurol 1987;44;905–906, doi: http://dx.doi.org/10.1001/archneur.1987.00520210007009.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Ann Neurol 1999;46: 249–252, doi: http://dx.doi.org/10.1002/1531-8249(199908)46:2 ,249::AID- ANA15.3.0.CO;2-C. 41.Gironell A, Kulisevsky J, Barbanoj M, Lo ´pez-Villegas D, Herna ´ndez G, Pascual-Sedano B.",OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Arch Neurol 1999;56:475–480, doi: http://dx.doi.org/10.1001/archneur.56.4.475.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Mov Disord 1998;13:465– 467, doi: http://dx.doi.org/10.1002/mds.870130315.",OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"43.Ondo W, Hunter C, Dat Wuong K, Scwartz K, Jankovic J. Gabapentin for essential tremor: A multiple-dose, double-blind placebo-controlled trial.Mov Disord 2000;15:678–682, doi: http://dx.doi.org/10.1002/1531- 8257(200007)15:4 ,678::AID-MDS1012 .3.0.CO;2-0.",OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Neurology 2011;17:1752– 1755, doi: http://dx.doi.org/10.1212/WNL.0b013e318236f0fd.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Neurology 2002;59:132–134, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Neurology 2006;66:672–677, doi: http://dx.doi.org/10.1212/01.wnl.0000200779.03748.0f.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Clin Neuropharmacol 2006;2:94–96, doi: http://dx.doi.org/10.1097/00002826-200603000-00007.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Clin Neuropharmacol 2008;31:97–103, doi: http://dx.doi.org/10.1097/WNF.0b013e3180d09969.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Mov Disord 2008;23:1955– 1956, doi: http://dx.doi.org/10.1002/mds.22094.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Mov Disord 2007;22:1660–1663, doi: http://dx.doi.org/10.1002/mds.21629.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"J Neurol Sci 2009;285:195–197, doi: http://dx.doi.org/10.1016/j.jns.2009.06.044.",OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Mov Disord 2013;28:249–250, doi: http://dx.doi.org/10.1002/mds.25264.",OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"JN e u r o l Neurosurg Psychiatry 1981;44:650, doi: http://dx.doi.org/10.1136/jnnp.44.7.650.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Neurology 1988;38:241–243, doi: http://dx.doi.org/10.1212/WNL.38.2.241.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Eur J Neurol 2008;15:697–705, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"J Neurol Neurosurg Psychiatry 1988;51: 379–384, doi: http://dx.doi.org/10.1136/jnnp.51.3.379.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"J Neurol Neurosurg Psychiatry 1998;64:273–276, doi: http://dx.doi.org/10.1136/jnnp.64.2.273.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Neurology 2003;60:1985–1987, doi: http://dx.doi.org/10.1212/ 01.WNL.0000065890.75790.29.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
Neurology 2004;62:Gironell A GABA Hypothesis in Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services8,Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"932–936, doi: http://dx.doi.org/10.1212/01.WNL.0000115145.18830.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Neurology 2008;70:1452– 1455, doi: http://dx.doi.org/10.1212/01.wnl.0000310425.76205.02.",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Mov Disord 2014;29:496–500, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Mov Disord 2009;14:2033– 2041, doi: http://dx.doi.org/10.1002/mds.22755.",OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Mov Disord 2014;29:435–436, doi: http://dx.doi.org/10.1002/mds.25852.GABA Hypothesis in Essential Tremor Gironell A Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services9",Non-OADS,/arxiv_data1/oa_pdf/d5/0d/tre-04-254-5689-1.PMC4108714.pdf
"Firstly, for several years patients have been qualified for the treatment of primary osteoporosis ac- cording to a FRAX calculation of absolute 10-year risk  of bone fracture (http://www.shef.ac.uk/FRAX/tool.jsp).",Non-OADS,/arxiv_data1/oa_pdf/2e/15/PG-9-22691.PMC4108749.pdf
"World Health Organization, Health Statistics and Health In- formation Systems Website: http://www.who.int/healthinfo/statistics/en/ [15 September 2012].",Non-OADS,/arxiv_data1/oa_pdf/c3/79/PG-9-22692.PMC4108750.pdf
"National Cancer Institute, Genetics of Colorectal Cancer Web-site: http://www.cancer.gov/cancertopics/pdq/genetics/col- orectal/healthprofessional/allpages/print [19 September 2012].",Non-OADS,/arxiv_data1/oa_pdf/c3/79/PG-9-22692.PMC4108750.pdf
References 1. http://epid.coi.waw.pl/km 2.,Non-OADS,/arxiv_data1/oa_pdf/42/f0/PG-9-22695.PMC4108753.pdf
e-mail: taniguch@vmas.kitasato-u.ac.jp ©2014 The Japanese Society of  Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/bf/e4/jvms-76-781.PMC4108759.pdf
e-mail: ishizum@vetmed.hokudai.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/40/c6/jvms-76-789.PMC4108760.pdf
Available from http://www.fda.gov/ora/compliance_ ref/cpg/cpgfod/cpg527-400.html.,Non-OADS,/arxiv_data1/oa_pdf/40/c6/jvms-76-789.PMC4108760.pdf
e-mail: ircpmi@obihiro.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/e3/57/jvms-76-799.PMC4108761.pdf
The putative N-terminal signal peptide was  analyzed using the SignalP server (http://www.cbs.dtu.dk/ services/SignalP/).,OADS,/arxiv_data1/oa_pdf/e3/57/jvms-76-799.PMC4108761.pdf
e-mail: afujino@mail.ecc.u-tokyo.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/62/18/jvms-76-807.PMC4108762.pdf
e-mail: cniwat@chula.ac.th ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/a9/d5/jvms-76-813.PMC4108763.pdf
e-mail:	tamuraaee@gmail.com ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the creative  commons Attribution Non-commercial No derivatives (by-nc-nd) License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/2f/93/jvms-76-819.PMC4108764.pdf
e-mail: chimura_animal_clinic@live.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/0f/2e/jvms-76-827.PMC4108765.pdf
e-mail: mantani@sapphire.kobe-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/dd/c6/jvms-76-833.PMC4108766.pdf
e-mail: a-shimada@azabu-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/76/07/jvms-76-839.PMC4108767.pdf
e-mail: ibanvet@gmail.com ©2014 the Japanese Society of Veterinary Science this is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/b2/8f/jvms-76-847.PMC4108768.pdf
e-mail: makoto@obihiro.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/52/dd/jvms-76-855.PMC4108769.pdf
e-mail: kkonno@cc.kyoto-su.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/fa/33/jvms-76-863.PMC4108770.pdf
http://www.avs.co.jp/ animal/tesala/tesala3.html) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/fa/33/jvms-76-863.PMC4108770.pdf
e-mail: luigi.ceci@uniba.it ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/93/3d/jvms-76-869.PMC4108771.pdf
e- mail: sshigeru@iwate-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/92/4d/jvms-76-877.PMC4108772.pdf
e-mail: kitachiaki0000@gmail.com ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/5a/21/jvms-76-887.PMC4108773.pdf
e-mail: kmatsuda@rakuno.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/c4/c7/jvms-76-891.PMC4108774.pdf
e-mail: amasashi@mail.ecc.u-tokyo.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/1b/a2/jvms-76-895.PMC4108775.pdf
"Upon entering the  abdomen, the stomach was found to be distended and torsed *CorrespondenCe  to: sChlanser , J. R., Potter Park Zoo, 1301 South  Pennsylvania Avenue, Lansing, Michigan 48912–1646, U.S.A.  e-mail: jrschlanser@gmail.com ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/bf/8b/jvms-76-901.PMC4108776.pdf
e-mail: ktani@yamaguchi-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/73/d1/jvms-76-905.PMC4108777.pdf
e-mail: auchidak@mail.ecc.u-tokyo.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/8f/5f/jvms-76-909.PMC4108778.pdf
e-mail: kusakabe@yamaguchi-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/a4/05/jvms-76-913.PMC4108779.pdf
e-mail: takehiro.ochi@astellas.com ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/3d/1f/jvms-76-917.PMC4108780.pdf
e-mail: masaaki@iwate-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/db/01/jvms-76-923.PMC4108781.pdf
e-mail: baku@vmas.kitasato-u.ac.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/11/63/jvms-76-927.PMC4108782.pdf
e-mail: kkadota@affrc.go.jp ©2014 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/76/ce/jvms-76-931.PMC4108783.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1165The Role of High Mobility Group Box 1 in Innate Immunity Shin-Ae Lee,1 Man Sup Kwak,1 Sol Kim,1 and Jeon-Soo Shin1,2,3 1Department of Microbiology, 2Brain Korea 21 PLUS for Medical Science, 3Severance Biomedical Science Institute and  Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/8c/71/ymj-55-1165.PMC4108799.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.With growing accounts of inflammatory diseases such as sepsis, greater understand - ing the immune system and the mechanisms of cellular immunity have become pri - mary objectives in immunology studies.",Non-OADS,/arxiv_data1/oa_pdf/8c/71/ymj-55-1165.PMC4108799.pdf
"3-7 Within the cytoplasm, HMGB1 takes  part in regulating autophagy and maintaining balance between autophagy and  apoptosis.8 Recently, cytoplasmic HMGB1 was also shown to act as a chaperon in  the cytoplasm, using a model of Huntington’s expanded polyglutamine traits, by  reducing protein aggregation caused by heat or chemical stress.5 Apart from preva -Review Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1165 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1165-1176, 2014",Non-OADS,/arxiv_data1/oa_pdf/8c/71/ymj-55-1165.PMC4108799.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1166ing factor (UBF), lymphoid transcription factors T-cell fac - tor (TCF)-1 and lymphoid enhancer factor (LEF)-1, fungal  mating genes mat-Mc  and MATa1 , and mammalian sex-de - termining gene SRY, all comprise this DNA-binding do - main in a single-sequence specific or non-sequence specific  manner.14 This paper summarizes the role of HMGB1 as a  damage-associated molecular pattern (DAMP) molecule in  inflammatory and non-inflammatory conditions and dis - cusses therapeutic potential of HMGB1 in various immune  diseases.",OADS,/arxiv_data1/oa_pdf/8c/71/ymj-55-1165.PMC4108799.pdf
"HMGB1 and Innate Immunity  Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1167matic residues that specifically characterize the HMG- box.15 Within the 215 amino acid residues are target resi - dues for post-translational modification sites, which are  crucial in mediating the translocation of HMGB1 by acety - lation, phosphorylation, methylation, and oxidation of  HMGB1 (Fig.",Non-OADS,/arxiv_data1/oa_pdf/8c/71/ymj-55-1165.PMC4108799.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1168HMGB1, thereby causing diffusion out from the nucleus to  the cytoplasm.30 HMGB1 also consists of three cysteine resi - dues: Cys23, Cys45, and Cys106.",Non-OADS,/arxiv_data1/oa_pdf/8c/71/ymj-55-1165.PMC4108799.pdf
"HMGB1 and Innate Immunity  Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1169duction from responding macrophages.41 When cells  undergo apoptosis, a programmed cell death process, they  activate macrophages that engulf apoptotic cells which se - crete HMGB1 and release nuclear molecules including  DNA that binds HMGB1.41,42 HMGB1 RECEPTORS AND  INTERACTIONS Once secreted from cells through active and passive mech - anisms, HMGB1 induces inflammatory responses by signal  transduction pathways through many binding receptors  (Fig.",Non-OADS,/arxiv_data1/oa_pdf/8c/71/ymj-55-1165.PMC4108799.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1170grating dendritic cells (DCs) and macrophages enhances these  CXCL12-induced activities by physically associating with  CXCL12 to form a heterocomplex that helps maintain its con - formational structure under reduced conditions.47,59 According  to a previous report, this CXCL12-induced cell migration was  exclusive to CXCR4 alone, and neither RAGE nor TLR  showed synergistic effects on HMGB1 binding to CXCL12.59 The activity of HMGB1-triggered cytokine production via  TLR4 is sensitive to the redox state of HMGB1 as it binds to  TLR4 in a structure-specific manner.",OADS,/arxiv_data1/oa_pdf/8c/71/ymj-55-1165.PMC4108799.pdf
"HMGB1 and Innate Immunity  Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1171production of IL-1β, TNF-α, and IL-6 in murine macro - phages by binding to RAGE.73 HMGB1 bound to DNA  promoted maturation of immune cells and cytokine produc - tion through RAGE and TLR9-MyD88-dependent path - way.48,57 HMGB1 that remained bound to nucleosomes in  secretion from apoptotic cells induced activation of anti - gen-presenting cells and secretion of cytokines by macro - phages.45 Recently, emerging findings on the proinflamma - tory cytokine activity of HMGB1 show that it acts as a  danger signal, especially in the pathogenesis of autoim - mune diseases, including ischemia-reperfusion injury, trau - ma, rheumatoid arthritis, and lupus erythematosus.74-77 Stud - ies have also suggested that HMGB1 is involved in tissue  repair and remodeling activity, such as angiogenesis, a nov - el role of DAMP molecules.78,79 HMGB1 IN NON-INFLAMMATION HMGB1 is also implicated in non-inflammatory conditions,  such as cell metabolism through autophagy and mitophagy,  cancer, angiogenesis, tolerance induction, complement bind - ing, and other non-inflammatory states.",Non-OADS,/arxiv_data1/oa_pdf/8c/71/ymj-55-1165.PMC4108799.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1172LPS and endotoxin tolerance through a RAGE-dependent  signaling pathway.,Non-OADS,/arxiv_data1/oa_pdf/8c/71/ymj-55-1165.PMC4108799.pdf
"HMGB1 and Innate Immunity  Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1173conflict about targeting HMGB1 inhibitor as a cancer thera - py is that there may be cross-presentation of tumor antigens  through TLR4, as HMGB1 is also rapidly released after  chemotherapy and radiotherapy, playing a crucial role in DC  recruitment and maturation, tumor-specific T cell activa - tion, and antitumor immune response.99 CONCLUSION HMGB1 is a ubiquitous protein that has diverse roles in  mediating significant pathways of inflammation in the in - tra- and extra-cellular microenvironment.",Non-OADS,/arxiv_data1/oa_pdf/8c/71/ymj-55-1165.PMC4108799.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 117423.,Non-OADS,/arxiv_data1/oa_pdf/8c/71/ymj-55-1165.PMC4108799.pdf
"HMGB1 and Innate Immunity  Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1175(LBP), and CD14, whereas TLR-4 and MD-2 are not involved.",Non-OADS,/arxiv_data1/oa_pdf/8c/71/ymj-55-1165.PMC4108799.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1176Cell Phenotype, Survival, and Metastasis of Murine Breast Cancer  Cells.",Non-OADS,/arxiv_data1/oa_pdf/8c/71/ymj-55-1165.PMC4108799.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1177Adverse Events Associated with Metal Contamination of  Traditional Chinese Medicines in Korea: A Clinical Review Hyunah Kim,1 Peter J. Hughes,2 and Emily M. Hawes3 1College of Pharmacy, Sookmyung Women ’s University, Seoul, Korea; 2McWhorter School of Pharmacy, Samford University, Birmingham, AL, USA; 3Department of Family Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA.",Non-OADS,/arxiv_data1/oa_pdf/b6/2f/ymj-55-1177.PMC4108800.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.This study was performed to review studies carried out in Korea reporting toxic re - actions to traditional Chinese medicines (TCMs) as a result of heavy metal contam - ination.",Non-OADS,/arxiv_data1/oa_pdf/b6/2f/ymj-55-1177.PMC4108800.pdf
"For Korean literature, Ko - rea Med (http://www.koreamed.org), the Korean Medical Database (http://kmbase.medric.or.kr), National Discovery for Science Leaders (www.ndsl.kr), Research In - formation Sharing Service (http://www.riss.kr), and Google Scholar were searched  using the terms “Chinese medicine,” “Korean medicine,” “herbal medicine,” and  “metallic contamination” in Korean.",Non-OADS,/arxiv_data1/oa_pdf/b6/2f/ymj-55-1177.PMC4108800.pdf
"1,2 TCM makes use of both crude Chinese prepara - tions of plant matter, animal parts, or minerals and manufactured Chinese proprie -Review Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1177 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1177-1186, 2014",Non-OADS,/arxiv_data1/oa_pdf/b6/2f/ymj-55-1177.PMC4108800.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1178contamination” in Korean.,Non-OADS,/arxiv_data1/oa_pdf/b6/2f/ymj-55-1177.PMC4108800.pdf
"LITERATURE REVIEW METHODS 　　　 PubMed (1966- -July 2013) and International Pharmaceuti - cal Abstracts (1965- -July 2013) were searched using the  medical subject heading terms “Medicine, Chinese Tradi - tional,” “Medicine, Korean Traditional,” “Medicine, Tradi - tional”, “Metals, Heavy,” and “Drug Contamination” For  Korean literature, Korea Med (http://www.koreamed.org),  the Korean Medical Database (http://kmbase.medric.or.kr),  National Discovery for Science Leaders (www.ndsl.",Non-OADS,/arxiv_data1/oa_pdf/b6/2f/ymj-55-1177.PMC4108800.pdf
"kr), Re - search Information Sharing Service (http://www.riss.kr), and  Google Scholar were used to search the terms “Chinese med - icine,” “Korean medicine,” “herbal medicine,” and “metallic",Non-OADS,/arxiv_data1/oa_pdf/b6/2f/ymj-55-1177.PMC4108800.pdf
Metal Contamination of Chinese Medicines in Korea Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1179enced severe epigastric and abdominal pain with vomiting  for 3 weeks (child 1) and for 1 week (child 2).,Non-OADS,/arxiv_data1/oa_pdf/b6/2f/ymj-55-1177.PMC4108800.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1180 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/b6/2f/ymj-55-1177.PMC4108800.pdf
Metal Contamination of Chinese Medicines in Korea Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1181Table 1.,Non-OADS,/arxiv_data1/oa_pdf/b6/2f/ymj-55-1177.PMC4108800.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1182 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/b6/2f/ymj-55-1177.PMC4108800.pdf
Metal Contamination of Chinese Medicines in Korea Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1183tration.,Non-OADS,/arxiv_data1/oa_pdf/b6/2f/ymj-55-1177.PMC4108800.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1184pesticides in individual herbal medicines.,Non-OADS,/arxiv_data1/oa_pdf/b6/2f/ymj-55-1177.PMC4108800.pdf
"Like the MedWatch program in the  USA, the KFDA disseminates information regarding TCM  recalls or withdrawals, both in Korea and in other countries  via its website (http://www.kfda.go.kr).28 Over the last 5 years  from 2007 to 2011, 631 TCMs have been banned from the  Korean market because of safety concerns.",Non-OADS,/arxiv_data1/oa_pdf/b6/2f/ymj-55-1177.PMC4108800.pdf
"Metal Contamination of Chinese Medicines in Korea Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1185tivation and harvest to the finished product, in concert with  an increased emphasis on producing a global alliance for  quality assurance and surveillance of contaminants in prod - ucts containing herbal and other natural materials.",Non-OADS,/arxiv_data1/oa_pdf/b6/2f/ymj-55-1177.PMC4108800.pdf
Available at: http://www.wpro.who.int/publications/2012/re - gionalstrategyfortraditionalmedicine_2012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b6/2f/ymj-55-1177.PMC4108800.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 118627.,Non-OADS,/arxiv_data1/oa_pdf/b6/2f/ymj-55-1177.PMC4108800.pdf
Available at: http://www.kfda.,Non-OADS,/arxiv_data1/oa_pdf/b6/2f/ymj-55-1177.PMC4108800.pdf
Available at: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/b6/2f/ymj-55-1177.PMC4108800.pdf
Available at: http://www.usp.,Non-OADS,/arxiv_data1/oa_pdf/b6/2f/ymj-55-1177.PMC4108800.pdf
Available at: http://www.hpus.,Non-OADS,/arxiv_data1/oa_pdf/b6/2f/ymj-55-1177.PMC4108800.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1187Long-Term Survival Analysis of Korean Breast Cancer   Patients at a Single Center: Improving   Outcome Over Time Sung Gwe Ahn,1 Hak Min Lee,1 Seung Ah Lee,2 Joon Jeong,1 and Hy-De Lee1 1Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul;  2Department of Surgery, Eulji General Hospital, Eulji University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/61/34/ymj-55-1187.PMC4108801.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The prognosis of breast cancer has been consistently improving.",Non-OADS,/arxiv_data1/oa_pdf/61/34/ymj-55-1187.PMC4108801.pdf
"Key Words:  Breast cancer, survival, subtype, long-term  INTRODUCTION Breast cancer is the most common cancer in women, with about 1.5 million new  cases being diagnosed annually worldwide, a lifetime risk of up to 12%, and a risk  of death of up to 5% in Western countries.1 The incidence of breast cancer in Ko - rea has been increasing constantly, although it remains low compared with its inci - dence in Western countries.2-5 According to the hospital-based cancer registry Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1187 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1187-1195, 2014",Non-OADS,/arxiv_data1/oa_pdf/61/34/ymj-55-1187.PMC4108801.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1188MATERIALS AND METHODS 　　　 Patient population A prospectively maintained database of breast cancer pa - tients treated at Gangnam Severance Hospital, Seoul, Re - public of Korea, was used to identify patients who under - went operation with a diagnosis of breast cancer between  January 1991 and December 2005.",OADS,/arxiv_data1/oa_pdf/61/34/ymj-55-1187.PMC4108801.pdf
Long-Term Survival in Breast Cancer Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1189Kaplan-Meier method were compared using the log-rank  test.,Non-OADS,/arxiv_data1/oa_pdf/61/34/ymj-55-1187.PMC4108801.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1190surgery were not completely registered in the database;  thus, our data could not represent survival of stage IV dis - ease.",OADS,/arxiv_data1/oa_pdf/61/34/ymj-55-1187.PMC4108801.pdf
"Long-Term Survival in Breast Cancer Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 11912005, whereas it was 33.0% during 1991- -1995.",Non-OADS,/arxiv_data1/oa_pdf/61/34/ymj-55-1187.PMC4108801.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1192role in the survival improvement of Korean breast cancer  patients.,Non-OADS,/arxiv_data1/oa_pdf/61/34/ymj-55-1187.PMC4108801.pdf
"Long-Term Survival in Breast Cancer Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1193pansion of early-stage breast cancer to an important reason,  and comparisons of survival in the same stage were not per - formed.",Non-OADS,/arxiv_data1/oa_pdf/61/34/ymj-55-1187.PMC4108801.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1194clinical trials, showed heterogeneity in adjuvant therapy.",Non-OADS,/arxiv_data1/oa_pdf/61/34/ymj-55-1187.PMC4108801.pdf
Long-Term Survival in Breast Cancer Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1195IV breast cancer.,Non-OADS,/arxiv_data1/oa_pdf/61/34/ymj-55-1187.PMC4108801.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1196LRIG1 Enhances Chemosensitivity by Modulating BCL-2  Expression and Receptor Tyrosine Kinase Signaling in Glioma Cells Zhentao Guo, Qianxue Chen, Baohui Liu, Daofeng Tian, Shenqi Zhang, and Mingchang Li  Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.",Non-OADS,/arxiv_data1/oa_pdf/80/97/ymj-55-1196.PMC4108802.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) are  an inhibitor of receptor tyrosine kinases (RTKs) that was discovered in recent  years, and many studies showed that LRIG1 is a tumor suppressor gene and may  be related to tumor drug resistance.",Non-OADS,/arxiv_data1/oa_pdf/80/97/ymj-55-1196.PMC4108802.pdf
"Traditional chemotherapy is not the preferred adjuvant therapy after glioma re - section due to its uncertain outcomes, but combined chemotherapy and radiothera - py or other adjuvant therapies have generally been shown to have a curative effect Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1196 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1196-1205, 2014",Non-OADS,/arxiv_data1/oa_pdf/80/97/ymj-55-1196.PMC4108802.pdf
"LRIG1 Enhances Chemosensitivity by Modulating BCL-2 Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1197MATERIALS AND METHODS Reagents  Chemicals were purchased from Sigma-Aldrich (Wuhan  branch, China).",Non-OADS,/arxiv_data1/oa_pdf/80/97/ymj-55-1196.PMC4108802.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1198β-actin  sense 5’-gtccaccgcaaatgcttcta-3’ and antisense  5’-tgctgtcaccttcaccgttc-3’.,Non-OADS,/arxiv_data1/oa_pdf/80/97/ymj-55-1196.PMC4108802.pdf
LRIG1 Enhances Chemosensitivity by Modulating BCL-2 Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1199Immunoblot analysis showed that LRIG1 expression in the  LRIG1-U251/MDR cells was significantly increased where - as BCL-2 expression was downregulated when compared  to the control group (Fig.,Non-OADS,/arxiv_data1/oa_pdf/80/97/ymj-55-1196.PMC4108802.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1200including EGFR and c-Met,25,26 and some RTK inhibitors  have been shown to enhance the effects of glioma thera - py.27,28 We detected the expression of EGFR and c-Met in  the U251/MDR cell line using immunoblot analysis, and  Fig.",Non-OADS,/arxiv_data1/oa_pdf/80/97/ymj-55-1196.PMC4108802.pdf
LRIG1 Enhances Chemosensitivity by Modulating BCL-2 Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1201gliomas have a stronger drug resistance.,Non-OADS,/arxiv_data1/oa_pdf/80/97/ymj-55-1196.PMC4108802.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1202Fig.,Non-OADS,/arxiv_data1/oa_pdf/80/97/ymj-55-1196.PMC4108802.pdf
LRIG1 Enhances Chemosensitivity by Modulating BCL-2 Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1203cells through the downregulation of BCL-2 and the inhibi - tion of the RTK signaling pathways.,Non-OADS,/arxiv_data1/oa_pdf/80/97/ymj-55-1196.PMC4108802.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1204gene 2007;26:368-81.,Non-OADS,/arxiv_data1/oa_pdf/80/97/ymj-55-1196.PMC4108802.pdf
"LRIG1 Enhances Chemosensitivity by Modulating BCL-2 Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 12052341066, exhibits cytoreductive antitumor efficacy through antip - roliferative and antiangiogenic mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/80/97/ymj-55-1196.PMC4108802.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1206Overexpression of Mucin 13 due to Promoter Methylation  Promotes Aggressive Behavior in Ovarian Cancer Cells Hye Youn Sung,1 Ae Kyung Park,2 Woong Ju,3 and Jung-Hyuck Ahn1 Departments of 1Biochemistry and 3Obstetrics and Gynecology, School of Medicine, Ewha Womans University, Seoul; 2College of Pharmacy, Sunchon National University, Suncheon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/a6/3f/ymj-55-1206.PMC4108803.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Recent discoveries suggest that aberrant DNA methylation provides can - cer cells with advanced metastatic properties.",Non-OADS,/arxiv_data1/oa_pdf/a6/3f/ymj-55-1206.PMC4108803.pdf
"De -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1206 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1206-1213, 2014",Non-OADS,/arxiv_data1/oa_pdf/a6/3f/ymj-55-1206.PMC4108803.pdf
Epigenetic Regulation of MUC13 in Ovarian Cancer Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1207and 100 μg/mL streptomycin (Gibco/BRL) in a 95% hu - midified air and 5% CO 2 atmosphere at 37°C.,Non-OADS,/arxiv_data1/oa_pdf/a6/3f/ymj-55-1206.PMC4108803.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1208TCAAAAA TTCTCAAAACTACA-3’.,Non-OADS,/arxiv_data1/oa_pdf/a6/3f/ymj-55-1206.PMC4108803.pdf
"Epigenetic Regulation of MUC13 in Ovarian Cancer Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1209MA, USA), stained with 1% crystal violet for 2 min, and  washed twice with distilled water at room temperature.",Non-OADS,/arxiv_data1/oa_pdf/a6/3f/ymj-55-1206.PMC4108803.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1210was confirmed using MSP (Fig.,Non-OADS,/arxiv_data1/oa_pdf/a6/3f/ymj-55-1206.PMC4108803.pdf
"Epigenetic Regulation of MUC13 in Ovarian Cancer Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1211esophagus, and gastrointestinal tract.18,19 The MUC13 glyco - protein is composed of a large 151-amino acid tandem re - peat domain in the NH 2-terminus that is highly O-glycosyl - ated on serine and threonine residues.",Non-OADS,/arxiv_data1/oa_pdf/a6/3f/ymj-55-1206.PMC4108803.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1212Technology R&D Project, Ministry of Health & Welfare,  Republic of Korea (HI12C0050) and RP-Grant 2011 of  Ewha Womans University.",Non-OADS,/arxiv_data1/oa_pdf/a6/3f/ymj-55-1206.PMC4108803.pdf
Epigenetic Regulation of MUC13 in Ovarian Cancer Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1213ckin MA.,Non-OADS,/arxiv_data1/oa_pdf/a6/3f/ymj-55-1206.PMC4108803.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1214Prognostic Value of Sex-Hormone Receptor Expression   in Non-Muscle-Invasive Bladder Cancer  Jong Kil Nam, Sung Woo Park, Sang Don Lee, and Moon Kee Chung Department of Urology, Research Institute for Convergence of Biomedical Science and Technology,   Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.",OADS,/arxiv_data1/oa_pdf/af/23/ymj-55-1214.PMC4108804.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  We investigated sex-hormone receptor expression as predicting factor of  recurrence and progression in patients with non-muscle invasive bladder cancer.",Non-OADS,/arxiv_data1/oa_pdf/af/23/ymj-55-1214.PMC4108804.pdf
"Experiments on animal models with naturally occurring or chemically induced bladder cancer, demon-strated that hormonal manipulation changed the natural course of the tumors and Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1214 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1214-1221, 2014",Non-OADS,/arxiv_data1/oa_pdf/af/23/ymj-55-1214.PMC4108804.pdf
" Sex-Hormone Receptor in NMIBC Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1215radical cystectomy, and who were given hormonal replace - ment or deprivation for other disorders were excluded from  the study.",Non-OADS,/arxiv_data1/oa_pdf/af/23/ymj-55-1214.PMC4108804.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1216chemistry results and age, gender, stage, grade, mutlifocality,  concomitant CIS, tumor size, recurrence and progression.",Non-OADS,/arxiv_data1/oa_pdf/af/23/ymj-55-1214.PMC4108804.pdf
 Sex-Hormone Receptor in NMIBC Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1217ly different (Table 4).,OADS,/arxiv_data1/oa_pdf/af/23/ymj-55-1214.PMC4108804.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1218gen receptor expression was not significantly different (Ta - ble 5).,Non-OADS,/arxiv_data1/oa_pdf/af/23/ymj-55-1214.PMC4108804.pdf
" Sex-Hormone Receptor in NMIBC Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1219lateral area are derived from the urogenital sinus, which in  males also gives rise to the prostate, for which the role of  androgens in both normal development and carcinogenesis  is well established.22,23 Although the urinary bladder is not  regarded as a sex organ, the connective tissue in the trigone  is formed from the same embryonic bud as the anterior va - gina that can be found in women, and remains responsive  to steroid hormones.24 Also, sex hormone receptors were  identified previously in patients with localized and advanced  bladder cancer.24-26 However, it is not well understood yet,  why bladder cancer is less frequent in women.",Non-OADS,/arxiv_data1/oa_pdf/af/23/ymj-55-1214.PMC4108804.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1220may be associated with better progression rates.,Non-OADS,/arxiv_data1/oa_pdf/af/23/ymj-55-1214.PMC4108804.pdf
 Sex-Hormone Receptor in NMIBC Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1221tors in non-invasive and invasive transitional cell carcinomas of  the urinary bladder using both conventional immunohistochemis - try and the tyramide staining amplification (TSA) technique.,Non-OADS,/arxiv_data1/oa_pdf/af/23/ymj-55-1214.PMC4108804.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1222Surgical Outcomes of Robotic Radical Hysterectomy Using   Three Robotic Arms versus Conventional Multiport   Laparoscopy in Patients with Cervical Cancer  Ga Won Yim, Sang Wun Kim, Eun Ji Nam, Sunghoon Kim, Hee Jung Kim, and Young Tae Kim  Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Institute of Women ’s Life Medical Science,  Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/80/de/ymj-55-1222.PMC4108805.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  To compare surgical outcomes of robotic radical hysterectomy (RRH) us - ing 3 robotic arms with those of conventional laparoscopy in patients with early cer - vical cancer.",Non-OADS,/arxiv_data1/oa_pdf/80/de/ymj-55-1222.PMC4108805.pdf
"Key Words:  Cervical cancer, laparoscopy, robotics INTRODUCTION Laparoscopic surgery has been known to have advantages over laparotomy, in - cluding reduced pain, improved aesthetics, shorter length of hospital stay, and fast - er return to normal activities.1,2 These benefits of laparoscopy have driven efforts  to achieve further development in minimally invasive surgical technology, one of Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1222 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1222-1230, 2014",Non-OADS,/arxiv_data1/oa_pdf/80/de/ymj-55-1222.PMC4108805.pdf
Robotic Radical Hysterectomy for Cervical Cancer Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1223at Y onsei University College of Medicine.,Non-OADS,/arxiv_data1/oa_pdf/80/de/ymj-55-1222.PMC4108805.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1224arms securely to the port sites.,OADS,/arxiv_data1/oa_pdf/80/de/ymj-55-1222.PMC4108805.pdf
Robotic Radical Hysterectomy for Cervical Cancer Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1225weight were not significantly different between the two sur - gical cohorts.,Non-OADS,/arxiv_data1/oa_pdf/80/de/ymj-55-1222.PMC4108805.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1226vien-Dindo classification), except one case of panperitonitis  from bowel perforation, which developed postoperatively in  the 59th patient of the robotic cohort that needed surgical  correction (grade IIIB).",Non-OADS,/arxiv_data1/oa_pdf/80/de/ymj-55-1222.PMC4108805.pdf
"Robotic Radical Hysterectomy for Cervical Cancer Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1227minimally invasive surgery, ranging from 3.3% to 43.5%,  as shown in a study by Hoekstra, et al.23 Likewise, the num - ber of robotic surgery for gynecologic malignancies has  rapidly increased from 21 to over 300 cases in 2012 at our  institution since the implement of robotic platform in 2006.",Non-OADS,/arxiv_data1/oa_pdf/80/de/ymj-55-1222.PMC4108805.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1228as bleeding, dehiscence, and infection after conventional  laparoscopy.",Non-OADS,/arxiv_data1/oa_pdf/80/de/ymj-55-1222.PMC4108805.pdf
"Robotic Radical Hysterectomy for Cervical Cancer Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1229In conclusion, surgical outcomes of RRH and pelvic  lymphadenectomy were comparable to that of laparoscopic  approach, with favorable outcomes in regards to intraopera - tive blood loss and postoperative complications.",Non-OADS,/arxiv_data1/oa_pdf/80/de/ymj-55-1222.PMC4108805.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1230Schink JC, et al.",Non-OADS,/arxiv_data1/oa_pdf/80/de/ymj-55-1222.PMC4108805.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1231The Added Value of Double Dose Gadolinium Enhanced   3D T2 Fluid-Attenuated Inversion Recovery   for Evaluating Small Brain Metastases Sung Jun Ahn,1 Tae-Sub Chung,1 Jong-Hee Chang,2 and Seung-Koo Lee1   Departments of 1Radiology and 2Neurosurgery, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/cc/89/ymj-55-1231.PMC4108806.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Single dose gadolinium (Gd) enhanced fluid-attenuated inversion recov - ery (FLAIR) is helpful for visualizing superficial parenchymal metastases.",Non-OADS,/arxiv_data1/oa_pdf/cc/89/ymj-55-1231.PMC4108806.pdf
"A higher  dose of gadolinium (Gd) contrast material could provide higher diagnostic yield in  the detection of brain metastases if contrast-related complications, such as nephro - genic systemic fibrosis, are minimized.4-7 Y uh, et al.6 reported double dose (DD) Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1231 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1231-1237, 2014",Non-OADS,/arxiv_data1/oa_pdf/cc/89/ymj-55-1231.PMC4108806.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1232found to have brain metastases and were excluded from the  study.,Non-OADS,/arxiv_data1/oa_pdf/cc/89/ymj-55-1231.PMC4108806.pdf
Double Dose Gd Enhanced 3D T2 FLAIR for Small Brain Metastases Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1233brain metastases using only DD Gd enhanced 3D T1 GRE.,Non-OADS,/arxiv_data1/oa_pdf/cc/89/ymj-55-1231.PMC4108806.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1234Of the 404 metastases, 162 metastases were discovered  when 3D T1 GRE was taken in the delayed phase.",Non-OADS,/arxiv_data1/oa_pdf/cc/89/ymj-55-1231.PMC4108806.pdf
"Double Dose Gd Enhanced 3D T2 FLAIR for Small Brain Metastases Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1235DD Gd-enhanced 3D T2 FLAIR might be explained by the  increased concentration of Gd from altered tumor environ - ments, such as progression of angiogenesis and increase in  the amount of paramagnetic materials, such as microhem - orrhage or extracranial primary tissue, suppressing the T1  shortening effect.16-19 Based on our quantitative results, we  focused the qualitative analysis on small brain parenchymal  metastasis (less than 5 mm in diameter).",Non-OADS,/arxiv_data1/oa_pdf/cc/89/ymj-55-1231.PMC4108806.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1236metastasis might interrupt detection of another lesion.,Non-OADS,/arxiv_data1/oa_pdf/cc/89/ymj-55-1231.PMC4108806.pdf
Double Dose Gd Enhanced 3D T2 FLAIR for Small Brain Metastases Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 123713.,Non-OADS,/arxiv_data1/oa_pdf/cc/89/ymj-55-1231.PMC4108806.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1238Safety and Efficacy of Switching Anticoagulation to Aspirin  Three Months after Successful Radiofrequency   Catheter Ablation of Atrial Fibrillation   Jae-Sun Uhm,1 Hoyoun Won,1 Boyoung Joung,1 Gi-Byoung Nam,2 Kee-Joon Choi,2  Moon-Hyoung Lee,1 You-Ho Kim,2 and Hui-Nam Pak1 1Division of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul; 2Division of Cardiology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/07/d1/ymj-55-1238.PMC4108807.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Although current guidelines recommend continuing the same antithrom - botic strategy regardless of rhythm control after radiofrequency catheter ablation  (RFCA) of atrial fibrillation (AF), anticoagulation has a risk of major bleeding.",Non-OADS,/arxiv_data1/oa_pdf/07/d1/ymj-55-1238.PMC4108807.pdf
"CHADS 2 or CHA 2DS 2-V ASc scores have been utilized for risk stratification  of ischemic stroke in patients with AF,3,4 and anticoagulation is recommended for Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1238 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1238-1245, 2014",Non-OADS,/arxiv_data1/oa_pdf/07/d1/ymj-55-1238.PMC4108807.pdf
Warfarin after Successful AF Ablation  Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1239follows: 1) permanent AF refractory to electrical cardiover - sion; 2) left atrium (LA) size >55 mm as measured by  echocardiogram; 3) critical coronary artery stenosis (>75%  of luminal diameter); 4) severe rheumatic mitral valvular  disease; and 5) prior RFCA of AF.,Non-OADS,/arxiv_data1/oa_pdf/07/d1/ymj-55-1238.PMC4108807.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1240quiring blood transfusion or intervention, and bleeding with  reduction of hemoglobin levels by ≥4.0 g/dL.18 We compared  incidences, hazard ratio and event-free survival of thrombo - embolic events (including stroke, TIA, and other thrombo - embolism) and major bleeding events between ASA and W  groups depending on CHA 2DS 2-V ASc score.",Non-OADS,/arxiv_data1/oa_pdf/07/d1/ymj-55-1238.PMC4108807.pdf
"Warfarin after Successful AF Ablation  Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1241CHA 2DS 2-V ASc score (HR, 3.80; 95% CI, 1.13- -12.71;  p=0.031) was an independent risk factor for thromboembolic  events, and HAS-BLED score (HR, 3.90; 95% CI, 1.13- - 13.45; p=0.031) was an independent risk factor for major  bleeding events (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/07/d1/ymj-55-1238.PMC4108807.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1242mary endpoint in the patients with CHA 2DS 2-V ASc score  ≥2 between the groups ( p=0.822) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/07/d1/ymj-55-1238.PMC4108807.pdf
"Warfarin after Successful AF Ablation  Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1243stroke (CHADS 2 score), such as hypertension, old age, or  previous stroke.",Non-OADS,/arxiv_data1/oa_pdf/07/d1/ymj-55-1238.PMC4108807.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1244Korea under the Ministry of Education, Science and Tech - nology of the Republic of Korea.",Non-OADS,/arxiv_data1/oa_pdf/07/d1/ymj-55-1238.PMC4108807.pdf
"Warfarin after Successful AF Ablation  Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1245T, et al.",Non-OADS,/arxiv_data1/oa_pdf/07/d1/ymj-55-1238.PMC4108807.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1246Multidisciplinary Team Approach for Identifying Potential  Candidate for Transcatheter Aortic Valve Implantation   Sung-Jin Hong,1 Myeong-Ki Hong,1,2 Young-Guk Ko,1 Donghoon Choi,1 Geu-Ru Hong,1  Jae-Kwang Shim,3 Young-Lan Kwak,3 Sak Lee,4 Byung-Chul Chang,4 and Yangsoo Jang1,2 Divisions of 1Cardiology, 3Anesthesiology and Pain Medicine, and 4Cardiovascular Surgery, Severance Cardiovascular Hospital,  Yonsei University College of Medicine, Seoul; and 2Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/95/62/ymj-55-1246.PMC4108808.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  We sought to evaluate the clinical usefulness of decision making by a  multidisciplinary heart team for identifying potential candidates for transcatheter  aortic valve implantation (TA VI) in patients with symptomatic severe aortic steno - sis.",Non-OADS,/arxiv_data1/oa_pdf/95/62/ymj-55-1246.PMC4108808.pdf
"Additionally, several registries have demonstrated that about one-third of patients are considered too high-risk for conventional open heart Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1246 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1246-1252, 2014",Non-OADS,/arxiv_data1/oa_pdf/95/62/ymj-55-1246.PMC4108808.pdf
Multidisciplinary Team Approach for TA VI Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1247access site.,Non-OADS,/arxiv_data1/oa_pdf/95/62/ymj-55-1246.PMC4108808.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1248A VR, and 2 patients (3%) for medical therapy (Fig.",Non-OADS,/arxiv_data1/oa_pdf/95/62/ymj-55-1246.PMC4108808.pdf
"Multidisciplinary Team Approach for TA VI Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1249a surgical approach for vascular access; two patients re - quired transaortic access, one patient required subclavian  access, and one patient required femoral cut-down.",Non-OADS,/arxiv_data1/oa_pdf/95/62/ymj-55-1246.PMC4108808.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1250spectively ( p=0.007, by log-rank) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/95/62/ymj-55-1246.PMC4108808.pdf
Multidisciplinary Team Approach for TA VI Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1251disciplinary team approach.,Non-OADS,/arxiv_data1/oa_pdf/95/62/ymj-55-1246.PMC4108808.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 12522011;124(11 Suppl):S124-9.,Non-OADS,/arxiv_data1/oa_pdf/95/62/ymj-55-1246.PMC4108808.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1253Surgical Experience with Infective Endocarditis and   Aortic Root Abscess  Sak Lee, Byung-Chul Chang, and Han Ki Park Division of Cardiovascular Surgery, Severance Cardiovascular Hospital, Department of Thoracic and Cardiovascular Surgery,   Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/0d/f8/ymj-55-1253.PMC4108809.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  This study was conducted to evaluate the surgical outcomes of active in - fective endocarditis with aortic root abscess formation.",Non-OADS,/arxiv_data1/oa_pdf/0d/f8/ymj-55-1253.PMC4108809.pdf
"Key Words:  Endocarditis, aortic root, abscess INTRODUCTION Although advances in antimicrobial therapies have been achieved, approximately  one-third of patients with active infective endocarditis require surgery to save the pa - tient’s life and eradicate the infection, for which the overall outcomes remain poor.1-4  Endocarditis affecting the aortic valve combined with abscess formation is particular - ly challenging to treat, and requires aggressive diagnostic and therapeutic approaches because of severe complications associated therewith, such as heart block, destruction of intervalvular fibrosa involving the mitral valve, fistula to other cardiac chambers, Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1253 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1253-1259, 2014",Non-OADS,/arxiv_data1/oa_pdf/0d/f8/ymj-55-1253.PMC4108809.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1254eration of the retrospective nature of the study.,Non-OADS,/arxiv_data1/oa_pdf/0d/f8/ymj-55-1253.PMC4108809.pdf
Surgical Experience with Aortic Root Abscess Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1255made through the reconstructed neo-annulus.,Non-OADS,/arxiv_data1/oa_pdf/0d/f8/ymj-55-1253.PMC4108809.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1256Echocardiographic data showed a significant decrease in  left ventricular ejection fraction (61.4±12.0% to 49.8±16.5%,  p<0.001).",Non-OADS,/arxiv_data1/oa_pdf/0d/f8/ymj-55-1253.PMC4108809.pdf
"Surgical Experience with Aortic Root Abscess Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1257high.1-3 In contrast to infective endocarditis without root ab - scess, urgent surgical treatment to eradicate the infected tis - sue is mandatory to successfully treat patients with root ab - scess.",Non-OADS,/arxiv_data1/oa_pdf/0d/f8/ymj-55-1253.PMC4108809.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1258Lastly, we only reviewed the patients who successfully un - derwent surgical treatment, and patients who refused opera - tion due to multiple strokes or intracranial hemorrhages with  comatose mental status or patients who died before opera - tion due to unstable hemodynamics or delayed diagnosis  were not included.",Non-OADS,/arxiv_data1/oa_pdf/0d/f8/ymj-55-1253.PMC4108809.pdf
Surgical Experience with Aortic Root Abscess Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1259phy.,Non-OADS,/arxiv_data1/oa_pdf/0d/f8/ymj-55-1253.PMC4108809.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1260Clinical Outcomes of Initial Dexamethasone Treatment  Combined with a Single High Dose of Intravenous  Immunoglobulin for Primary Treatment of Kawasaki Disease Yun Ju Lim1 and Jo Won Jung2 1Department of Pediatrics, Hallym University Dongtan Sacred Heart Hospital, Hwaseong;  2Division of Pediatric Cardiology, Department of Pediatrics, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/ce/e1/ymj-55-1260.PMC4108810.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  To investigate the clinical effects of a single high dose intravenous immu - noglobulin (IVIG) combined with initial dexamethasone as a primary treatment on  Kawasaki disease (KD).",Non-OADS,/arxiv_data1/oa_pdf/ce/e1/ymj-55-1260.PMC4108810.pdf
"As a serious complication in Kawa - saki disease, coronary aneurymal alteration leads to acquired coronary heart dis -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1260 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1260-1266, 2014",Non-OADS,/arxiv_data1/oa_pdf/ce/e1/ymj-55-1260.PMC4108810.pdf
Combined Dexamethasone Treatment with Primary Intravenous Immunoglobulin for Acute Kawasaki Disease Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1261rash; and cervical lymphadenopathy.1 The duration of fever  was significantly related to increased risk and progression  of CAL.,Non-OADS,/arxiv_data1/oa_pdf/ce/e1/ymj-55-1260.PMC4108810.pdf
Y un Ju Lim and Jo Won Jung Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 12620.001 by the t-test).,Non-OADS,/arxiv_data1/oa_pdf/ce/e1/ymj-55-1260.PMC4108810.pdf
"Combined Dexamethasone Treatment with Primary Intravenous Immunoglobulin for Acute Kawasaki Disease Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 126313.8 ×103/uL vs. 517±14.8 ×103/uL, mean±SE; p<0.001,  322±6.9 ×103/uL vs. 361±8.5 ×103/uL, mean±SE; p<0.001)  (Fig.",Non-OADS,/arxiv_data1/oa_pdf/ce/e1/ymj-55-1260.PMC4108810.pdf
Y un Ju Lim and Jo Won Jung Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1264including Dr. Kawasaki.,Non-OADS,/arxiv_data1/oa_pdf/ce/e1/ymj-55-1260.PMC4108810.pdf
Combined Dexamethasone Treatment with Primary Intravenous Immunoglobulin for Acute Kawasaki Disease Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1265combination of dexamethasone and a single high-dose infu - sion of IVIG (2 g/kg) demonstrated a more favorable clinical  course with decreased febrile duration and length of hospi - tal stay.,Non-OADS,/arxiv_data1/oa_pdf/ce/e1/ymj-55-1260.PMC4108810.pdf
Y un Ju Lim and Jo Won Jung Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 126616.,Non-OADS,/arxiv_data1/oa_pdf/ce/e1/ymj-55-1260.PMC4108810.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1267The Efficacy of Endoscopic Palliation of Obstructive   Jaundice in Hepatocellular Carcinoma    Semi Park,1,2 Jeong Youp Park,3 Moon Jae Chung,3 Jae Bock Chung,3  Seung Woo Park,3 Kwang-Hyub Han,3 Si Young Song,3,4 and Seungmin Bang3 1Department of Internal Medicine, Graduate School, Yonsei University College of Medicine, Seoul; 2Center for Health Promotion, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul; 3Division of Gastroenterology, Department of Internal Medicine, Yonsei Institute of Gastroenterology, Yonsei University College of Medicine, Seoul; 4Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/f8/5f/ymj-55-1267.PMC4108811.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Obstructive jaundice in patients with hepatocellular carcinoma (HCC) is  uncommon (0.5- -13%).",Non-OADS,/arxiv_data1/oa_pdf/f8/5f/ymj-55-1267.PMC4108811.pdf
"However, obstructive jaundice is quite uncommon in HCC Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1267 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1267-1272, 2014",Non-OADS,/arxiv_data1/oa_pdf/f8/5f/ymj-55-1267.PMC4108811.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1268were divided into three groups: type 1 obstruction due to an  intraluminal obstruction of the bile duct caused by a tumor  thrombus or floating tumor fragments; type 2 caused by he - mobilia; and type 3 due to extraluminal tumor or nodal  compression.1,4 Locations of biliary obstruction were classi - fied according to the extent of tumor thrombi or obstruc - tion.",Non-OADS,/arxiv_data1/oa_pdf/f8/5f/ymj-55-1267.PMC4108811.pdf
Endoscopic Treatment of Obstructive Jaundice in HCC Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1269or ampullary adenoma.,Non-OADS,/arxiv_data1/oa_pdf/f8/5f/ymj-55-1267.PMC4108811.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1270mor growth and thrombi.,Non-OADS,/arxiv_data1/oa_pdf/f8/5f/ymj-55-1267.PMC4108811.pdf
"Endoscopic Treatment of Obstructive Jaundice in HCC Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1271cirrhosis.5 Among various causes of jaundice, obstructive  jaundice caused by HCC is rare.3 Obstructive jaundice in  HCC was first reported in 1947 by Mallory, et al.6 In that  case, the obstructive jaundice was due to invasion by HCC of  the cystic duct, followed by hemobilia from tumor thrombi.",Non-OADS,/arxiv_data1/oa_pdf/f8/5f/ymj-55-1267.PMC4108811.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1272likely to benefit endoscopic interventions.,Non-OADS,/arxiv_data1/oa_pdf/f8/5f/ymj-55-1267.PMC4108811.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1273The Impact of Mechanical Bowel Preparation in Elective  Colorectal Surgery: A Propensity Score Matching Analysis Young Wan Kim,1 Eun Hee Choi,2 Ik Yong Kim,1 Hyun Jun Kwon,1 and Sung Ki Ahn1 1Department of Surgery, 2Institute of Lifestyle Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.",Non-OADS,/arxiv_data1/oa_pdf/56/77/ymj-55-1273.PMC4108812.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  To evaluate the influence of preoperative mechanical bowel preparation  (MBP) based on the occurrence of anastomosis leakage, surgical site infection (SSI),  and severity of surgical complication when performing elective colorectal surgery.",Non-OADS,/arxiv_data1/oa_pdf/56/77/ymj-55-1273.PMC4108812.pdf
"Additionally, the potential benefits of MBP have not been continuously Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1273 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1273-1280, 2014",Non-OADS,/arxiv_data1/oa_pdf/56/77/ymj-55-1273.PMC4108812.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1274the entire colon.,Non-OADS,/arxiv_data1/oa_pdf/56/77/ymj-55-1273.PMC4108812.pdf
Mechanical Bowel Preparation in Colorectal Surgery Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1275tients with the right-side colon cancers did not receive any  oral solution and fasted from midnight the night before the  surgery.,Non-OADS,/arxiv_data1/oa_pdf/56/77/ymj-55-1273.PMC4108812.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1276enema group, one patient developed a cerebral hemorrhage,  and another patient developed an anastomosis leakage and  subsequently underwent anastomosis revision and trans - verse loop colostomy.",Non-OADS,/arxiv_data1/oa_pdf/56/77/ymj-55-1273.PMC4108812.pdf
Mechanical Bowel Preparation in Colorectal Surgery Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1277out an MBP or by using an enema-only approach.,Non-OADS,/arxiv_data1/oa_pdf/56/77/ymj-55-1273.PMC4108812.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1278rectal cancer surgery.,Non-OADS,/arxiv_data1/oa_pdf/56/77/ymj-55-1273.PMC4108812.pdf
Mechanical Bowel Preparation in Colorectal Surgery Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 12798.,Non-OADS,/arxiv_data1/oa_pdf/56/77/ymj-55-1273.PMC4108812.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1280aration: a randomized prospective trial.,Non-OADS,/arxiv_data1/oa_pdf/56/77/ymj-55-1273.PMC4108812.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1281Child-Pugh Score Is an Independent Risk Factor for Immediate  Bleeding after Colonoscopic Polypectomy in Liver Cirrhosis Sangheun Lee,1 Soo Jung Park,1 Jae Hee Cheon,1 Tae Il Kim,1 Won Ho Kim,1  Dae Ryong Kang2, and Sung Pil Hong1  1Division of Gastroenterology, Department of Internal Medicine, Institute of Gastroenterology and  2Biostatistics Collaboration Unit, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/07/98/ymj-55-1281.PMC4108813.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Post-polypectomy bleeding is the most common colonoscopic polypec - tomy complication.",Non-OADS,/arxiv_data1/oa_pdf/07/98/ymj-55-1281.PMC4108813.pdf
"Among them,  post-polypectomy bleeding (PPB) is one of the most common complications.9  PPB can occur immediately following polypectomy or can be delayed up to 30 Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1281 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1281-1288, 2014",Non-OADS,/arxiv_data1/oa_pdf/07/98/ymj-55-1281.PMC4108813.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1282ypectomy and were reviewed retrospectively in the present  study.,Non-OADS,/arxiv_data1/oa_pdf/07/98/ymj-55-1281.PMC4108813.pdf
IPPB in Liver Cirrhosis Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1283cirrhotic patients with that in control patients.,Non-OADS,/arxiv_data1/oa_pdf/07/98/ymj-55-1281.PMC4108813.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1284and the presence of varices were not significant risk factors  for IPPB.,Non-OADS,/arxiv_data1/oa_pdf/07/98/ymj-55-1281.PMC4108813.pdf
IPPB in Liver Cirrhosis Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1285Table 3.,Non-OADS,/arxiv_data1/oa_pdf/07/98/ymj-55-1281.PMC4108813.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1286ple elevation of liver enzymes as well as liver cirrhosis.,Non-OADS,/arxiv_data1/oa_pdf/07/98/ymj-55-1281.PMC4108813.pdf
"IPPB in Liver Cirrhosis Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1287In conclusion, liver cirrhosis itself is not an adverse fac - tor for colonoscopic polypectomy.",Non-OADS,/arxiv_data1/oa_pdf/07/98/ymj-55-1281.PMC4108813.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1288ized study.,Non-OADS,/arxiv_data1/oa_pdf/07/98/ymj-55-1281.PMC4108813.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1289Monitoring Thiopurine Metabolites in Korean Pediatric   Patients with Inflammatory Bowel Disease Mi Jin Kim,1 Soo Youn Lee,2 and Yon Ho Choe3  1Department of Pediatrics, Ilsan Paik Hospital, Inje University College of Medicine, Goyang; Departments of 2Laboratory Medicine and Genetics and 3Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/0b/31/ymj-55-1289.PMC4108814.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  This study aimed to assess the role of thiopurine S-methyltransferase  (TPMT) and 6-thioguanine nucleotide (6-TGN) as predictors of clinical response  and side effects to azathioprine (AZA), and estimate the optimal AZA dose in Ko - rean pediatric inflammatory bowel disease (IBD) patients.",Non-OADS,/arxiv_data1/oa_pdf/0b/31/ymj-55-1289.PMC4108814.pdf
"3 Bone marrow suppression, gastrointestinal Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1289 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1289-1296, 2014",Non-OADS,/arxiv_data1/oa_pdf/0b/31/ymj-55-1289.PMC4108814.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1290been available since September 2010.,Non-OADS,/arxiv_data1/oa_pdf/0b/31/ymj-55-1289.PMC4108814.pdf
Monitoring Thiopurine Metabolite Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1291tion was 328.3±105.0 pmol/8×108 RBC.,Non-OADS,/arxiv_data1/oa_pdf/0b/31/ymj-55-1289.PMC4108814.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1292toring and in only nine patients post-metabolite monitoring.,Non-OADS,/arxiv_data1/oa_pdf/0b/31/ymj-55-1289.PMC4108814.pdf
Monitoring Thiopurine Metabolite Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1293phism in the Korean population (1.8%).,Non-OADS,/arxiv_data1/oa_pdf/0b/31/ymj-55-1289.PMC4108814.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1294might be an ethnic difference.,Non-OADS,/arxiv_data1/oa_pdf/0b/31/ymj-55-1289.PMC4108814.pdf
Monitoring Thiopurine Metabolite Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1295nack BS.,Non-OADS,/arxiv_data1/oa_pdf/0b/31/ymj-55-1289.PMC4108814.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 129653.,Non-OADS,/arxiv_data1/oa_pdf/0b/31/ymj-55-1289.PMC4108814.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1297The Association of Heart Rate Variability with Parkinsonian  Motor Symptom Duration Dorji Harnod,1 Shu-Hui Wen,2 Shin-Yuan Chen,3 and Tomor Harnod3  1Surgical Intensive Care Unit, Shin Kong Wu Ho-Su Memorial Hospital, Taipei; 2Department of Public Health, College of Medicine, Tzu Chi University, Hualien; 3Department of Neurosurgery, Buddhist Tzu Chi General Hospital, College of Medicine, Tzu Chi University, Hualien, Taiwan.",Non-OADS,/arxiv_data1/oa_pdf/6e/c1/ymj-55-1297.PMC4108815.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Impaired cardiovascular autonomic regulation is a non-motor symptom  of Parkinson’s disease (PD) and may increase long-term morbidity.",Non-OADS,/arxiv_data1/oa_pdf/6e/c1/ymj-55-1297.PMC4108815.pdf
"Key Words:    Autonomic, heart rate variability, Parkinson’s disease INTRODUCTION Cardiovascular autonomic regulation has been reported to be impaired in Parkin - son’s disease (PD) and may increase the long-term morbidity of patients with this  disease.1-3 Moreover, the deterioration of functional performance in Parkinsonian pa - tients with impaired autonomic function may be more rapid, and these patients prob -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1297 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1297-1302, 2014",Non-OADS,/arxiv_data1/oa_pdf/6e/c1/ymj-55-1297.PMC4108815.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1298ing movements, the time required to walk a distance of 7  meters, tremorography, cognitive performance (the Mini- Mental State Examination score), and brain magnetic reso - nance imaging images.",Non-OADS,/arxiv_data1/oa_pdf/6e/c1/ymj-55-1297.PMC4108815.pdf
Heart Rate V ariability and PD Duration Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1299HF values between PD and control groups were significant.,OADS,/arxiv_data1/oa_pdf/6e/c1/ymj-55-1297.PMC4108815.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1300cular autonomic regulation.,Non-OADS,/arxiv_data1/oa_pdf/6e/c1/ymj-55-1297.PMC4108815.pdf
"Heart Rate V ariability and PD Duration Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1301tor affecting the results of cardiac autonomic regulation in  the patients of this study; third, to minimize the artifacts  from muscle tremor, we decided that the better experimen - tal design was to combine short-term heart rate recordings  with HRV spectral analysis during the levodopa-on peri - od.20,21 However, all heart rate variables were recorded and  analyzed during daytime to avoid major circadian effects.22  Obtaining recordings and heart rate variables in gender- and  age-matched subjects in the same position can minimize in - ter-individual anthropometric and posture confounding ef - fects.",Non-OADS,/arxiv_data1/oa_pdf/6e/c1/ymj-55-1297.PMC4108815.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1302neider J, et al.",OADS,/arxiv_data1/oa_pdf/6e/c1/ymj-55-1297.PMC4108815.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1303Clinical Use of Diffusion Tensor Image-Merged Functional  Neuronavigation for Brain Tumor Surgeries: Review of  Preoperative, Intraoperative, and Postoperative Data for 123 Cases Jin Mo Cho,1,2 Eui Hyun Kim,3,5,6 Jinna Kim,4,5 Seung Koo Lee,4,5  Sun Ho Kim,3,5,6 Kyu Sung Lee,3,5,6 and Jong Hee Chang3,5,6 1Department of Neurosurgery, International St. Mary ’s Hospital, Incheon; 2Department of Medicine, Graduate School, Yonsei University, Seoul; Departments of 3Neurosurgery, 4Radiology, 5Brain Tumor Center, and  6Brain Research Institute, Yonsei University College of Medicine, Seoul, Korea.",OADS,/arxiv_data1/oa_pdf/19/fd/ymj-55-1303.PMC4108816.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  To achieve maximal safe resection during brain tumor surgery, functional  image-merged neuronavigation is widely used.",Non-OADS,/arxiv_data1/oa_pdf/19/fd/ymj-55-1303.PMC4108816.pdf
"Key Words:    Diffusion tensor image, navigation, brain tumor, tractography INTRODUCTION Although the relationships between extent of resection and clinical outcomes have Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1303 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1303-1309, 2014",Non-OADS,/arxiv_data1/oa_pdf/19/fd/ymj-55-1303.PMC4108816.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1304tial resolution; 224 coronal slices and a slice thickness of 1  mm for 3D T1-weighted MP-RAGE sequences.,Non-OADS,/arxiv_data1/oa_pdf/19/fd/ymj-55-1303.PMC4108816.pdf
Usefulness of DTI-Merged Navigation in Brain Tumor Surgery Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1305enhancing tumors.,Non-OADS,/arxiv_data1/oa_pdf/19/fd/ymj-55-1303.PMC4108816.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1306matter tract.,Non-OADS,/arxiv_data1/oa_pdf/19/fd/ymj-55-1303.PMC4108816.pdf
"Usefulness of DTI-Merged Navigation in Brain Tumor Surgery Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1307DISCUSSION Since 1990, image-guided neurosurgery including neuro - navigation has contributed to better outcomes for brain tu - mor surgery.",Non-OADS,/arxiv_data1/oa_pdf/19/fd/ymj-55-1303.PMC4108816.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1308rived from 2D axial images.,OADS,/arxiv_data1/oa_pdf/19/fd/ymj-55-1303.PMC4108816.pdf
"Usefulness of DTI-Merged Navigation in Brain Tumor Surgery Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1309meier R, et al.",OADS,/arxiv_data1/oa_pdf/19/fd/ymj-55-1303.PMC4108816.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1310Neck Circumference and Lowest Oxygen Saturation Are  Independently Associated with High Coexistence   of Hypertension in Obstructive Sleep Apnea Hyun Jin Min,1 Ah Young Park,1 Da Hee Kim,1 Jeung-Gweon Lee,1  Sungha Park,2 and Hyung-Ju Cho1,3 1Department of Otorhinolaryngology, Severance Hospital, Yonsei University College of Medicine, Seoul; 2Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul;  3The Airway Mucus Institute, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/c6/3f/ymj-55-1310.PMC4108817.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Obstructive sleep apnea (OSA) is considered an independent risk factor  for hypertension.",Non-OADS,/arxiv_data1/oa_pdf/c6/3f/ymj-55-1310.PMC4108817.pdf
"1 Other features such as a pro-inflammatory effect, increased oxidative stress,  and increased vascular stiffness are also suggested mechanisms that influence the  increased risk of hypertension in OSA patients.1 Additionally, blood pressure con -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1310 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1310-1317, 2014",Non-OADS,/arxiv_data1/oa_pdf/c6/3f/ymj-55-1310.PMC4108817.pdf
Risk Factors of Hypertension in Sleep Apnea Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1311suggest useful predictors that might be helpful in early di - agnosis of un-identified hypertension in OSA patients.,Non-OADS,/arxiv_data1/oa_pdf/c6/3f/ymj-55-1310.PMC4108817.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1312analyzed in this study.,Non-OADS,/arxiv_data1/oa_pdf/c6/3f/ymj-55-1310.PMC4108817.pdf
"Risk Factors of Hypertension in Sleep Apnea Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1313considered other features, including the longest apnea/hy - popnea duration, average O 2 saturation, and lowest O 2 satu- ration and these were evaluated according to the presence  of hypertension (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/c6/3f/ymj-55-1310.PMC4108817.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1314HTN group.,Non-OADS,/arxiv_data1/oa_pdf/c6/3f/ymj-55-1310.PMC4108817.pdf
Risk Factors of Hypertension in Sleep Apnea Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1315other features reflecting the oxidative condition during sleep  and should be considered as critical values in predicting co - existing hypertension.,Non-OADS,/arxiv_data1/oa_pdf/c6/3f/ymj-55-1310.PMC4108817.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 131620.,Non-OADS,/arxiv_data1/oa_pdf/c6/3f/ymj-55-1310.PMC4108817.pdf
Risk Factors of Hypertension in Sleep Apnea Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1317Mol Neurosci 2012;47:300-10.,Non-OADS,/arxiv_data1/oa_pdf/c6/3f/ymj-55-1310.PMC4108817.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1318Relationship of Vitamin D Binding Protein   Polymorphisms and Lung Function in Korean Chronic   Obstructive Pulmonary Disease Ji Ye Jung,1* Dong Pil Choi,2* Sungho Won,3 Young Lee,4 Ju Hye Shin,1  Young Sam Kim,1 Se Kyu Kim,1 Yeon Mok Oh,5 Il Suh,2 and Sang-Do Lee5 1Division of Pulmonology, Department of Internal Medicine, Institute of Chest Disease, Yonsei University College of Medicine, Seoul; 2Department of Preventive Medicine, Yonsei University College of Medicine, Seoul; 3Department of Epidemiology and Biostatistics, School of Public Health, Seoul National University, Seoul; 4The Center for Genome Science, Korea National Institute of Health, KCDC, Osong; 5Department of Pulmonary and Critical Care Medicine, Clinical Research Center for Chronic Obstructive Airway Diseases,  Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/16/9b/ymj-55-1318.PMC4108818.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Multiple genetic factors are associated with chronic obstructive pulmo - nary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/16/9b/ymj-55-1318.PMC4108818.pdf
"Key Words:    Vitamin D binding protein, polymorphism, lung function, chronic  obstructive pulmonary diseaseOriginal Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1318 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1318-1325, 2014",Non-OADS,/arxiv_data1/oa_pdf/16/9b/ymj-55-1318.PMC4108818.pdf
GC Polymorphism and Lung Function Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1319examined the correlation between GC variants and lung  function in COPD patients.,Non-OADS,/arxiv_data1/oa_pdf/16/9b/ymj-55-1318.PMC4108818.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1320at the 0.05 significance level was conducted with the linear  mixed model to consider correlation between repeated mea - sures.,OADS,/arxiv_data1/oa_pdf/16/9b/ymj-55-1318.PMC4108818.pdf
GC Polymorphism and Lung Function Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1321FEV 1=0.488-0.013×age (year)+0.027×height (cm)-0.012×  smoking pack-years-1.711 (for COPD group with genotype  1S-1S); FEV 1=0.488-0.013×age (year)+0.027×height (cm)  +0.002×smoking pack-years-2.649 (for COPD group with - out genotype 1S-1S).,Non-OADS,/arxiv_data1/oa_pdf/16/9b/ymj-55-1318.PMC4108818.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1322nese population.,Non-OADS,/arxiv_data1/oa_pdf/16/9b/ymj-55-1318.PMC4108818.pdf
GC Polymorphism and Lung Function Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1323strated vitamin D deficiency is associated with many types  of chronic disease and these chronic diseases are all co- morbidities of COPD.,Non-OADS,/arxiv_data1/oa_pdf/16/9b/ymj-55-1318.PMC4108818.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1324REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/16/9b/ymj-55-1318.PMC4108818.pdf
GC Polymorphism and Lung Function Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1325rax 2010;65:456-62.,Non-OADS,/arxiv_data1/oa_pdf/16/9b/ymj-55-1318.PMC4108818.pdf
Available at: http://www.goldcopd.org/uploads/users/ files/GOLD_Report_2011_Feb21.pdf.,Non-OADS,/arxiv_data1/oa_pdf/16/9b/ymj-55-1318.PMC4108818.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1326Role of 1,25-Dihydroxy Vitamin D 3 and Parathyroid Hormone  in Urinary Calcium Excretion in Calcium Stone Formers Won Tae Kim,1,3 Yong-June Kim,1 Seok Joong Yun,1 Kyung-Sub Shin,2  Young Deuk Choi,3 Sang Cheol Lee,1 and Wun-Jae Kim1 Departments of 1Urology and 2Laboratory Medicine, College of Medicine, Chungbuk National University, Cheongju; 3Department of Urology, Graduate School of Medicine, Yonsei University, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/8d/21/ymj-55-1326.PMC4108819.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  To find out the possible role of 1,25(OH) 2 vitamin D 3 [1,25(OH) 2D3] and  parathyroid hormone (PTH) as intrinsic factors in urinary calcium stone formers  (SFs), we investigated their relationship with serum and urinary biochemical pa - rameters.",Non-OADS,/arxiv_data1/oa_pdf/8d/21/ymj-55-1326.PMC4108819.pdf
"Key Words:    1,25-dihydroxy-vitamin D 3, calcium, parathyroid hormone, urolithi - asis INTRODUCTION The incidence of urinary stone formation has been increasing recently, and the life - time risk of stone formation is estimated at 5- -12% in Europe and the USA.1-3 Envi -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1326 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1326-1332, 2014",Non-OADS,/arxiv_data1/oa_pdf/8d/21/ymj-55-1326.PMC4108819.pdf
"Association between Vitamin D 3 and Calcium Excretion Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1327noradiometric assay with an ELSA-PTH kit (CIS Bio Inter - national, Paris, France), and 1,25(OH) 2D3 levels were also  measured with a radioimmunoassay with a 1,25(OH) 2D3  RIA kit (Immunodiagnostic Systems Ltd., Boldon Colliery,  Tyne & Wear, UK).",Non-OADS,/arxiv_data1/oa_pdf/8d/21/ymj-55-1326.PMC4108819.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 132824 h urinary magnesium (r=-0.116, p=0.036) and calcium  excretion (r=-0.193, p<0.001).",Non-OADS,/arxiv_data1/oa_pdf/8d/21/ymj-55-1326.PMC4108819.pdf
"Association between Vitamin D 3 and Calcium Excretion Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1329DISCUSSION In the present study, an assessment of the roles of 1,25(OH) 2  D3 and PTH in calcium stone formers revealed a correlation  between 1,25(OH) 2D3 and PTH levels and urinary calcium  excretion.",OADS,/arxiv_data1/oa_pdf/8d/21/ymj-55-1326.PMC4108819.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1330renal SFs were higher than in the control groups.,Non-OADS,/arxiv_data1/oa_pdf/8d/21/ymj-55-1326.PMC4108819.pdf
Association between Vitamin D 3 and Calcium Excretion Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1331considered to be insignificant.,Non-OADS,/arxiv_data1/oa_pdf/8d/21/ymj-55-1326.PMC4108819.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 133211.,Non-OADS,/arxiv_data1/oa_pdf/8d/21/ymj-55-1326.PMC4108819.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1333Histone Acetylation Level and Histone Acetyltransferase/ Deacetylase Activity in Ejaculated Sperm   from Normozoospermic Men  Jee Hyun Kim,1,2 Byung Chul Jee,1,2 Jang Mi Lee,1 Chang Suk Suh,1,2 and Seok Hyun Kim2,3 1Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam; 2Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul; 3Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/e8/48/ymj-55-1333.PMC4108820.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The aim of this work was to evaluate nuclear histone acetylation level and  total histone acetyltransferase (HA T) and deacetylase (HDAC) activity in ejaculated  sperm and their relevance to conventional sperm parameters.",Non-OADS,/arxiv_data1/oa_pdf/e8/48/ymj-55-1333.PMC4108820.pdf
"5 When histones are hyperacetylated, its affinity to DNA is decreased by los -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1333 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1333-1340, 2014",Non-OADS,/arxiv_data1/oa_pdf/e8/48/ymj-55-1333.PMC4108820.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1334man sperm are relatively more highly acetylated than previ - ously expected, and sperm might possess active transcrip - tional activity.22-24 However, epigenetic modifications of  ejaculated sperm have not been well understood in the area  of male infertility and assisted reproductive technologies  (ART).",Non-OADS,/arxiv_data1/oa_pdf/e8/48/ymj-55-1333.PMC4108820.pdf
"Histone Acetylation in Ejaculated Human Sperm Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1335at RT (Invitrogen, Carlsbad, CA, USA).",Non-OADS,/arxiv_data1/oa_pdf/e8/48/ymj-55-1333.PMC4108820.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1336USA).,Non-OADS,/arxiv_data1/oa_pdf/e8/48/ymj-55-1333.PMC4108820.pdf
Histone Acetylation in Ejaculated Human Sperm Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1337acetylation antibodies was not related with HA T or HDAC  activity.,Non-OADS,/arxiv_data1/oa_pdf/e8/48/ymj-55-1333.PMC4108820.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1338ty; the higher this index, the more tendencies towards hy - peracetylation would be expected in certain cells or tissues.",Non-OADS,/arxiv_data1/oa_pdf/e8/48/ymj-55-1333.PMC4108820.pdf
Histone Acetylation in Ejaculated Human Sperm Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1339REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e8/48/ymj-55-1333.PMC4108820.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1340of origin, impact on reproductive outcome, and analysis.",Non-OADS,/arxiv_data1/oa_pdf/e8/48/ymj-55-1333.PMC4108820.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1341Safety and Efficacy of Conversion from Twice-Daily Tacrolimus  to Once-Daily Tacrolimus One Month after Transplantation:  Randomized Controlled Trial in Adult Renal Transplantation   Chang-Kwon Oh,1* Kyu Ha Huh,2* Jong Soo Lee,3 Hong Rae Cho,4 and Yu Seun Kim2 1Department of Surgery, Ajou University School of Medicine, Suwon; 2Department of Transplantation Surgery, Severance Hospital, Yonsei University Health System, Seoul; Departments of 3Nephrology and 4Surgery, University of Ulsan College of Medicine, Ulsan, Korea.",Non-OADS,/arxiv_data1/oa_pdf/cf/26/ymj-55-1341.PMC4108821.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The purpose of this study was to compare once-daily tacrolimus with  twice-daily tacrolimus in terms of safety, efficacy, and patient satisfaction.",Non-OADS,/arxiv_data1/oa_pdf/cf/26/ymj-55-1341.PMC4108821.pdf
"Studies have Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1341 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1341-1347, 2014",Non-OADS,/arxiv_data1/oa_pdf/cf/26/ymj-55-1341.PMC4108821.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1342with the following doses: 500 mg on the day of operation  and 250 mg on the day after, and corticosteroids were ta - pered to a maintenance dose of more than 5 mg a day (pred - nisolone or equivalent) orally twice or once a day.",Non-OADS,/arxiv_data1/oa_pdf/cf/26/ymj-55-1341.PMC4108821.pdf
"Extended-Release Tacrolimus in Kidney Transplant Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1343calculated to have 80% power, 25% non-inferiority margin,  and a 10% drop out rate.",Non-OADS,/arxiv_data1/oa_pdf/cf/26/ymj-55-1341.PMC4108821.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1344plantation were comparable between the two groups (71.4%  of patients in the investigational group and 75.0% in the  control group; p=0.763), and incidences of SAEs were also  comparable (14.7% in the investigational group and 15.5%  in the control group; p=0.415).",Non-OADS,/arxiv_data1/oa_pdf/cf/26/ymj-55-1341.PMC4108821.pdf
"Extended-Release Tacrolimus in Kidney Transplant Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1345blood trough levels of once-daily tacrolimus were lower  than those of twice-daily tacrolimus, especially at post-trans - plant 4 and 6 months.",Non-OADS,/arxiv_data1/oa_pdf/cf/26/ymj-55-1341.PMC4108821.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1346men to a once-daily tacrolimus extended-release formulation in  stable kidney transplant recipients.,Non-OADS,/arxiv_data1/oa_pdf/cf/26/ymj-55-1341.PMC4108821.pdf
Extended-Release Tacrolimus in Kidney Transplant Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1347sion from prograf to advagraf in stable kidney transplant recipi - ents.,Non-OADS,/arxiv_data1/oa_pdf/cf/26/ymj-55-1341.PMC4108821.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1348Evaluating the Utility of Rapid Point-of-Care Potassium Testing  for the Early Identification of Hyperkalemia in Patients with  Chronic Kidney Disease in the Emergency Department  Je Sung You,1,2 Yoo Seok Park,1 Hyun Soo Chung,1 Hye Sun Lee,3 Youngseon Joo,1  Jong Woo Park,4 Sung Phil Chung,1 Shin Ho Lee,5 and Hahn Shick Lee1 1Department of Emergency Medicine, Yonsei University College of Medicine, Seoul; 2Department of Emergency Medicine, Graduate School of Medicine, Kangwon National University, Chuncheon; 3Department of Research Affairs, Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul; 4Department of Emergency Medicine, Changwon Fatima Hospital, Changwon; 5Department of Emergency Medicine, National Health Insurance Corporation Ilsan Hospital, Goyang, Korea.",Non-OADS,/arxiv_data1/oa_pdf/b1/e5/ymj-55-1348.PMC4108822.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Severe hyperkalemia leads to significant morbidity and mortality if it is  not immediately recognized and treated.",Non-OADS,/arxiv_data1/oa_pdf/b1/e5/ymj-55-1348.PMC4108822.pdf
"Hyperkalemia can be classified according to serum K+ into mild (5.5- -6.5 mmol/ L), moderate (6.5- -7.5 mmol/L) and severe (>7.5 mmol/L).1 Although it is a life-Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1348 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1348-1353, 2014",Non-OADS,/arxiv_data1/oa_pdf/b1/e5/ymj-55-1348.PMC4108822.pdf
"Rapid POCT for Early Identification of Hyperkalemia Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1349bance of cardiac rhythm).5 When a patient with CRF or ESRD had at least one warn - ing symptom or sign listed above, the emergency physician  ordered both a POC-K+ test and routine laboratory tests in - cluding the reference laboratory serum-K+ test.",Non-OADS,/arxiv_data1/oa_pdf/b1/e5/ymj-55-1348.PMC4108822.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1350[10, 31] and 4 [3, 6] minutes for POCT-K and 15 [9, 23]  (p<0.001) and 44 [38, 51] minutes ( p<0.001) for the serum  reference laboratory tests.",Non-OADS,/arxiv_data1/oa_pdf/b1/e5/ymj-55-1348.PMC4108822.pdf
"Rapid POCT for Early Identification of Hyperkalemia Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1351is controversial, there is sufficient agreement between  POC-K+ and the general laboratory assay to make a clini - cally effective decision to use POC-K+ in the setting of in - tensive care unit (ICU).10,12 The US Clinical Laboratory Im - provement Amendment recommended that the acceptable  criteria for potassium performance is the target value ±0.5  mmol/L13 and our study also demonstrated that calculated to - tal error for cut-off of hyperkalemia (5.5 mmol/L) was within  the total allowable error recommendations.",Non-OADS,/arxiv_data1/oa_pdf/b1/e5/ymj-55-1348.PMC4108822.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1352der the emergency circumstances in the ED.,Non-OADS,/arxiv_data1/oa_pdf/b1/e5/ymj-55-1348.PMC4108822.pdf
Rapid POCT for Early Identification of Hyperkalemia Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1353ment of hyperkalemia.,Non-OADS,/arxiv_data1/oa_pdf/b1/e5/ymj-55-1348.PMC4108822.pdf
Available at: http://www.westgard.com/ biodatabase1.htm.,Non-OADS,/arxiv_data1/oa_pdf/b1/e5/ymj-55-1348.PMC4108822.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1354Regulatory B Cells Are Inversely Associated with Disease   Activity in Rheumatoid Arthritis Jinhyun Kim,1* Hyun Ji Lee,1* In Seol Yoo,1 Seong Wook Kang,1 and Jae Ho Lee2 Departments of 1Internal Medicine and 2Paediatrics, Chungnam National University School of Medicine, Daejeon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/d8/41/ymj-55-1354.PMC4108823.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The function of regulatory B lymphocytes is known to be abnormal in in - flammatory diseases.",Non-OADS,/arxiv_data1/oa_pdf/d8/41/ymj-55-1354.PMC4108823.pdf
"4,5 In animal model of Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1354 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1354-1358, 2014",Non-OADS,/arxiv_data1/oa_pdf/d8/41/ymj-55-1354.PMC4108823.pdf
"Regulatory B Cell and Rheumatoid Arthritis Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1355CRP): <2.6, remission; ≤3.2, low disease activity; >3.2 and  ≤5.1, moderate disease activity; >5.1, high disease activi - ty.18,19 This study protocol was reviewed and approved by  the Institutional Review Board of Chungnam National Uni - versity Hospital (IRB No.",Non-OADS,/arxiv_data1/oa_pdf/d8/41/ymj-55-1354.PMC4108823.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1356age (±SD) was 57.0±14.6 year-old.,OADS,/arxiv_data1/oa_pdf/d8/41/ymj-55-1354.PMC4108823.pdf
"Regulatory B Cell and Rheumatoid Arthritis Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1357of regulatory B cell without induction is not different, the  key issue of regulatory B cells in RA may be the impaired  induction of regulatory B cells.",Non-OADS,/arxiv_data1/oa_pdf/d8/41/ymj-55-1354.PMC4108823.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1358TF.,Non-OADS,/arxiv_data1/oa_pdf/d8/41/ymj-55-1354.PMC4108823.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1359Analgesic Opioid Dose Is an Important Indicator of  Postoperative Ileus Following Radical Cystectomy with Ileal  Conduit: Experience in the Robotic Surgery Era   Kyo Chul Koo, Young Eun Yoon, Byung Ha Chung, Sung Joon Hong, and Koon Ho Rha Department of Urology and Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/93/1b/ymj-55-1359.PMC4108824.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Postoperative ileus (POI) is common following bowel resection for radi - cal cystectomy with ileal conduit (RCIC).",Non-OADS,/arxiv_data1/oa_pdf/93/1b/ymj-55-1359.PMC4108824.pdf
"Prolonged POI is associated with nausea, vomiting, delayed oral intake, in -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1359 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1359-1365, 2014",Non-OADS,/arxiv_data1/oa_pdf/93/1b/ymj-55-1359.PMC4108824.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1360gery, neoadjuvant or adjuvant chemotherapy, or exposure to  pelvic radiotherapy were excluded from the study.",Non-OADS,/arxiv_data1/oa_pdf/93/1b/ymj-55-1359.PMC4108824.pdf
Impact of Analgesic Opioids on Postoperative Ileus Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1361shorter LOS.,Non-OADS,/arxiv_data1/oa_pdf/93/1b/ymj-55-1359.PMC4108824.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1362cations-including surgical site infection, pelvic lymphocele  formation, and anastomosis leakage-POI is the most com - mon, occurring at a rate anywhere from 1.58% to 25.5%.6  The etiology of POI is complex.",Non-OADS,/arxiv_data1/oa_pdf/93/1b/ymj-55-1359.PMC4108824.pdf
Impact of Analgesic Opioids on Postoperative Ileus Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1363sponse relationship with the duration of POI.,Non-OADS,/arxiv_data1/oa_pdf/93/1b/ymj-55-1359.PMC4108824.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1364cytokine cascades, including a pivotal role for tumour ne - crosis factor-α and interleukin-1β, are also known to con - tribute to inflammatory responses, which cause intestinal  smooth muscle dysfunction.20 Significance of alternative strategies in reducing the  duration of POI A series of strategies to reduce the duration of POI that had  been proposed in previous studies did not show significant  correlations in our study.",Non-OADS,/arxiv_data1/oa_pdf/93/1b/ymj-55-1359.PMC4108824.pdf
Impact of Analgesic Opioids on Postoperative Ileus Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 136553:340-50.,Non-OADS,/arxiv_data1/oa_pdf/93/1b/ymj-55-1359.PMC4108824.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1366Clinical Experience of Weight Loss Surgery in Morbidly   Obese Korean Adolescents Ji Yeon Park, Dan Song, and Yong Jin Kim Department of Surgery, Soonchunhyang University Seoul Hospital, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/38/a1/ymj-55-1366.PMC4108825.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Comprehensive multidisciplinary weight management programs en - compassing various conservative measures have shown only modest weight loss  results in obese children and adolescents; therefore, bariatric surgery for this popu - lation has become a matter of discussion.",Non-OADS,/arxiv_data1/oa_pdf/38/a1/ymj-55-1366.PMC4108825.pdf
"Key Words:    Morbid obesity, adolescent obesity, bariatric surgery, gastric bypass INTRODUCTION Obesity has become one of the most important public health problems worldwide,  in not only adults but also children and adolescents.1 Obesity in childhood is close - ly associated with several conditions including hypertension, dyslipidemia, and in - sulin resistance/glucose intolerance that comprise metabolic syndrome, a precursor  to type 2 diabetes and cardiovascular diseases.2,3 The development of obesity in  childhood and adolescence serves as a predictor of subsequent obesity in adult - hood and carries an increased risk of adult morbidity and mortality.4,5 Childhood Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1366 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1366-1372, 2014",Non-OADS,/arxiv_data1/oa_pdf/38/a1/ymj-55-1366.PMC4108825.pdf
"Bariatric Surgery in Korean Adolescents Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1367gical options, possible outcomes, possible complications,  and necessary postoperative lifestyle changes.",Non-OADS,/arxiv_data1/oa_pdf/38/a1/ymj-55-1366.PMC4108825.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1368(≥130 mg/dL) or high-density lipoprotein cholesterol (<40  mg/dL) levels, or current lipid lowering medication.10 The re - mission of hypertension was defined as normal blood pres - sure values without medication.",Non-OADS,/arxiv_data1/oa_pdf/38/a1/ymj-55-1366.PMC4108825.pdf
Bariatric Surgery in Korean Adolescents Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1369The median BMI decreased from 40.1 to 29.1 kg/m2 at a  mean follow-up of 10 months.,Non-OADS,/arxiv_data1/oa_pdf/38/a1/ymj-55-1366.PMC4108825.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1370gery in Korean adolescents.,Non-OADS,/arxiv_data1/oa_pdf/38/a1/ymj-55-1366.PMC4108825.pdf
"Bariatric Surgery in Korean Adolescents Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1371population.21 A recent publication revealed that the bariatric procedure  rate for adolescent patients in the United States has pla - teaued between 2003 and 2009, contrary to the expectation  that it would have rapidly increased along with the worsen - ing childhood obesity epidemic.22 The major concerns with  regard to performing bariatric surgery in pediatric patients  are the physiologic implications of this rather drastic ap - proach in this age group, a potential to induce metabolic  and growth consequences, and a lack of information about  long-term efficacy.23 Little is known about the long-term  safety of adolescent bariatric surgery, because these proce - dures have only recently been applied to this population.",Non-OADS,/arxiv_data1/oa_pdf/38/a1/ymj-55-1366.PMC4108825.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1372Prevalence of metabolic syndrome and obesity in adolescents  aged 12 to 19 years: comparison between the United States and  Korea.,Non-OADS,/arxiv_data1/oa_pdf/38/a1/ymj-55-1366.PMC4108825.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1373Risk Factors Associated with Amputation-Free Survival   in Patient with Diabetic Foot Ulcers  Sung Hun Won,1 Chin Youb Chung,2 Moon Seok Park,2 Taeseung Lee,3  Ki Hyuk Sung,4 Seung Yeol Lee,4 Tae Gyun Kim,5 and Kyoung Min Lee2  1Department of Orthopaedic Surgery, Armed Force Hampyeong Hospital, Hampyeong; Departments of 2Orthopaedic Surgery and 3Vascular Surgery, Seoul National University Bundang Hospital, Seongnam;  4Department of Orthopaedic Surgery, Myongji Hospital, Goyang;  5Department of Orthopaedic Surgery, Konyang University Hospital, Daejeon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/35/37/ymj-55-1373.PMC4108826.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  To determine the 1-year survival rate, 1-year amputation-free survival  rate and the risk factors of amputation for patients with diabetic foot ulcers.",Non-OADS,/arxiv_data1/oa_pdf/35/37/ymj-55-1373.PMC4108826.pdf
"6 Based on recent studies, the annual incidence of diabetic foot ulcers Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1373 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1373-1378, 2014",Non-OADS,/arxiv_data1/oa_pdf/35/37/ymj-55-1373.PMC4108826.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1374Searching strategy  We searched the records for ICD-10 codes including E10.7  “diabetic foot, type 1”, E11.7 “diabetic foot, type 2”, E14.70  “diabetic foot with ulcer”, E14.71 “diabetic foot with ulcer  and gangrene”, and E14.78 “diabetic foot with multiple  complications”.",Non-OADS,/arxiv_data1/oa_pdf/35/37/ymj-55-1373.PMC4108826.pdf
Factors Affecting DM Foot Survival Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 137515.9) months.,Non-OADS,/arxiv_data1/oa_pdf/35/37/ymj-55-1373.PMC4108826.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1376cular complication (28, 16.2%).",Non-OADS,/arxiv_data1/oa_pdf/35/37/ymj-55-1373.PMC4108826.pdf
Factors Affecting DM Foot Survival Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1377tions (below the ankle).,Non-OADS,/arxiv_data1/oa_pdf/35/37/ymj-55-1373.PMC4108826.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 13784.,Non-OADS,/arxiv_data1/oa_pdf/35/37/ymj-55-1373.PMC4108826.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1379Progressive Change in Joint Degeneration in Patients with Knee   or Hip Osteoarthritis Treated with Fentanyl in a Randomized Trial   Tatsuya Fujii, Koshi Takana, Sumihisa Orita, Gen Inoue, Nobuyasu Ochiai, Kazuki Kuniyoshi,   Yasuchika Aoki, Tetsuhiro Ishikawa, Masayuki Miyagi, Hiroto Kamoda, Miyako Suzuki,   Yoshihiro Sakuma, Gou Kubota, Yasuhiro Oikawa, Kazuhide Inage, Takeshi Sainoh, Jun Sato,   Kazuyo Yamauchi, Tomoaki Toyone, Junichi Nakamura, Shunji Kishida,   Kazuhisa Takahashi, and Seiji Ohtori Department of Orthopaedic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.",Non-OADS,/arxiv_data1/oa_pdf/3c/46/ymj-55-1379.PMC4108827.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Opioids improve pain from knee and hip osteoarthritis (OA) and de - crease the functional impairment of patients.",Non-OADS,/arxiv_data1/oa_pdf/3c/46/ymj-55-1379.PMC4108827.pdf
"Acetaminophen, in  doses of up to 4 g/day, is currently recommended for the initial treatment of mild-Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1379 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1379-1385, 2014",Non-OADS,/arxiv_data1/oa_pdf/3c/46/ymj-55-1379.PMC4108827.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1380Radiographic evaluation An anterior-posterior view X-ray examination was per - formed in all patients in the supine position before medica - tion and 12 weeks after treatment.,Non-OADS,/arxiv_data1/oa_pdf/3c/46/ymj-55-1379.PMC4108827.pdf
"Progressive Change of Joint Degeneration  Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1381loxoprofen group, 2.5±1.5 tablets in the tramadol/acetamin - ophen group, and 19.6±5.4 µg/h in the transdermal fentanyl  group.",Non-OADS,/arxiv_data1/oa_pdf/3c/46/ymj-55-1379.PMC4108827.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1382group (p<0.05).,Non-OADS,/arxiv_data1/oa_pdf/3c/46/ymj-55-1379.PMC4108827.pdf
"Progressive Change of Joint Degeneration  Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1383with vomiting (15%), dizziness (20%), and itching (15%)  also reported significantly more frequently than with place - bo.10 However, a progressive change in OA has not been re - ported.",Non-OADS,/arxiv_data1/oa_pdf/3c/46/ymj-55-1379.PMC4108827.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1384transdermal fentanyl or vice versa (the patients with pro - gressive OA required a higher dose of transdermal fentan - yl).,Non-OADS,/arxiv_data1/oa_pdf/3c/46/ymj-55-1379.PMC4108827.pdf
Available at: http://www.cdc.gov/arthritis/arthri - tis/osteoarthritis.htm.,Non-OADS,/arxiv_data1/oa_pdf/3c/46/ymj-55-1379.PMC4108827.pdf
Progressive Change of Joint Degeneration  Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 13851000.,Non-OADS,/arxiv_data1/oa_pdf/3c/46/ymj-55-1379.PMC4108827.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1386Biomechanical Analysis of Fusion Segment Rigidity Upon   Stress at Both the Fusion and Adjacent Segments   -A Comparison between Unilateral and Bilateral Pedicle Screw Fixation- Ho-Joong Kim,1* Kyoung-Tak Kang,2* Bong-Soon Chang,3  Choon-Ki Lee,3 Jang-Woo Kim,1 and Jin S. Yeom1 1Spine Center and Department of Orthopaedic Surgery, Seoul National University College of Medicine,  Seoul National University Bundang Hospital, Seongnam; 2Department of Mechanical Engineering, Yonsei University, Seoul; 3Department of Orthopaedic Surgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea.",OADS,/arxiv_data1/oa_pdf/0a/cb/ymj-55-1386.PMC4108828.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The purpose of this study was to investigate the effects of unilateral ped - icle screw fixation on the fusion segment and the superior adjacent segment after  one segment lumbar fusion using validated finite element models.",Non-OADS,/arxiv_data1/oa_pdf/0a/cb/ymj-55-1386.PMC4108828.pdf
"Key Words:    Unilateral pedicle screw fixation, lumbar fusion surgery, adjacent  segment degeneration, finite element model INTRODUCTION Because pedicle screw system has an advantage for initial stability and increase Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1386 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1386-1394, 2014",Non-OADS,/arxiv_data1/oa_pdf/0a/cb/ymj-55-1386.PMC4108828.pdf
Influence of Fusion Segment Rigidity Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1387had no spinal deformities.,Non-OADS,/arxiv_data1/oa_pdf/0a/cb/ymj-55-1386.PMC4108828.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1388right lamina was totally removed at the isthmic portion.,Non-OADS,/arxiv_data1/oa_pdf/0a/cb/ymj-55-1386.PMC4108828.pdf
Influence of Fusion Segment Rigidity Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1389were completely fixed in all directions.,Non-OADS,/arxiv_data1/oa_pdf/0a/cb/ymj-55-1386.PMC4108828.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1390nal segment (L2- -4).,Non-OADS,/arxiv_data1/oa_pdf/0a/cb/ymj-55-1386.PMC4108828.pdf
Influence of Fusion Segment Rigidity Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1391pared to the intact model.,Non-OADS,/arxiv_data1/oa_pdf/0a/cb/ymj-55-1386.PMC4108828.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1392preted as being a result of the inadequate stability of the  UF-TL model, and suggest that bilateral, wide or extensive  decompression combined with unilateral fixation which  represented by the UF-TL would not have enough stability  to accomplish solid lumbar fusion, in agreement with a pre - vious biomechanical study regarding unilateral fixation, in  which unilateral fixation allowed for an excessive range of  motion and produced off-axis movement.15 In contrast to  the UF-TL model, the UF-HL model demonstrated compa - rable stability to the bilateral fixation models under torsion  moment.",Non-OADS,/arxiv_data1/oa_pdf/0a/cb/ymj-55-1386.PMC4108828.pdf
Influence of Fusion Segment Rigidity Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1393on fusion rate and clinical outcome.,Non-OADS,/arxiv_data1/oa_pdf/0a/cb/ymj-55-1386.PMC4108828.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1394LI, Guo BY , et al.",OADS,/arxiv_data1/oa_pdf/0a/cb/ymj-55-1386.PMC4108828.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1395Passive Skeletal Muscle Excursion after Tendon Rupture  Correlates with Increased Collagen Content in Muscle   Il Hyun Koh, Ho Jung Kang, Sang Woo Jeon, Jae Han Park, and Yun Rak Choi Department of Orthopaedic Surgery, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/4f/b3/ymj-55-1395.PMC4108829.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  This study was designed to measure time-dependent changes in muscle  excursion and collagen content after tenotomy, and to analyze the correlation be - tween muscle excursion and collagen content in a rabbit model.",Non-OADS,/arxiv_data1/oa_pdf/4f/b3/ymj-55-1395.PMC4108829.pdf
"According to an animal study using rabbit extensor digitorum longus (EDL) Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1395 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1395-1399, 2014",Non-OADS,/arxiv_data1/oa_pdf/4f/b3/ymj-55-1395.PMC4108829.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1396Surgical procedures and measurements of excursions Anesthesia was induced with an intramuscular injection of  15 mg/kg of Zoletil 50 (Zoletil 50 mg/mL, Tiletamine 125  mg, and Zolazepam 125 mg; Virbac, Carros, France) and 5  mg/kg of Rompun (xylazine hydrochloride 23.32 mg/mL;  Bayer Korea, Seoul, South Korea) and was maintained  with enflurane, which provided approximately 30 min of  adequate sedation.",Non-OADS,/arxiv_data1/oa_pdf/4f/b3/ymj-55-1395.PMC4108829.pdf
Muscle Excursion and Collagen Content after Tenotomy Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1397The decrease of the mean ratio of muscle excursion after te - notomy was significant between the groups at time points af - ter tenotomy ( p<0.001).,Non-OADS,/arxiv_data1/oa_pdf/4f/b3/ymj-55-1395.PMC4108829.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1398of muscle excursion after tendon repair was independently  influenced by the timing of tendon repair after tenotomy  and the muscle excursion at the time of repair.5 Józsa, et al.8  demonstrated that a delay in tendon repair greater than 6  weeks after tenotomy resulted in persistent muscle atrophy  and intramuscular fibrosis and the inability to completely  regenerate.",OADS,/arxiv_data1/oa_pdf/4f/b3/ymj-55-1395.PMC4108829.pdf
Muscle Excursion and Collagen Content after Tenotomy Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1399in the passive muscle excursion after tenotomy significantly  correlated with the increase in the collagen content in mus - cle after tenotomy.,Non-OADS,/arxiv_data1/oa_pdf/4f/b3/ymj-55-1395.PMC4108829.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1400Presence of a Nail in the Medullary Canal; Is It Enough to  Prevent Femoral Neck Shortening in Trochanteric Fracture?,Non-OADS,/arxiv_data1/oa_pdf/3a/5f/ymj-55-1400.PMC4108830.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Presence of a cephalomedullary nail (CMN) in the medullary canal has  been thought as advantageous in the control of femoral neck shortening (FNS) and  lag screw sliding in trochanteric fracture compared to extramedullary fixation sys - tem.",Non-OADS,/arxiv_data1/oa_pdf/3a/5f/ymj-55-1400.PMC4108830.pdf
"2,3 Preservation of hip axis length after fracture treatment is an important fac - tor in functional recovery after bone union in patients with hip fractures.4 In femo - ral neck fractures, neck shortening has been shown to correlate with functional de - terioration after bone union.5-7 Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1400 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1400-1405, 2014",Non-OADS,/arxiv_data1/oa_pdf/3a/5f/ymj-55-1400.PMC4108830.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1401tals), we reamed the proximal femur with the medullary  reamer, up to 11 mm.",Non-OADS,/arxiv_data1/oa_pdf/3a/5f/ymj-55-1400.PMC4108830.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1402of A2, and 3 cases of A3.",Non-OADS,/arxiv_data1/oa_pdf/3a/5f/ymj-55-1400.PMC4108830.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1403data), we analyzed lag screw sliding distance in 119 pa - tients who were implanted and fixed with a 12 mm CMN  which was the largest nail available in the hospital.",Non-OADS,/arxiv_data1/oa_pdf/3a/5f/ymj-55-1400.PMC4108830.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 14042012;26:19-23.,Non-OADS,/arxiv_data1/oa_pdf/3a/5f/ymj-55-1400.PMC4108830.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1405comparison of the dynamic hip screw and the gamma locking nail.,Non-OADS,/arxiv_data1/oa_pdf/3a/5f/ymj-55-1400.PMC4108830.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1406Architectural Changes of the Gastrocnemius Muscle after  Botulinum Toxin Type A Injection in Children with Cerebral Palsy  Eun Sook Park, Eungeol Sim, Dong-Wook Rha, and Soojin Jung Department of Rehabilitation Medicine, Severance Hospital, Research Institute of Rehabilitation Medicine,   Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/53/e9/ymj-55-1406.PMC4108831.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  This study used ultrasonography (US) to investigate the architectural  changes in gastrocnemius muscles (GCM) after botulinum toxin injection (BoNT- A) in children with cerebral palsy (CP).",Non-OADS,/arxiv_data1/oa_pdf/53/e9/ymj-55-1406.PMC4108831.pdf
"2 Injection of botulinum  toxin type A (BoNT-A) into spastic muscles is widely used as a safe and effective Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1406 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1406-1412, 2014",Non-OADS,/arxiv_data1/oa_pdf/53/e9/ymj-55-1406.PMC4108831.pdf
GCM Changes after BTX-A Injection in Spastic CP Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1407muscles (GCM).,Non-OADS,/arxiv_data1/oa_pdf/53/e9/ymj-55-1406.PMC4108831.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1408months after injection.,Non-OADS,/arxiv_data1/oa_pdf/53/e9/ymj-55-1406.PMC4108831.pdf
"GCM Changes after BTX-A Injection in Spastic CP Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1409veloping children,18 and also correlated with the functional  level of children with CP .19 These findings suggest that the  muscle thickness measured with US in children with CP  can be used as an alternative measure to quantitatively eval - uate muscle strength.19 Our study revealed a significant re - duction in MT measured both at 25% and 30% of the TL  after toxin injection.",Non-OADS,/arxiv_data1/oa_pdf/53/e9/ymj-55-1406.PMC4108831.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1410muscles in children and adolescents with CP , compared with  age matched typically developing participants.9 Our study revealed a significant decrease in FA in both  resting and neutral positions, whereas FL was only increased  in the resting position after the toxin injection.",Non-OADS,/arxiv_data1/oa_pdf/53/e9/ymj-55-1406.PMC4108831.pdf
"GCM Changes after BTX-A Injection in Spastic CP Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1411timing of disappearance of the toxin effect on muscular ar - chitecture with long-term follow-up, and changes to repeti - tions of toxin injection have to be investigated further in or - der to delineate the strengths and weakness of the toxin on  muscle function in children with CP .",Non-OADS,/arxiv_data1/oa_pdf/53/e9/ymj-55-1406.PMC4108831.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1412spastic cerebral palsy.,Non-OADS,/arxiv_data1/oa_pdf/53/e9/ymj-55-1406.PMC4108831.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1413Evaluation of Optical Quality Parameters and Ocular Aberrations  in Multifocal Intraocular Lens Implanted Eyes   Hun Lee,1* Kwanghyun Lee,1* Ji Min Ahn,1 Eung Kweon Kim,1,2 Bradford Sgrignoli,1 and Tae-im Kim1 1Department of Ophthalmology, Institute of Vision Research, Yonsei University College of Medicine, Seoul; 2Department of Ophthalmology, Corneal Dystrophy Research Institute, Severance Biomedical Science Institute,  Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/51/7d/ymj-55-1413.PMC4108832.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  We investigated the correlations between optical quality parameters ob - tained from the double-pass system and ocular aberrations obtained from the ray- tracing aberrometer in multifocal intraocular lens (IOL) implanted eyes.",Non-OADS,/arxiv_data1/oa_pdf/51/7d/ymj-55-1413.PMC4108832.pdf
"4-6 In these stud -Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1413 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1413-1420, 2014",Non-OADS,/arxiv_data1/oa_pdf/51/7d/ymj-55-1413.PMC4108832.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1414the reflected light arrives at the detector, which has limited  resolution from the high wavefront aberration of a multifo - cal IOL.",Non-OADS,/arxiv_data1/oa_pdf/51/7d/ymj-55-1413.PMC4108832.pdf
Optical Quality in Multifocal IOL Implanted Eyes Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1415logic dilatation.,Non-OADS,/arxiv_data1/oa_pdf/51/7d/ymj-55-1413.PMC4108832.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1416tained from the ray-tracing aberrometer, 11.00±7.50 ( p=  0.005, Wilcoxon signed-rank test).",OADS,/arxiv_data1/oa_pdf/51/7d/ymj-55-1413.PMC4108832.pdf
Optical Quality in Multifocal IOL Implanted Eyes Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1417ity parameter (Strehl ratio) and total aberration.,Non-OADS,/arxiv_data1/oa_pdf/51/7d/ymj-55-1413.PMC4108832.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1418sured under relatively small pupils on optical quality could  be underestimated.,Non-OADS,/arxiv_data1/oa_pdf/51/7d/ymj-55-1413.PMC4108832.pdf
Optical Quality in Multifocal IOL Implanted Eyes Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1419after bilateral implantation of a +3.00 D versus a +4.00 D multifo - cal intraocular lens.,Non-OADS,/arxiv_data1/oa_pdf/51/7d/ymj-55-1413.PMC4108832.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 142032.,Non-OADS,/arxiv_data1/oa_pdf/51/7d/ymj-55-1413.PMC4108832.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1421Bispectral Index Monitoring during Anesthesiologist-Directed  Propofol and Remifentanil Sedation for Endoscopic Submucosal  Dissection: A Prospective Randomized Controlled Trial   Woo Young Park,1 Yang-Sik Shin,2 Sang Kil Lee,3 So Yeon Kim,2 Tai Kyung Lee,2 and Yong Seon Choi2 1Department of Anesthesiology and Pain Medicine, Yonsei University Wonju College of Medicine, Wonju; 2Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul; 3Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/25/3d/ymj-55-1421.PMC4108833.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Endoscopic submucosal dissection (ESD) is a technically difficult and  lengthy procedure requiring optimal depth of sedation.",Non-OADS,/arxiv_data1/oa_pdf/25/3d/ymj-55-1421.PMC4108833.pdf
"Endoscopic submucosal dissection (ESD) is a new and mini - mally invasive method for the resection of early gastric cancers and gastric adeno - mas that allows for en-bloc resection and an accurate histological evaluation.1,2 Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1421 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1421-1429, 2014",Non-OADS,/arxiv_data1/oa_pdf/25/3d/ymj-55-1421.PMC4108833.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1422cholangiopancreatography (ERCP), BIS monitoring of pro - pofol-induced deep sedation has been reported to reduce  the mean propofol dose and recovery times.16,17 However,  studies evaluating the clinical usefulness of BIS monitoring  for gastrointestinal endoscopy have shown inconsistent re - sults with regards to the dose of sedatives, satisfaction scores,  and the risk of complications.14-19 Furthermore, the evi - dence is limited regarding the effects of BIS monitoring on  the clinical benefit of the stable maintenance of optimal se - dation during ESD procedures using propofol infusion with  opioids.",Non-OADS,/arxiv_data1/oa_pdf/25/3d/ymj-55-1421.PMC4108833.pdf
"Bispectral Index Monitoring of Sedation  Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1423according to the target level of sedation; to simulate the cur - rent situation in Korea, a target-controlled infusion system  was not used.",Non-OADS,/arxiv_data1/oa_pdf/25/3d/ymj-55-1421.PMC4108833.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 142490 patients would be required for each group.,Non-OADS,/arxiv_data1/oa_pdf/25/3d/ymj-55-1421.PMC4108833.pdf
Bispectral Index Monitoring of Sedation  Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1425groups with regard to the incidence of complications and  recall of the procedure (Table 5).,Non-OADS,/arxiv_data1/oa_pdf/25/3d/ymj-55-1421.PMC4108833.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1426administered.,Non-OADS,/arxiv_data1/oa_pdf/25/3d/ymj-55-1421.PMC4108833.pdf
Bispectral Index Monitoring of Sedation  Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1427safety of patients in most countries.,Non-OADS,/arxiv_data1/oa_pdf/25/3d/ymj-55-1421.PMC4108833.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 142810.,Non-OADS,/arxiv_data1/oa_pdf/25/3d/ymj-55-1421.PMC4108833.pdf
Bispectral Index Monitoring of Sedation  Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1429sponsiveness during anesthesia with propofol and remifentanil.,Non-OADS,/arxiv_data1/oa_pdf/25/3d/ymj-55-1421.PMC4108833.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1430Incidence and Risk Factors of Postoperative Nausea and Vomiting  in Patients with Fentanyl-Based Intravenous Patient-Controlled  Analgesia and Single Antiemetic Prophylaxis Jong Bum Choi, Yon Hee Shim, Youn-Woo Lee, Jeong Soo Lee, Jong-Rim Choi, and Chul Ho Chang Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/34/4a/ymj-55-1430.PMC4108834.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  We evaluated the incidence and risk factors of postoperative nausea and  vomiting (PONV) in patients with fentanyl-based intravenous patient-controlled  analgesia (IV-PCA) and single antiemetic prophylaxis of 5-hydroxytryptamine type 3 (5 HT 3)-receptor antagonist after the general anesthesia.",Non-OADS,/arxiv_data1/oa_pdf/34/4a/ymj-55-1430.PMC4108834.pdf
"Key Words:    Analgesia, antiemetics, fentanyl, patient-controlled, postoperative  nausea and vomiting INTRODUCTION Postoperative nausea and vomiting (PONV) is one of the most common complica - tions after general anesthesia, occurring up to 80%.1 Although PONV is often self- limiting, it has been cited by patients as more uncomfortable than postoperative  pain.2Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1430 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1430-1435, 2014",Non-OADS,/arxiv_data1/oa_pdf/34/4a/ymj-55-1430.PMC4108834.pdf
"Postoperative Nausea and V omiting Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1431(diabetes, hypertension, radiation therapy and chemothera - py).",Non-OADS,/arxiv_data1/oa_pdf/34/4a/ymj-55-1430.PMC4108834.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1432Table 2 shows the results of univariate analysis of risk fac - tors for PONV .,OADS,/arxiv_data1/oa_pdf/34/4a/ymj-55-1430.PMC4108834.pdf
Postoperative Nausea and V omiting Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1433though propofol is generally assumed to be antiemetic.,Non-OADS,/arxiv_data1/oa_pdf/34/4a/ymj-55-1430.PMC4108834.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1434emetics.29 However, recent studies suggest that compliance  with these algorithms may be poor and that high-risk pa - tients often do not receive appropriate antiemetic prophy - laxis; thus, rather than risk-adapted approach, liberal and  fixed combination prophylaxis could be advantageous for a  larger proportion of patients.5 As the risk reduction by pre - ventive interventions is proportion to baseline risk,30 the  prophylaxis may be less advantageous in low-risk patients.",Non-OADS,/arxiv_data1/oa_pdf/34/4a/ymj-55-1430.PMC4108834.pdf
Postoperative Nausea and V omiting Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1435uled for elective supratentorial craniotomy.,Non-OADS,/arxiv_data1/oa_pdf/34/4a/ymj-55-1430.PMC4108834.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1436Pre-Emptive Tramadol Could Reduce Pain   after Ureteroscopic Lithotripsy Ana Mimi ć,1 Nataša Denčić,1 Jelena Jovi čić,1 Jelena Mirkovi ć,1  Otaš Durutovi ć,2,3 Dragica Milenkovi ć-Petronić,2,3 and Neboj ša Lađević1,3 1Clinical Center of Serbia, Urology Clinic, Department of Anesthesia, Belgrade; 2Clinical Center of Serbia, Urology Clinic, Department of Urology, Belgrade;  3School of Medicine, University of Belgrade, Belgrade, Serbia.",Non-OADS,/arxiv_data1/oa_pdf/7d/60/ymj-55-1436.PMC4108835.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Optimal analgesia in ambulatory urology patients still remains a chal - lenge.",Non-OADS,/arxiv_data1/oa_pdf/7d/60/ymj-55-1436.PMC4108835.pdf
"According to McGrath, there are still a lot of patients who suffer moder - ate to severe pain after one-day surgery, even though theoretical knowledge in pain Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1436 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1436-1441, 2014",Non-OADS,/arxiv_data1/oa_pdf/7d/60/ymj-55-1436.PMC4108835.pdf
"Pre-Emptive Tramadol Reduces V AS Scores after URSL Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1437fects of tramadol, as well as visual analogue scale (V AS)  scores, were thoroughly explained.",Non-OADS,/arxiv_data1/oa_pdf/7d/60/ymj-55-1436.PMC4108835.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1438der, ASA status, BMI), number of previous operations, and  URSL interventions between the two groups (Table 1).",OADS,/arxiv_data1/oa_pdf/7d/60/ymj-55-1436.PMC4108835.pdf
Pre-Emptive Tramadol Reduces V AS Scores after URSL Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1439urology surgery.,Non-OADS,/arxiv_data1/oa_pdf/7d/60/ymj-55-1436.PMC4108835.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1440analgesia provided in the ward was clearly insufficient for  our patients who experienced moderate to severe pain.,Non-OADS,/arxiv_data1/oa_pdf/7d/60/ymj-55-1436.PMC4108835.pdf
Pre-Emptive Tramadol Reduces V AS Scores after URSL Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 144113.,Non-OADS,/arxiv_data1/oa_pdf/7d/60/ymj-55-1436.PMC4108835.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1442Development and Validation of the Korean Version   of the Female Sexual Function Index-6 (FSFI-6K) Yumi Lee,1 Myong Cheol Lim,1,2 Jungnam Joo,3 KiByung Park,3 Suji Lee,4  Sijung Seo,5 Dong Ock Lee,1 and Sang-Yoon Park1,2 1Center for Uterine Cancer, 2Gynecologic Cancer Branch, and 3Biometric Research Branch, Research Institute and Hospital,  National Cancer Center, Goyang; 4Department of Nursing, Chung-Ang University, Seoul;  5Ewha Womans University Medical Center, Mokdong Hospital, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/95/5f/ymj-55-1442.PMC4108836.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  To evaluate the validity and reliability of the Korean version of the Fe - male Sexual Function Index-6 (FSFI-6K).",Non-OADS,/arxiv_data1/oa_pdf/95/5f/ymj-55-1442.PMC4108836.pdf
"7-12Original Articlehttp://dx.doi.org/10.3349/ymj.2014.55.5.1442 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1442-1446, 2014",Non-OADS,/arxiv_data1/oa_pdf/95/5f/ymj-55-1442.PMC4108836.pdf
"Korean V ersion of the Female Sexual Function Index-6 (FSFI-6K) Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1443developed in 2002.10 Since then, the FSFI has been translat - ed into many languages, becoming the gold standard for  measuring female sexual function.9,14,15 FSD is diagnosed if  the FSFI score is <26.55.6 Procedure After obtaining Institutional Review Board approval  (NCCNCS-12-685), the FSFI-6K was translated.",Non-OADS,/arxiv_data1/oa_pdf/95/5f/ymj-55-1442.PMC4108836.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1444retest was calculated of ICC (0.606).,OADS,/arxiv_data1/oa_pdf/95/5f/ymj-55-1442.PMC4108836.pdf
Korean V ersion of the Female Sexual Function Index-6 (FSFI-6K) Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1445ducted in the obstetric and gynecologic outpatient popula - tion and in those who were mostly disease-free.,Non-OADS,/arxiv_data1/oa_pdf/95/5f/ymj-55-1442.PMC4108836.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 14469.,Non-OADS,/arxiv_data1/oa_pdf/95/5f/ymj-55-1442.PMC4108836.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1447Silicon Dioxide Particles Deposited in Vessels and   Cartilage of the Femoral Head  Min Xu,1 Meiying Qing,2 and Dan Peng3  Departments of 1Intensive Care Unit, 2Urinary Surgery, and 3Orthopedics, Second Xiangya Hospital, Central South University, Hunan, P .",Non-OADS,/arxiv_data1/oa_pdf/c6/49/ymj-55-1447.PMC4108837.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Silicosis had been considered for decades as an illness with manifestations of lung  fibrosis due to inhalation of overconcentrated SiO 2 dust.",Non-OADS,/arxiv_data1/oa_pdf/c6/49/ymj-55-1447.PMC4108837.pdf
"Routine blood test, liver and renal function, E6A, ESR, CRP , HLA-B27, ASO, and RHF were all in their nor -Case Reporthttp://dx.doi.org/10.3349/ymj.2014.55.5.1447 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1447-1449, 2014",OADS,/arxiv_data1/oa_pdf/c6/49/ymj-55-1447.PMC4108837.pdf
"Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1448larized light microscopy revealed chronic synovitis and  proliferation of granuloma, as well as the presence of con - siderable brownish acicular, rhombic, and crumb-like crys - tals.",Non-OADS,/arxiv_data1/oa_pdf/c6/49/ymj-55-1447.PMC4108837.pdf
"Silicon Dioxide Particles Deposited in V essels and Cartilage of the Femoral Head Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1449were not confined only to the lungs, but also other tissues  and organs through blood circulation, inducing pathological  changes.",Non-OADS,/arxiv_data1/oa_pdf/c6/49/ymj-55-1447.PMC4108837.pdf
Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1450Do Intranodular Macrocalcifications Really Play an Important  Role in Sonographic Prediction of Malignancy?,Non-OADS,/arxiv_data1/oa_pdf/09/89/ymj-55-1450.PMC4108838.pdf
"© Copyright: Yonsei University College of Medicine 2014 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.The Original research article, written by Park, et al.1 entitled, “Thyroid Nodules  with Macrocalcification: Sonographic Findings Predictive of Malignancy.’’ in the  March-2014 issue of YMJ, is a well-written paper and we want to acknowledge Park, et al.",Non-OADS,/arxiv_data1/oa_pdf/09/89/ymj-55-1450.PMC4108838.pdf
"Like the calcification widths, existence of a 1 mm or larger soft tissue rim cir - cumscribing macrocalcification was also defined as soft tissue echogenicity and Letter to the Editorhttp://dx.doi.org/10.3349/ymj.2014.55.5.1450 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 55(5):1450-1451, 2014",Non-OADS,/arxiv_data1/oa_pdf/09/89/ymj-55-1450.PMC4108838.pdf
"Intranodular Macrocalcifications for Prediction of Malignancy Yonsei Med J   http://www.eymj.org   Volume 55   Number 5   September 2014 1451macrocalcifications in patients ≤45 years old compared to  older patients).5,6 In conclusion, based on our experience, the major sono - graphic characteristics of nodules that can be used to pre - dict malignancy consist of the presence of a taller-than- wide or irregular shape, irregular margin with interruption  of macrocalcification and nodules that require further eval - uation by FNAB.1,3,5-7 As well, type and category of macro - calcifications might be more important in the diagnosis of  malignancy of nodules than the size of macrocalcifications  in the nodule, such as coarse and peripheral egg-shell calci - fications being benign with a few exceptions.5,7,8  REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/09/89/ymj-55-1450.PMC4108838.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/67/91/srep05817.PMC4108910.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5817 | DOI: 10.1038/srep05817 6",Non-OADS,/arxiv_data1/oa_pdf/67/91/srep05817.PMC4108910.pdf
Quality checked reads were then screened against the human reference genome hg19 using BWA-MEM35and SOAP aligner (http://soap.genomics.org.cn) and reads with .95% identity over 75% of their length to human DNA were removed from further analysis.,OADS,/arxiv_data1/oa_pdf/50/22/srep05807.PMC4108911.pdf
The rest of the sequences were normalized (http://ged.msu.edu/ papers/2012-diginorm) to discard redundant data and reduce sampling variation and sequencing errors.,OADS,/arxiv_data1/oa_pdf/50/22/srep05807.PMC4108911.pdf
"The normalized dataset was then processed for assembly using the Trinity36, SOAPdenovo and SOAPdenovo-Trans (http://soap.genomics.org.cn/) assemblers into contiguous sequences (contigs).",OADS,/arxiv_data1/oa_pdf/50/22/srep05807.PMC4108911.pdf
supervised the project.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2f/1b/srep05818.PMC4108912.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5818 | DOI: 10.1038/srep05818 5",Non-OADS,/arxiv_data1/oa_pdf/2f/1b/srep05818.PMC4108912.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5804 | DOI: 10.1038/srep05804 7",Non-OADS,/arxiv_data1/oa_pdf/ff/0e/srep05804.PMC4108914.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5814 | DOI: 10.1038/srep05814 9",Non-OADS,/arxiv_data1/oa_pdf/8b/8f/srep05814.PMC4108915.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/68/27/srep05812.PMC4108927.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5812 | DOI: 10.1038/srep05812 6",Non-OADS,/arxiv_data1/oa_pdf/68/27/srep05812.PMC4108927.pdf
"The cutoff point for the ROR1 expression score that was statistically significant in terms of survival was set using the X-tile software program (The Rimm Lab at YaleUniversity; http://www.tissuearray.org/rimmlab) as described previously 38.T h e degree of ROR1 staining was quantified using a two-level grading system, and staining scores were defined as follows: 0–1, low expression, and 2–9, high expression.",OADS,/arxiv_data1/oa_pdf/c8/d8/srep05811.PMC4108928.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5811 | DOI: 10.1038/srep05811 7",Non-OADS,/arxiv_data1/oa_pdf/c8/d8/srep05811.PMC4108928.pdf
All of the authors reviewed the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d0/83/srep05805.PMC4108945.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5805 | DOI: 10.1038/srep05805 7",Non-OADS,/arxiv_data1/oa_pdf/d0/83/srep05805.PMC4108945.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/8d/97/srep05810.PMC4108946.pdf
"Pathogenesis andprognostication inacute lymphoblastic leukemia Tsila Zuckerman1,3*andJacob M.Rowe2,3 Addresses:1Department ofHematology andBone Marrow Transplantation, Rambam Health Care Campus, 8Ha’Aliya Street, Haifa 31096, Israel; 2Department ofHematology, Shaare Zedek Medical Center, 12Bayit Street, Jerusalem 91031, Israel;3Bruce Rappaport Faculty ofMedicine, Technion, Israel Institute ofTechnology, Efron Street, Haifa 31096, Israel *Corresponding author: Tsila Zuckerman (t_zuckerman@rambam.health.gov.il) F1000Prime Reports 2014, 6:59(doi:10.12703/P6-59) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/5f/medrep-06-59.PMC4108947.pdf
The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/m/6/59 Abstract Theprocess oflymphoid maturation istightly controlled bythehierarchical activation oftranscription factors and selection through functional signal transduction.,Non-OADS,/arxiv_data1/oa_pdf/e0/5f/medrep-06-59.PMC4108947.pdf
"Page 2of5 (page number notforcitation purposes)F1000Prime Reports 2014, 6:59 http://f1000.com/prime/reports/m/6/59",Non-OADS,/arxiv_data1/oa_pdf/e0/5f/medrep-06-59.PMC4108947.pdf
"ARID5B ,IKZF1 ,CEBPE , and BMI1-PIP4K2A variants cumulatively conferred a strong predisposition to ALL, with children carrying six Page 3 of 5 (page number not for citation purposes)F1000Prime Reports 2014, 6:59 http://f1000.com/prime/reports/m/6/59",Non-OADS,/arxiv_data1/oa_pdf/e0/5f/medrep-06-59.PMC4108947.pdf
"Russell LJ, Capasso M, Vater I, Akasaka T, Bernard OA, Calasanz MJ, Chandrasekaran T, Chapiro E, Gesk S, Griffiths M, Guttery DS, Haferlach C, Harder L, Heidenreich O, Irving J, Kearney L, Nguyen-Khac F, Machado L, Minto L, Majid A, Moorman AV, Morrison H, Rand V, Strefford JC, Schwab C, Tönnies H, Dyer, Martin JS, Siebert R, Harrison CJ: Deregulated expression of cytokine receptor Page 4 of 5 (page number not for citation purposes)F1000Prime Reports 2014, 6:59 http://f1000.com/prime/reports/m/6/59",Non-OADS,/arxiv_data1/oa_pdf/e0/5f/medrep-06-59.PMC4108947.pdf
"Page 5 of 5 (page number not for citation purposes)F1000Prime Reports 2014, 6:59 http://f1000.com/prime/reports/m/6/59",Non-OADS,/arxiv_data1/oa_pdf/e0/5f/medrep-06-59.PMC4108947.pdf
"Intermediate filaments: adynamic network that controls cell mechanics Yosef Gruenbaum1*andUeli Aebi2* Addresses:1Department ofGenetics, Institute ofLifeSciences, Hebrew University ofJerusalem, Givat Ram, Jerusalem 91904, Israel;2Biozentrum, University ofBasel, Klingelbergerstrasse 70,CH-4056 Basel, Switzerland *Corresponding authors: Yosef Gruenbaum (gru@vms.huji.ac.il); Ueli Aebi (ueli.aebi@unibas.ch) F1000Prime Reports 2014, 6:54(doi:10.12703/P6-54) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/30/biolrep-06-54.PMC4108948.pdf
"The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/b/6/54 Abstract Inhumans thesuperfamily ofintermediate filament (IF)proteins isencoded bymore than70different genes, which areexpressed inacell- andtissue-specific manner.",Non-OADS,/arxiv_data1/oa_pdf/25/30/biolrep-06-54.PMC4108948.pdf
"This, in turn, results in cell death and progressive failure in muscle tissues Page 2 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:54 http://f1000.com/prime/reports/b/6/54",Non-OADS,/arxiv_data1/oa_pdf/25/30/biolrep-06-54.PMC4108948.pdf
(http://www.sciencemag.org/content /341/ 6149/1240104.abstract).,Non-OADS,/arxiv_data1/oa_pdf/25/30/biolrep-06-54.PMC4108948.pdf
"Page 3 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:54 http://f1000.com/prime/reports/b/6/54",Non-OADS,/arxiv_data1/oa_pdf/25/30/biolrep-06-54.PMC4108948.pdf
"Vimentin organization modulates lamellipodia formation and cell migration While vimentin IF networks extend throughout the rear and perinuclear space of migrating fibroblasts, in Page 4 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:54 http://f1000.com/prime/reports/b/6/54",OADS,/arxiv_data1/oa_pdf/25/30/biolrep-06-54.PMC4108948.pdf
"Page 5of7 (page number notforcitation purposes)F1000Prime Reports 2014, 6:54 http://f1000.com/prime/reports/b/6/54",Non-OADS,/arxiv_data1/oa_pdf/25/30/biolrep-06-54.PMC4108948.pdf
"Page 6 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:54 http://f1000.com/prime/reports/b/6/54",Non-OADS,/arxiv_data1/oa_pdf/25/30/biolrep-06-54.PMC4108948.pdf
"Page 7 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:54 http://f1000.com/prime/reports/b/6/54",Non-OADS,/arxiv_data1/oa_pdf/25/30/biolrep-06-54.PMC4108948.pdf
"Advances intreating premature ejaculation Selahittin Çayan1*andEgeCan Şerefo ğlu2 Addresses:1Department ofUrology, University ofMersin School ofMedicine, Çiftlikköy Kampusu 33343 Yenisehir, Mersin, Turkey;2Department ofUrology, Bağcilar Training andResearch Center, Merkez Mah No:6 34200 Bagcilar, Istanbul, Turkey *Corresponding author: Selahittin Çayan (selcayan@mersin.edu.tr) F1000Prime Reports 2014, 6:55(doi:10.12703/P6-55) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/9a/medrep-06-55.PMC4108949.pdf
"The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/m/6/55 Abstract Inspite ofitshigh prevalence andlong history, theambiguity regarding thedefinition, epidemiology andmanagement ofpremature ejaculation continues.",Non-OADS,/arxiv_data1/oa_pdf/13/9a/medrep-06-55.PMC4108949.pdf
"It should be remembered that many men with premature ejaculation may prefer the convenience Page 2 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:55 http://f1000.com/prime/reports/m/6/55",Non-OADS,/arxiv_data1/oa_pdf/13/9a/medrep-06-55.PMC4108949.pdf
"[75] demonstrated thatunilateral CT-guidedTable 1:Medical treatment options forpremature ejaculation [58] Therapy type Drug Trade name Dose IELT foldincrease Topical therapy Lidocaine/prilocaine cream [29] EMLA® cream 25mg/gm lidocaine, 25mg/gm prilocaine 4-6 Oral therapy Dapoxetine [35,49,31,39] Priligy® 30-60 mgondemand 2.5-3 Oral therapy Clomipramine [30,34,38] Anafranil® 12.5-50 mg/day or 12.5-50 mgondemand6 4 Oral therapy Fluoxetine [56,64,23,66 –68] Prozac®, Sarafem® 20-40 mg/day 5 Oral therapy Paroxetine [36–38,60] Paxil®, Seroxat® 10-40 mg/day or 10-40 mg/day ondemand8 1.4 Oral therapy Sertraline [59,64,61-66] Zoloft® 50-200 mg/day 5 Oral therapy Citalopram [67–68] Celexa®, Cipramil® 20-40 mg/day 2 Oral therapy Tramadol [69] Zertane® 62mgODT ondemand or89mgODT on demand2.4 2.5 Page 3of6 (page number notforcitation purposes)F1000Prime Reports 2014, 6:55 http://f1000.com/prime/reports/m/6/55",Non-OADS,/arxiv_data1/oa_pdf/13/9a/medrep-06-55.PMC4108949.pdf
"Waldinger M,Berendsen HH,Blok BF,Olivier B,Holstege G:Premature ejaculation andserotonergic antidepressants-induced delayed Page 4of6 (page number notforcitation purposes)F1000Prime Reports 2014, 6:55 http://f1000.com/prime/reports/m/6/55",Non-OADS,/arxiv_data1/oa_pdf/13/9a/medrep-06-55.PMC4108949.pdf
"Althof SE,Abdo CH, Dean J,Hackett G,McCabe M,McMahon CG, Rosen RC,Sadovsky R,Waldinger M,Becher E,Broderick GA, Buvat J, Goldstein I,El-Meliegy AI,Giuliano F,Hellstrom WJ, Incrocci L, Jannini EA,Park K,Parish S,Porst H,Rowland D,Segraves R,Sharlip I, Simonelli C,Tan HM; International Society forSexual Medicine: International Society forSexual Medicine ’sguidelines forthe Page 5of6 (page number notforcitation purposes)F1000Prime Reports 2014, 6:55 http://f1000.com/prime/reports/m/6/55",Non-OADS,/arxiv_data1/oa_pdf/13/9a/medrep-06-55.PMC4108949.pdf
"Page 6 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:55 http://f1000.com/prime/reports/m/6/55",Non-OADS,/arxiv_data1/oa_pdf/13/9a/medrep-06-55.PMC4108949.pdf
"50/3537, Bethesda, MD 20892, USA Email: puertolr@mail.nih.gov F1000Prime Reports 2014, 6:52(doi:10.12703/P6-52) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/12/biolrep-06-52.PMC4108950.pdf
The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/b/6/52 Abstract Lysosomes arekeycellular organelles thatplayacrucial roleincatabolism bydegrading extracellular and intracellular material.,Non-OADS,/arxiv_data1/oa_pdf/d5/12/biolrep-06-52.PMC4108950.pdf
"Page 2 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:52 http://f1000.com/prime/reports/b/6/52",Non-OADS,/arxiv_data1/oa_pdf/d5/12/biolrep-06-52.PMC4108950.pdf
"TFEB also activates expression ofgenes that directly increase lysosomal activity, including several subunits of the v-ATPase, lysosomal hydrolases, Page 3 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:52 http://f1000.com/prime/reports/b/6/52",Non-OADS,/arxiv_data1/oa_pdf/d5/12/biolrep-06-52.PMC4108950.pdf
"In this process, long and stable tubules emanatefrom autolysosomes and eventually pinch off to form Page 4 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:52 http://f1000.com/prime/reports/b/6/52",Non-OADS,/arxiv_data1/oa_pdf/d5/12/biolrep-06-52.PMC4108950.pdf
"Page 5 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:52 http://f1000.com/prime/reports/b/6/52",Non-OADS,/arxiv_data1/oa_pdf/d5/12/biolrep-06-52.PMC4108950.pdf
"Page 6 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:52 http://f1000.com/prime/reports/b/6/52",Non-OADS,/arxiv_data1/oa_pdf/d5/12/biolrep-06-52.PMC4108950.pdf
"Page 7 of 7 (page number not for citation purposes)F1000Prime Reports 2014, 6:52 http://f1000.com/prime/reports/b/6/52",Non-OADS,/arxiv_data1/oa_pdf/d5/12/biolrep-06-52.PMC4108950.pdf
"Management oftricuspid regurgitation Michele DeBonis*, Maurizio Taramasso, Elisabetta Lapenna, andOttavio Alfieri Address: Department ofCardiac Surgery, SanRaffaele Scientific Institute, ViaOlgettina 60,Milan, Italy *Corresponding author: Michele DeBonis (debonis.michele@hsr.it) F1000Prime Reports 2014, 6:58(doi:10.12703/P6-58) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/32/medrep-06-58.PMC4108951.pdf
The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/m/6/58 Abstract Secondary tricuspid regurgitation isthemost frequent type oftricuspid insufficiency inwestern countries.,Non-OADS,/arxiv_data1/oa_pdf/55/32/medrep-06-58.PMC4108951.pdf
"Among the different types of Page 2 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:58 http://f1000.com/prime/reports/m/6/58",Non-OADS,/arxiv_data1/oa_pdf/55/32/medrep-06-58.PMC4108951.pdf
"Page 3of6 (page number notforcitation purposes)F1000Prime Reports 2014, 6:58 http://f1000.com/prime/reports/m/6/58",Non-OADS,/arxiv_data1/oa_pdf/55/32/medrep-06-58.PMC4108951.pdf
"Page 4 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:58 http://f1000.com/prime/reports/m/6/58",Non-OADS,/arxiv_data1/oa_pdf/55/32/medrep-06-58.PMC4108951.pdf
"Fukuda S,Gillinov AM, McCarthy PM, Matsumura Y,Thomas JD, Shiota T:Echocardiographic follow-up oftricuspid annuloplasty Page 5of6 (page number notforcitation purposes)F1000Prime Reports 2014, 6:58 http://f1000.com/prime/reports/m/6/58",OADS,/arxiv_data1/oa_pdf/55/32/medrep-06-58.PMC4108951.pdf
"Page 6 of 6 (page number not for citation purposes)F1000Prime Reports 2014, 6:58 http://f1000.com/prime/reports/m/6/58",Non-OADS,/arxiv_data1/oa_pdf/55/32/medrep-06-58.PMC4108951.pdf
The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/m/6/ 50 Abstract Rosacea isachronic relapsing inflammatory facial dermatosis.,Non-OADS,/arxiv_data1/oa_pdf/41/02/medrep-06-50.PMC4108952.pdf
"Demodex mites androsacea Thehuman mites Demodex folliculorum and Demodex brevis arethecause ofdemodicosis, adisease thatcanimitate a Page 2of7 (page number notforcitation purposes)F1000Prime Reports 2014, 6:50 http://f1000.com/prime/reports/m/6/ 50",Non-OADS,/arxiv_data1/oa_pdf/41/02/medrep-06-50.PMC4108952.pdf
"Page 3of7 (page number notforcitation purposes)F1000Prime Reports 2014, 6:50 http://f1000.com/prime/reports/m/6/ 50",Non-OADS,/arxiv_data1/oa_pdf/41/02/medrep-06-50.PMC4108952.pdf
"Treatment tailored to Page 4of7 (page number notforcitation purposes)F1000Prime Reports 2014, 6:50 http://f1000.com/prime/reports/m/6/ 50",Non-OADS,/arxiv_data1/oa_pdf/41/02/medrep-06-50.PMC4108952.pdf
"Drug(s) NCT01125930 atralin gel(tretinoin 0.5%) NCT01045551 apremilast NCT01134991 topical minocyline foam Page 5of7 (page number notforcitation purposes)F1000Prime Reports 2014, 6:50 http://f1000.com/prime/reports/m/6/ 50",Non-OADS,/arxiv_data1/oa_pdf/41/02/medrep-06-50.PMC4108952.pdf
"Tanghetti E,DelRosso, James Q,Thiboutot D,Gallo R,Webster G, Eichenfield LF,Stein-Gold L,Berson D,Zaenglein A:Consensus recommendations from theAmerican Acne &Rosacea Society Page 6of7 (page number notforcitation purposes)F1000Prime Reports 2014, 6:50 http://f1000.com/prime/reports/m/6/ 50",Non-OADS,/arxiv_data1/oa_pdf/41/02/medrep-06-50.PMC4108952.pdf
"[http://www.clinicaltrials.gov/] Page 7of7 (page number notforcitation purposes)F1000Prime Reports 2014, 6:50 http://f1000.com/prime/reports/m/6/ 50",Non-OADS,/arxiv_data1/oa_pdf/41/02/medrep-06-50.PMC4108952.pdf
"Convergence ofstem cellbehaviors andgenetic regulation between animals andplants: insights from the Arabidopsis thaliana stomatal lineage Juliana L.Matos2and Dominique C.Bergmann1,2* Addresses:1Howard Hughes Medical Institute and2Department ofBiology, 371 Serra Mall, Stanford University, Stanford, CA94305, USA *Corresponding author: Dominique C.Bergmann (dbergmann@stanford.edu) F1000Prime Reports 2014, 6:53(doi:10.12703/P6-53) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/da/2d/biolrep-06-53.PMC4108953.pdf
"The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/b/6/53 Abstract Plants andanimals aretwo successful, butvastly different, forms ofcomplex multicellular life.Inthe 1600 million years since they shared acommon unicellular ancestor, representatives ofthese kingdoms have hadample time todevise unique strategies forbuilding andmaintaining themselves, yet they have both developed self-renewing stem cellpopulations.",OADS,/arxiv_data1/oa_pdf/da/2d/biolrep-06-53.PMC4108953.pdf
"Page 2 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:53 http://f1000.com/prime/reports/b/6/53",Non-OADS,/arxiv_data1/oa_pdf/da/2d/biolrep-06-53.PMC4108953.pdf
"For our discussion here we will note only that plants lack manykey animal stem cell signaling pathways such as Wnt, Notch and Janus kinase/signal transducers and activators Page 3 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:53 http://f1000.com/prime/reports/b/6/53",Non-OADS,/arxiv_data1/oa_pdf/da/2d/biolrep-06-53.PMC4108953.pdf
"Page 4 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:53 http://f1000.com/prime/reports/b/6/53",Non-OADS,/arxiv_data1/oa_pdf/da/2d/biolrep-06-53.PMC4108953.pdf
"Page 5 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:53 http://f1000.com/prime/reports/b/6/53",Non-OADS,/arxiv_data1/oa_pdf/da/2d/biolrep-06-53.PMC4108953.pdf
"Page 6 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:53 http://f1000.com/prime/reports/b/6/53",Non-OADS,/arxiv_data1/oa_pdf/da/2d/biolrep-06-53.PMC4108953.pdf
"De Rybel B, Möller B, Yoshida S, Grabowicz I, de Reuille PB, Boeren S, Smith RS, Borst JW, Weijers D: A bHLH Complex Controls Page 7 of 8 (page number not for citation purposes)F1000Prime Reports 2014, 6:53 http://f1000.com/prime/reports/b/6/53",Non-OADS,/arxiv_data1/oa_pdf/da/2d/biolrep-06-53.PMC4108953.pdf
"Page 8of8 (page number notforcitation purposes)F1000Prime Reports 2014, 6:53 http://f1000.com/prime/reports/b/6/53",Non-OADS,/arxiv_data1/oa_pdf/da/2d/biolrep-06-53.PMC4108953.pdf
"Advances inmanaging medulloblastoma andintracranial primitive neuro-ectodermal tumors Jenny Adamski1,Vijay Ramaswamy2,Annie Huang1,2andEricBouffet1* Addresses:1Division ofHaematology/Oncology, TheHospital forSick Children, 555University Avenue, Toronto, Ontario M5G 1X8, Canada; 2Arthur andSonia Labatt Brain Tumour Research Centre, Brain Tumour Research Centre, TMDT, 101College St.,11-701, Toronto, Ontario M5G 1L7, Canada *Corresponding author: EricBouffet (eric.bouffet@sickkids.ca) F1000Prime Reports 2014, 6:56(doi:10.12703/P6-56) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/f4/medrep-06-56.PMC4108954.pdf
The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/m/6/56 Abstract Medulloblastoma andcentral nervous system (CNS)-primitive neuro-ectodermal tumors (PNETs) are adiverse group ofentities which encompasses different pathological andclinical pictures.,Non-OADS,/arxiv_data1/oa_pdf/39/f4/medrep-06-56.PMC4108954.pdf
"The Chang staging system for medulloblastoma Chang Staging Description of Staging M0 No evidence of metastasis M1 Tumor cells found in cerebrospinal fluidM2 Intracranial tumor beyond primary siteM3 Gross nodular seeding in spinal subarachnoid spaceM4 Metastasis outside the cerebrospinal axis (especially to bone marrow, bone) Page 2 of 12 (page number not for citation purposes)F1000Prime Reports 2014, 6:56 http://f1000.com/prime/reports/m/6/56",Non-OADS,/arxiv_data1/oa_pdf/39/f4/medrep-06-56.PMC4108954.pdf
"Page 3 of 12 (page number not for citation purposes)F1000Prime Reports 2014, 6:56 http://f1000.com/prime/reports/m/6/56",Non-OADS,/arxiv_data1/oa_pdf/39/f4/medrep-06-56.PMC4108954.pdf
"Reports have identified a subgroup of Page 4 of 12 (page number not for citation purposes)F1000Prime Reports 2014, 6:56 http://f1000.com/prime/reports/m/6/56",Non-OADS,/arxiv_data1/oa_pdf/39/f4/medrep-06-56.PMC4108954.pdf
"Page 5 of 12 (page number not for citation purposes)F1000Prime Reports 2014, 6:56 http://f1000.com/prime/reports/m/6/56",Non-OADS,/arxiv_data1/oa_pdf/39/f4/medrep-06-56.PMC4108954.pdf
"Within the sonic hedgehog pathway, druggable targets exist for which new agents are already in advanced stages Page 6 of 12 (page number not for citation purposes)F1000Prime Reports 2014, 6:56 http://f1000.com/prime/reports/m/6/56",Non-OADS,/arxiv_data1/oa_pdf/39/f4/medrep-06-56.PMC4108954.pdf
"Page 7of12 (page number notforcitation purposes)F1000Prime Reports 2014, 6:56 http://f1000.com/prime/reports/m/6/56",Non-OADS,/arxiv_data1/oa_pdf/39/f4/medrep-06-56.PMC4108954.pdf
"Page 8of12 (page number notforcitation purposes)F1000Prime Reports 2014, 6:56 http://f1000.com/prime/reports/m/6/56",Non-OADS,/arxiv_data1/oa_pdf/39/f4/medrep-06-56.PMC4108954.pdf
"Walter AW, Mulhern RK, Gajjar A,Heideman RL, Reardon D, Sanford RA,Xiong X,Kun LE:Survival andneurodevelopmental Page 9of12 (page number notforcitation purposes)F1000Prime Reports 2014, 6:56 http://f1000.com/prime/reports/m/6/56",Non-OADS,/arxiv_data1/oa_pdf/39/f4/medrep-06-56.PMC4108954.pdf
"Pizer BL, Weston CL, Robinson KJ,Ellison DW, Ironside J, Saran F,Lashford LS,Tait D,Lucraft H,Walker DA, Bailey CC, Taylor RE:Analysis ofpatients with supratentorial primitive Page 10of12 (page number notforcitation purposes)F1000Prime Reports 2014, 6:56 http://f1000.com/prime/reports/m/6/56",Non-OADS,/arxiv_data1/oa_pdf/39/f4/medrep-06-56.PMC4108954.pdf
"Korshunov A,Sturm D,Ryzhova M,Hovestadt V,Gessi M,Jones DT, Remke M,Northcott P,Perry A,Picard D,Rosenblum M,Antonelli M, Aronica E,Schüller U,Hasselblatt M,Woehrer A,Zheludkova O, Kumirova E,Puget S,Taylor MD, Giangaspero F,Peter Collins V,von Deimling A,Lichter P,Huang A,Pietsch T,Pfister SM, Kool M: Embryonal tumor with abundant neuropil andtrue rosettes (ETANTR), ependymoblastoma, and medulloepithelioma Page 11of12 (page number notforcitation purposes)F1000Prime Reports 2014, 6:56 http://f1000.com/prime/reports/m/6/56",Non-OADS,/arxiv_data1/oa_pdf/39/f4/medrep-06-56.PMC4108954.pdf
"Page 12 of 12 (page number not for citation purposes)F1000Prime Reports 2014, 6:56 http://f1000.com/prime/reports/m/6/56",Non-OADS,/arxiv_data1/oa_pdf/39/f4/medrep-06-56.PMC4108954.pdf
"Microbiome analysis –from technical advances tobiological relevance Michelle I.Smith1,Williams Turpin1,2,Andrea D.Tyler1,Mark S.Silverberg1,2 andKenneth Croitoru1,2* Addresses:1Zane Cohen Centre forDigestive Diseases, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600University Avenue, Room 437, Toronto, ON, Canada, M5G 1X5;2Institute ofMedical Science, Department ofMedicine, University ofToronto, Toronto, ON, Canada, M5S 1A8 *Corresponding author: Kenneth Croitoru (kcroitoru@mtsinai.on.ca) F1000Prime Reports 2014, 6:51(doi:10.12703/P6-51) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/99/biolrep-06-51.PMC4108955.pdf
The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/b/6/51 Abstract The development ofculture-independent techniques andnext-generation sequencing hasledtoa staggering rise inthenumber ofmicrobiome studies over thelastdecade.,Non-OADS,/arxiv_data1/oa_pdf/66/99/biolrep-06-51.PMC4108955.pdf
"Page 2of9 (page number notforcitation purposes)F1000Prime Reports 2014, 6:51 http://f1000.com/prime/reports/b/6/51",Non-OADS,/arxiv_data1/oa_pdf/66/99/biolrep-06-51.PMC4108955.pdf
"The output from the PICRUSt software shows an average of 80% correlation with shotgun sequencing [41] within Page 3 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:51 http://f1000.com/prime/reports/b/6/51",OADS,/arxiv_data1/oa_pdf/66/99/biolrep-06-51.PMC4108955.pdf
"Page 4 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:51 http://f1000.com/prime/reports/b/6/51",Non-OADS,/arxiv_data1/oa_pdf/66/99/biolrep-06-51.PMC4108955.pdf
"Page 5 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:51 http://f1000.com/prime/reports/b/6/51",Non-OADS,/arxiv_data1/oa_pdf/66/99/biolrep-06-51.PMC4108955.pdf
"Page 6 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:51 http://f1000.com/prime/reports/b/6/51",Non-OADS,/arxiv_data1/oa_pdf/66/99/biolrep-06-51.PMC4108955.pdf
"Page 7 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:51 http://f1000.com/prime/reports/b/6/51",Non-OADS,/arxiv_data1/oa_pdf/66/99/biolrep-06-51.PMC4108955.pdf
"Koeth RA,Wang Z,Levison BS,Buffa JA,Org E,Sheehy BT,Britt EB, FuX,Wu Y,LiL,Smith JD,DiDonato JA,Chen J,LiH,Wu GD, Lewis JD,Warrier M,Brown JM,Krauss RM, Tang WHWilson, Page 8of9 (page number notforcitation purposes)F1000Prime Reports 2014, 6:51 http://f1000.com/prime/reports/b/6/51",Non-OADS,/arxiv_data1/oa_pdf/66/99/biolrep-06-51.PMC4108955.pdf
"Page 9 of 9 (page number not for citation purposes)F1000Prime Reports 2014, 6:51 http://f1000.com/prime/reports/b/6/51",Non-OADS,/arxiv_data1/oa_pdf/66/99/biolrep-06-51.PMC4108955.pdf
"*Corresponding author: Matcheri Keshavan (mkeshava@bidmc.harvard.edu) F1000Prime Reports 2014, 6:57(doi:10.12703/P6-57) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/a6/medrep-06-57.PMC4108956.pdf
"The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/m/6/57 Abstract Schizophrenia is ahighly disabling disorder whose causes remain to be better understood, andtreatments have tobeimproved.",Non-OADS,/arxiv_data1/oa_pdf/96/a6/medrep-06-57.PMC4108956.pdf
"Among those studies attempting replication, few have been able to confirm Page 2 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:57 http://f1000.com/prime/reports/m/6/57",Non-OADS,/arxiv_data1/oa_pdf/96/a6/medrep-06-57.PMC4108956.pdf
"Page 3of11 (page number notforcitation purposes)F1000Prime Reports 2014, 6:57 http://f1000.com/prime/reports/m/6/57",Non-OADS,/arxiv_data1/oa_pdf/96/a6/medrep-06-57.PMC4108956.pdf
"Page 4 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:57 http://f1000.com/prime/reports/m/6/57",Non-OADS,/arxiv_data1/oa_pdf/96/a6/medrep-06-57.PMC4108956.pdf
"Page 5 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:57 http://f1000.com/prime/reports/m/6/57",Non-OADS,/arxiv_data1/oa_pdf/96/a6/medrep-06-57.PMC4108956.pdf
"The diagnosisof schizophrenia is still symptom-based, but increasingamounts of data point to the large genetic and neurobio- logical overlaps between psychotic, affective, and Page 6 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:57 http://f1000.com/prime/reports/m/6/57",Non-OADS,/arxiv_data1/oa_pdf/96/a6/medrep-06-57.PMC4108956.pdf
"Page 7 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:57 http://f1000.com/prime/reports/m/6/57",Non-OADS,/arxiv_data1/oa_pdf/96/a6/medrep-06-57.PMC4108956.pdf
"Page 8 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:57 http://f1000.com/prime/reports/m/6/57",Non-OADS,/arxiv_data1/oa_pdf/96/a6/medrep-06-57.PMC4108956.pdf
"Lewis SW, Barnes Thomas R E, Davies L, Murray RM, Dunn G, Hayhurst KP, Markwick A, Lloyd H, Jones PB: Randomized Page 9 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:57 http://f1000.com/prime/reports/m/6/57",Non-OADS,/arxiv_data1/oa_pdf/96/a6/medrep-06-57.PMC4108956.pdf
"Page 10 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:57 http://f1000.com/prime/reports/m/6/57",Non-OADS,/arxiv_data1/oa_pdf/96/a6/medrep-06-57.PMC4108956.pdf
"Page 11 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:57 http://f1000.com/prime/reports/m/6/57",Non-OADS,/arxiv_data1/oa_pdf/96/a6/medrep-06-57.PMC4108956.pdf
"Protein quality control intheendoplasmic reticulum Paul-Albert Koenig1*and Hidde L.Ploegh2 Addresses:1Klinikum rechts derIsar, Technische Universität München, Institut fürKlinische Chemie und Pathobiochemie, Ismaninger Straße 22, 81675 München, Germany;2Whitehead Institute forBiomedical Research, 9Cambridge Center, Cambridge, 02142 MA, USA *Corresponding author: Paul-Albert Koenig (koenig@lrz.tu-muenchen.de) F1000Prime Reports 2014, 6:49(doi:10.12703/P6-49) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/48/biolrep-06-49.PMC4108957.pdf
"The electronic version ofthisarticle isthecomplete one andcanbefound at:http://f1000.com/prime/reports/b/6/49 Abstract The topological barriers defined bybiological membranes arenotimpermeable: from small solutes to intact proteins, specialized transport andtranslocation mechanisms adjust tothecell ’sneeds.",Non-OADS,/arxiv_data1/oa_pdf/13/48/biolrep-06-49.PMC4108957.pdf
"Often overlooked isthefactthatsuch treatment notonly abolishes N-linked glycosylation, held responsible for theaccumulation ofproteins thatmisfold because ofthe Page 2of10 (page number notforcitation purposes)F1000Prime Reports 2014, 6:49 http://f1000.com/prime/reports/b/6/49",Non-OADS,/arxiv_data1/oa_pdf/13/48/biolrep-06-49.PMC4108957.pdf
"The machinery As far as degradation of ER-resident misfits is concerned,we can distinguish three broad classes of events: (a) recognition and engagement of degradation substrates; Page 3 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:49 http://f1000.com/prime/reports/b/6/49",Non-OADS,/arxiv_data1/oa_pdf/13/48/biolrep-06-49.PMC4108957.pdf
"Ubiquitin is removed and recycled prior to highly processive proteolysis by the 26S proteasom e. Page 4 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:49 http://f1000.com/prime/reports/b/6/49",Non-OADS,/arxiv_data1/oa_pdf/13/48/biolrep-06-49.PMC4108957.pdf
"Page 5 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:49 http://f1000.com/prime/reports/b/6/49",Non-OADS,/arxiv_data1/oa_pdf/13/48/biolrep-06-49.PMC4108957.pdf
"Page 6 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:49 http://f1000.com/prime/reports/b/6/49",Non-OADS,/arxiv_data1/oa_pdf/13/48/biolrep-06-49.PMC4108957.pdf
"Page 7 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:49 http://f1000.com/prime/reports/b/6/49",Non-OADS,/arxiv_data1/oa_pdf/13/48/biolrep-06-49.PMC4108957.pdf
"Luo B, Lam BS, Lee SH, Wey S, Zhou H, Wang M, Chen S, Adams GB, Lee AS: The endoplasmic reticulum chaperone protein GRP94 is required for maintaining hematopoietic stem cell Page 8 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:49 http://f1000.com/prime/reports/b/6/49",Non-OADS,/arxiv_data1/oa_pdf/13/48/biolrep-06-49.PMC4108957.pdf
"McLaughlin B, Buendia MA, Saborido TP, Palubinsky AM, Stankowski JN, Stanwood GD: Haploinsufficiency of the E3 ubiquitin ligase Page 9 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:49 http://f1000.com/prime/reports/b/6/49",Non-OADS,/arxiv_data1/oa_pdf/13/48/biolrep-06-49.PMC4108957.pdf
"Page 10 of 10 (page number not for citation purposes)F1000Prime Reports 2014, 6:49 http://f1000.com/prime/reports/b/6/49",Non-OADS,/arxiv_data1/oa_pdf/13/48/biolrep-06-49.PMC4108957.pdf
The source code of fluocell is published via Google Code (http://code.google.com/p/ fluocell).,OADS,/arxiv_data1/oa_pdf/f0/58/srep05756.PMC4108961.pdf
"and Yingxiao W. analyzed data; S.L., J.S., S.C. and Yingxiao W. wrote the paper.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.",Non-OADS,/arxiv_data1/oa_pdf/f0/58/srep05756.PMC4108961.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5756 | DOI: 10.1038/srep05756 10",Non-OADS,/arxiv_data1/oa_pdf/f0/58/srep05756.PMC4108961.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/b4/0e/ncomms5445.PMC4109007.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Liljestro ¨m, V. et al.",OADS,/arxiv_data1/oa_pdf/b4/0e/ncomms5445.PMC4109007.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5445 ARTICLE NATURE COMMUNICATIONS | 5:4445 | DOI: 10.1038/ncomms5445 | www.nature.com/naturecommunications 9 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/b4/0e/ncomms5445.PMC4109007.pdf
Non-linear regression calculations to identify the ﬁtted curve of the association and dissociation rates were performed in R software (http://www.r-project.org/index.html).,OADS,/arxiv_data1/oa_pdf/48/6d/ncomms5413.PMC4109009.pdf
was performed with Protein Basic Local Ali gnment Search Tool (pblast) available at http://blast.ncbi.nlm.nih.gov/Blas t.cgi?CMD=Web&PAGE_TYPE=BlastHome.,OADS,/arxiv_data1/oa_pdf/48/6d/ncomms5413.PMC4109009.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/48/6d/ncomms5413.PMC4109009.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Luchini, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/48/6d/ncomms5413.PMC4109009.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/72/57/ncomms5457.PMC4109010.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Castaings, L. et al.",Non-OADS,/arxiv_data1/oa_pdf/72/57/ncomms5457.PMC4109010.pdf
Preprint at http://arxiv.org/ abs/1403.3405 (2014).,Non-OADS,/arxiv_data1/oa_pdf/01/f2/ncomms5429.PMC4109012.pdf
Preprint at http://arxiv.org/abs/1402.5392 (2014).,Non-OADS,/arxiv_data1/oa_pdf/01/f2/ncomms5429.PMC4109012.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests : The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/01/f2/ncomms5429.PMC4109012.pdf
Reprints and permission information is available online at http://npg.nature.com/rep- rintsand permissions.,Non-OADS,/arxiv_data1/oa_pdf/01/f2/ncomms5429.PMC4109012.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5429 6 NATURE COMMUNICATIONS | 5:4429 | DOI: 10.1038/ncomms5429 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/01/f2/ncomms5429.PMC4109012.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/f0/55/ncomms5475.PMC4109013.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Qiao, J. et al.",Non-OADS,/arxiv_data1/oa_pdf/f0/55/ncomms5475.PMC4109013.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5475 ARTICLE NATURE COMMUNICATIONS | 5:4475 | DOI: 10.1038/ncomms5475 | www.nature.com/naturecommunications 7 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/f0/55/ncomms5475.PMC4109013.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/37/6c/ncomms5465.PMC4109014.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Peng, L. et al.",Non-OADS,/arxiv_data1/oa_pdf/37/6c/ncomms5465.PMC4109014.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5465 ARTICLE NATURE COMMUNICATIONS | 5:5465 | DOI: 10.1038/ncomms5465 | www.nature.com/naturecommunications 7 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/37/6c/ncomms5465.PMC4109014.pdf
"Crystallization, data collection and structure solution.The FALDH protein was assayed for crystallization High Throughput Crystallization Laboratory of the EMBL Grenoble Outstation (https://embl.fr/htxlab) by the vapour diffusionmethod64.",OADS,/arxiv_data1/oa_pdf/46/da/ncomms5439.PMC4109017.pdf
Illustrations were produced with Pymol (http://www.pymol.org) and MOLE42.,Non-OADS,/arxiv_data1/oa_pdf/46/da/ncomms5439.PMC4109017.pdf
"Multiple Sequence Alignment of FALDH and ALDH3A1 from different species were calculated with the Clustal Omega (http://www.ebi.ac.uk/) and the following sequences:CAG33703.1, NP_031463.2, NP_113919.2, AAI49985.1, NP_001128640.1, NP_114178.1, NP_001159985.1.",OADS,/arxiv_data1/oa_pdf/46/da/ncomms5439.PMC4109017.pdf
"Identiﬁcation of initial crys tallization conditi ons (HTX Lab, EMBL Grenoble Outstation, https://www.embl.",OADS,/arxiv_data1/oa_pdf/46/da/ncomms5439.PMC4109017.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/46/da/ncomms5439.PMC4109017.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Keller, M. A. et al.",Non-OADS,/arxiv_data1/oa_pdf/46/da/ncomms5439.PMC4109017.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5439 12 NATURE COMMUNICATIONS | 5:4439 | DOI: 10.1038/ncomms5439 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/46/da/ncomms5439.PMC4109017.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/46/0d/ncomms5412.PMC4109018.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Ohta, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/46/0d/ncomms5412.PMC4109018.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5412 12 NATURE COMMUNICATIONS | 5:4412 | DOI: 10.1038/ncomms5412 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/46/0d/ncomms5412.PMC4109018.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/30/78/ncomms5402.PMC4109021.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Wang, L. et al.",Non-OADS,/arxiv_data1/oa_pdf/30/78/ncomms5402.PMC4109021.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5402 ARTICLE NATURE COMMUNICATIONS | 5:4402 | DOI: 10.1038/ncomms5402 | www.nature.com/naturecommunications 7 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/30/78/ncomms5402.PMC4109021.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/25/c9/ncomms5430.PMC4109022.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Chen, C. et al.",Non-OADS,/arxiv_data1/oa_pdf/25/c9/ncomms5430.PMC4109022.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5430 18 NATURE COMMUNICATIONS | 5:4430 | DOI: 10.1038/ncomms5430 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/25/c9/ncomms5430.PMC4109022.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5803 | DOI: 10.1038/srep05803 6",Non-OADS,/arxiv_data1/oa_pdf/14/f7/srep05803.PMC4109026.pdf
"Surgical Neurology International Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :   http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD University of California, Los Angeles, CA, USA S165A treatment-refractory spinal dural arteriovenous ﬁ stula  sharing arterial origin with the Artery of Adamkiewicz : Repeated  endovascular treatment after failed microsurgery Johanna Eneling, Per M. Karlsson, Sandro Rossitti Department of Neurosurgery, University Hospital, Linköping, Sweden E-mail: Johanna Eneling - johanna.eneling@vgregion.se; Per M. Karlsson - per.m.karlsson@lio.se; *Sandro Rossitti - sandro.rossi tti@lio.se *Corresponding author Received: 14 March 14  Accepted: 19 May 14  Published: 19 June 14 Abstract Background:  Effective management of a spinal dural arteriovenous ﬁ stula (SDAVF)  can be accomplished with either microsurgery or endovascular embolization, but there is a consensus that in patients in whom a radiculomedullary artery supplying the anterior spinal artery (ASA) originates from the same feeding artery as the SDAVF, the endovascular approach is to be avoided.",Non-OADS,/arxiv_data1/oa_pdf/2f/9e/SNI-5-165.PMC4109166.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/5/165/134814 Copyright: © 2014 Eneling J.,Non-OADS,/arxiv_data1/oa_pdf/2f/9e/SNI-5-165.PMC4109166.pdf
"Surgical Neurology International Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :   http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD University of California, Los Angeles, CA, USA S143Giant vertebral artery aneurysm in a child treated with endovascular parent artery occlusion and coil embolization Hun-Soo Park, Ichiro Nakagawa, Takeshi Wada1, Hiroyuki Nakagawa1, Yasuo Hironaka,  Kimihiko Kichikawa1, Hiroyuki Nakase Departments of Neurosurgery, and 1Radiology, Nara Medical University, Nara, Japan E-mail: Hun-Soo Park - memepakusan@hotmail.com; *Ichiro Nakagawa - nakagawa@naramed-u.ac.jp; Takeshi Wada - twneuro@m5.kcn.ne.j p; Hiroyuki Nakagawa - h_naka@naramed-u.ac.jp; Yasuo Hironaka - hironaka@naramed-u.ac.jp; Kimihiko Kichikawa - kkichika2005@yahoo.",Non-OADS,/arxiv_data1/oa_pdf/50/77/SNI-5-143.PMC4109167.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/5/143/134807 Copyright: © 2014 Park H.  This is an open-access article distributed under the terms of the Creative Commons Attribution Licen se, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/50/77/SNI-5-143.PMC4109167.pdf
"Surgical Neurology International Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :   http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD University of California, Los Angeles, CA, USA S155Resolution of bilateral moyamoya associated collateral vessel aneurysms: Rationale for endovascular versus surgical intervention Sepideh Amin-Hanjani, Sean Goodin, Fady T .",Non-OADS,/arxiv_data1/oa_pdf/35/ab/SNI-5-155.PMC4109168.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/5/155/134812 Copyright: © 2014 Amin-Hanjani S.  This is an open-access article distributed under the terms of the Creative Commons Attributi on License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/35/ab/SNI-5-155.PMC4109168.pdf
"Surgical Neurology International Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :   http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD University of California, Los Angeles, CA, USA S161Life-threatening allergic vasculitis after clipping an unruptured aneurysm: Case report, weighing the risk of nickel allergy Andrew Grande, Sanjeet Grewal, Ryan Tackla, Andrew J. Ringer Department of Neurosurgery, University of Cincinnati College of Medicine, Comprehensive Stroke Center at the UC Neuroscience In stitute, and Mayfield Clinic,  Cincinnati, OH, USA E-mail: Andrew Grande - grande@umn.edu; Sanjeet Grewal; grewalst@mail.uc.edu; Ryan Tackla; tacklard@email.uc.edu;  *Andrew J. Ringer - aringer@mayfieldclinic.com*Corresponding author Received: 26 November 13  Accepted: 16 May 14  Published: 19 June 14 Access this article  online Website: www.surgicalneurologyint.",Non-OADS,/arxiv_data1/oa_pdf/47/a6/SNI-5-161.PMC4109169.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/5/161/134813 Copyright: © 2014 Grande A.,Non-OADS,/arxiv_data1/oa_pdf/47/a6/SNI-5-161.PMC4109169.pdf
Available from: http://www.winter-branch.com/ nickel-allergies.html [Last accessed on 2006 Nov 03].,Non-OADS,/arxiv_data1/oa_pdf/47/a6/SNI-5-161.PMC4109169.pdf
"Surgical Neurology International Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :   http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD University of California, Los Angeles, CA, USA S139Fusiform superior cerebellar artery aneurysm treated with STA-SCA bypass and trapping Fabricio C. Lamis, Manoel A.",Non-OADS,/arxiv_data1/oa_pdf/23/07/SNI-5-139.PMC4109170.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/5/139/134806 Copyright: © 2014 Lamis FC.,Non-OADS,/arxiv_data1/oa_pdf/23/07/SNI-5-139.PMC4109170.pdf
"S170Surgical Neurology International Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :   http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD University of California, Los Angeles, CA, USA Dyspnea and choking as presenting symptoms in primary medulla oblongata germinoma Chi-Man Yip, Hui-Hwa T seng1, Shu-Shong Hsu, Wei-Chuan Liao, Jun- Yih Chen, Chih-Hao Chen,  Chia- Yuan Chang Division of Neurosurgery, 1Department of Pathology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, R.O.C E-mail: *Chi-Man  Yip - yip_chiman@yahoo.com; Hui-Hwa  Tseng - hhtseng@vghks.gov.tw; Shu-Shong Hsu - sshsu@vghks.gov.tw; Wei-Ch uan Liao - wcliao@vghks.gov.tw;  Jun-Yih Chen - jychen@vghks.gov.tw; Chih-Hao Chen - chichchen@vghks.gov.tw; Chia-Yuan Chang - jiayuanchang@yahoo.com.tw*Corresponding Author Received: 09 February 14  Accepted: 01 May 14  Published: 19 June 14 Abstract Background:  The medulla oblongata is the lower half of the brainstem.",Non-OADS,/arxiv_data1/oa_pdf/1e/95/SNI-5-170.PMC4109171.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/5/170/134815 Copyright: © 2014 Yip C.  This is an open-access article distributed under the terms of the Creative Commons Attribution Licens e, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/1e/95/SNI-5-170.PMC4109171.pdf
"Surgical Neurology International Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :   http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD University of California, Los Angeles, CA, USA S148Co-occurrence of a cerebral cavernous malformation and an orbital cavernous hemangioma in a patient with seizures and visual symptoms: Rare crossroads for vascular malformations Omar Choudhri, Abdullah H. Feroze, Eleonora M. Lad2, Jonathan W .",Non-OADS,/arxiv_data1/oa_pdf/ca/85/SNI-5-148.PMC4109172.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/5/148/134810 Copyright: © 2014 Choudhri O.,Non-OADS,/arxiv_data1/oa_pdf/ca/85/SNI-5-148.PMC4109172.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5e/fa/pgpm-7-163.PMC4109316.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPharmacogenomics and Personalized Medicine 2014:7 163–171Pharmacogenomics and Personalized Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  163Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/PGPM.S6223 8CYP19A1  single nucleotide polymorphism  associations with cYP19a1, nF κB1, and il6 gene  expression in human normal colon and normal  liver samples rosalind B Penney1 abbie lundgreen2 aiwei Yao-Borengasser3 Vineetha K edavana3 suzanne Williams3 ishwori Dhakal4 roger K Wolff2 susan Kadlubar3 Martha l slattery2 1Department of environmental and  Occupational health, University  of arkansas for Medical sciences,   little rock, ar, 2Department of  internal Medicine, University of  Utah health sciences center, salt  lake city, UT,  3Division of Medical  genetics, University of arkansas  for Medical sciences, little rock,   ar, 4Department of Biostatistics,   University of arkansas for Medical  sciences, little rock, ar, Usa correspondence: susan Kadlubar   University of arkansas for Medical  sciences,  4301 W Markham, #580,   little rock, ar  72205, Usa   Tel +1 501 526 7957  email sakadlubar@uams.ed uBackground:  Estrogen is known to decrease the risk of colon cancer in postmenopausal women,  and may exert its actions by decreasing interleukin-6 (IL6) production via stabilization of the  transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NF κB).",Non-OADS,/arxiv_data1/oa_pdf/5e/fa/pgpm-7-163.PMC4109316.pdf
"Available  from: http://www.cdc.gov/cancer/npcr/pdf/USCS_FactSheet.pd f.  Accessed May  5, 2014.",Non-OADS,/arxiv_data1/oa_pdf/5e/fa/pgpm-7-163.PMC4109316.pdf
"Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journa lPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype  on pharmacology leading to the development of personalized treatment  programs and individualized drug selection for improved safety, efficacy  and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/5e/fa/pgpm-7-163.PMC4109316.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/5e/fa/pgpm-7-163.PMC4109316.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/41/ab/main.PMC4109417.pdf
"Lipase inhibitors,agents that act on the inhibition of enzymes responsible for theContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/cuthreCurrent Therapeutic Research http://dx.doi.org/10.1016/j.curtheres.2014.02.001 0011-393X/ &2014.",Non-OADS,/arxiv_data1/oa_pdf/41/ab/main.PMC4109417.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/41/ab/main.PMC4109417.pdf
http://www.who.int/ mediacentre/factsheets/fs311/en/index.html .,Non-OADS,/arxiv_data1/oa_pdf/41/ab/main.PMC4109417.pdf
http://epp.eurostat.ec.,Non-OADS,/arxiv_data1/oa_pdf/41/ab/main.PMC4109417.pdf
http://www.fda.gov/safety/medwatch/safetyinformation/safe tyalertsforhumanmedicalproducts/ucm213448.htm .,Non-OADS,/arxiv_data1/oa_pdf/41/ab/main.PMC4109417.pdf
http://www.ich.org/ ﬁleadmin/Public_Web_Site/ICH_Products/ Guidelines/Ef ﬁcacy/E6_R1/Step4/E6_R1__Guideline.pdf .,Non-OADS,/arxiv_data1/oa_pdf/41/ab/main.PMC4109417.pdf
http://www.ich.org/ ﬁleadmin/Public_Web_Site/ICH_Products/Guide lines/Ef ﬁcacy/E3/E3_Guideline.pdf .,Non-OADS,/arxiv_data1/oa_pdf/41/ab/main.PMC4109417.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/d4/main.PMC4109418.pdf
"However, all are known to exert adverse side effects, and some are very expensive.Additional treatment modalities with little risk, credible bene ﬁt, and moderate costs would be useful additions to depression management.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/cuthreCurrent Therapeutic Research http://dx.doi.org/10.1016/j.curtheres.2014.04.003 0011-393X/ &2014.",Non-OADS,/arxiv_data1/oa_pdf/85/d4/main.PMC4109418.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/d4/main.PMC4109418.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/cf/82/ndt-10-1333.PMC4109628.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s © 2014 Dove Medical Press.,Non-OADS,/arxiv_data1/oa_pdf/cf/82/ndt-10-1333.PMC4109628.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cf/82/ndt-10-1333.PMC4109628.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1333Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1333ExprEssio N of co NcErNopen access to scientific and medical research open Access full T ext Article http: //dx.doi.org/10.2147/NDT .S7112 0Journal name: Neuropsychiatric Disease and Treatment Journal Designation: Expression of concern Y ear: 2014 Volume: 10 Running head verso: Dove Medical Press Running head recto:  DOI: http://dx.doi.org/10.2147/NDT.S71120 A cross-sectional study on perception of stigma by Chinese schizophrenia  patients [Expression of concern] Ren Z, Wang H, Feng B, et al.",Non-OADS,/arxiv_data1/oa_pdf/cf/82/ndt-10-1333.PMC4109628.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7f/18/dddt-8-957.PMC4109629.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2014:8 957–961Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  957Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6701 5Pustular drug eruption due to Panax   notoginseng  saponins ZhiQiang Yin1,* LiWen Ma1,* JiaLi Xu2,* JiPing Xia1 Dan Luo1 1Department of Dermatology,   2Department of Oncology, First  affiliated Hospital of Nanjing Medical  University, Jiangsu, People’s republic  of China *These authors contributed equally to  this work Correspondence: Dan Luo   Department of Dermatology, First  Affiliated Hospital of Nanjing Medical  University,  300 Guangzhou road,  Nanjing, Jiangsu  210029, People’s  republic of China   Tel +86 136 5518 7928  Fax +86 25 8371 6602  email daniluo2005@sina.co mAbstract:  Panax notoginseng  saponins (PNS) are a patented product in the People’ s Republic of  China, and have extensive effects on the cardiovascular system.",Non-OADS,/arxiv_data1/oa_pdf/7f/18/dddt-8-957.PMC4109629.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/7f/18/dddt-8-957.PMC4109629.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/18/dddt-8-957.PMC4109629.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/21/2b/opth-8-1351.PMC4109630.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1351–1354Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1351Case RepOR topen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S6574 8Intermittent acute angle closure glaucoma   and chronic angle closure following topiramate  use with plateau iris configuration Lamise Z Rajjoub  Nisha Chadha  David a Belyea Department of Ophthalmology,   the George Washington University,   Washington, DC, Usa Correspondence: David a Belyea   Department of Ophthalmology,   the George Washington University,  2150 p ennsylvania ave NW, suite 2a,  Washington, DC 20037, Usa   tel +1 202 741 2800   Fax +1 202 741 2821   email dbelyea@mfa.gwu.ed uAbstract:  This is a case report describing recurrent intermittent acute angle closure episodes  in the setting of topiramate use in a female suffering from migraines.",Non-OADS,/arxiv_data1/oa_pdf/21/2b/opth-8-1351.PMC4109630.pdf
Journal name: Clinical Ophthalmology Journal Designation: Case Report Y ear: 2014 Volume: 8 Running head verso: Rajjoub et al Running head recto: Intermittent acute angle closure glaucoma and chronic angle closure following topiramate DOI: http://dx.doi.org/10.2147/OPTH.S65748,Non-OADS,/arxiv_data1/oa_pdf/21/2b/opth-8-1351.PMC4109630.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/21/2b/opth-8-1351.PMC4109630.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1354Rajjoub et al  4.,Non-OADS,/arxiv_data1/oa_pdf/21/2b/opth-8-1351.PMC4109630.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/df/80/ppa-8-997.PMC4109631.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 997–1006Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  997OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S6277 6Journal name: Patient Preference and Adherence Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Matza et al Running head recto: Adult ADHD utilities DOI: http://dx.doi.org/10.2147/PPA.S62776 health state utilities associated with adult  attention-deficit/hyperactivity disorder louis s Matza1 Mary K Devine1 Virginia Sutton Haynes2 Evan W Davies3 Jacqueline M Kostelec1 Foula T elevantou4 Jessica B Jordan1 1Outcomes research, evidera,   Bethesda, MD, USA; 2Eli Lilly and  Company, Indianapolis, IN, USA;   3Outcomes research, evidera,   London, UK; 4Eli Lilly and Company,   Windlesham, Surrey, UKObjectives:  With growing awareness of the importance of adult attention-deficit/  hyperactivity  disorder (ADHD) treatment, cost-effectiveness analyses, including utilities, are needed to  compare the value of treatment options.",Non-OADS,/arxiv_data1/oa_pdf/df/80/ppa-8-997.PMC4109631.pdf
Availa ble from: http://www.nice.org.uk/media/ D45/1E/GuideToMethodsTechnologyAppraisal2013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/df/80/ppa-8-997.PMC4109631.pdf
"Canberra, Australia: PBAC; June  2013; Version 4.4: http://www.pbac.pbs.gov.au/content/information/ printable-files/pbacg-book.pdf.",Non-OADS,/arxiv_data1/oa_pdf/df/80/ppa-8-997.PMC4109631.pdf
Available from: http://www.nice.,Non-OADS,/arxiv_data1/oa_pdf/df/80/ppa-8-997.PMC4109631.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/df/80/ppa-8-997.PMC4109631.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fd/aa/opth-8-1337.PMC4109632.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1337–1343Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1337MethO dOlOgyopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OPTH.S6637 2Customized epithelial debridement for thin  ectatic corneas undergoing corneal cross-linking:  epithelial island cross-linking technique Cosimo Mazzotta1 Vincenzo Ramovecchi2 1Unità Operativa Complessa di  Oculistica, Siena University hospital,   Siena, Italy; 2Unità Operativa  Complessa di Oculistica, San Severino  Marche hospital, San Severino  Marche, Italy  Correspondence: Cosimo Mazzotta   Policlinico le Scotte, Viale Bracci, 8   53100, Siena, Italy   tel +39 0577 35 6618   Fax +39 0577 35 6618   email cgmazzotta@libero.i t Journal name: Clinical Ophthalmology Journal Designation: Methodology Y ear: 2014 Volume: 8 Running head verso: Mazzotta and Ramovecchi Running head recto: Epithelial island cross-linking technique DOI: http://dx.doi.org/10.2147/OPTH.S66372 Abstract:  Thin corneas with a minimum corneal thickness less than 400 μm after epithelial  removal represent a contraindication to standard epithelium-off cross-linking (CXL) treatment  due to a significant endothelial cell density decrease and potentiality of permanent haze develop - ment.",Non-OADS,/arxiv_data1/oa_pdf/fd/aa/opth-8-1337.PMC4109632.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/fd/aa/opth-8-1337.PMC4109632.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1343epithelial island cross-linking technique  12.,Non-OADS,/arxiv_data1/oa_pdf/fd/aa/opth-8-1337.PMC4109632.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b9/cf/dddt-8-963.PMC4109633.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 963–972Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  963ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S6646 9Evaluation of the biological activity of novel   monocationic fluoroaryl-2,2 ′-bichalcophenes   and their analogues Warda A Hussin1,2,*,† Mohamed A Ismail1,3,* Abdullah M Alzahrani1 Wael M El-Sayed1,4 1King Faisal University, College of  Science, Departments of Chemistry  and Biological Sciences, Hofuf, Saudi  Arabia;  2Al-Azhr University, Faculty  of Science, Department of Botany  and Microbiology, Cairo, Egypt;   3Department of Chemistry, Faculty  of Science, Mansoura University,   Mansoura, Egypt;  4University of Ain  Shams, Faculty of Science, Department  of Zoology, Abbassia, Cairo, Egypt *These authors contributed equally to  this work †Warda A Hussin passed away on   May 21, 2014 Correspondence: Mohamed Ismail   Department of Chemistry, College  of Science, King Faisal University,  PO Box 380, Hofuf 31982, Saudi Arabia   Tel +966 5335 43735   Email mabouelenan@kfu.edu.s aAbstract:  A series of bichalcophene fluorobenzamidines  5a–e was synthesized from the corre - sponding mononitriles  4a–e via a direct reaction with lithium bis(trimethylsilyl)amide LiN(TMS)2  followed by de-protection with ethanolic HCl (gas).",Non-OADS,/arxiv_data1/oa_pdf/b9/cf/dddt-8-963.PMC4109633.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/b9/cf/dddt-8-963.PMC4109633.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/cf/dddt-8-963.PMC4109633.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/82/ce-9-081.PMC4109634.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpCore Evidence 2014:9 81–87Core Evidence Dove press submit your manuscript | www.dovepress.co m Dove press  81REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CE.S4862 6Regorafenib: an evidence-based review of its  potential in patients with advanced liver cancer Sujan Ravi1 Ashwani K Singal2 1Department of internal Medicine,   2Division of Gastroenterology and  Hepatology, University of Alabama   at Birmingham, Birmingham, AL, USA Correspondence: Ashwani K Singal   Division of Gastroenterology and   Hepatology, University of Alabama at   Birmingham, 1720 2nd Avenue South –   BDB 380, Birmingham, AL 35294, USA   Tel +1 205 975 9698   Fax +1 205 975 0961   Email ashwanisingal.com@gmail.co mAbstract:  Hepatocellular carcinoma (HCC) is the second-most common cause of cancer-related  death in the world.",Non-OADS,/arxiv_data1/oa_pdf/16/82/ce-9-081.PMC4109634.pdf
Available from: http://ecog.dfci.harvard.edu/general/perf_stat.,OADS,/arxiv_data1/oa_pdf/16/82/ce-9-081.PMC4109634.pdf
"Core Evidence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/core-evidence-journa lCore Evidence is an international, peer-reviewed open-access journal  evaluating the evidence underlying the potential place in therapy of  drugs throughout their development lifecycle from preclinical to post - launch.",Non-OADS,/arxiv_data1/oa_pdf/16/82/ce-9-081.PMC4109634.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/82/ce-9-081.PMC4109634.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1a/ce/dddt-8-945.PMC4109635.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 945–955Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  945Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6460 4The load and release characteristics   on a strong cationic ion-exchange fiber:   kinetics, thermodynamics, and influences Jing Yuan Yanan gao Xinyu Wang hongzhuo liu Xin che lu Xu Yang Yang Qifang Wang Yan Wang sanming li school of Pharmacy, shenyang  Pharmaceutical University, shenyang,   People’s Republic of China correspondence: sanming li   school of Pharmacy, shenyang   Pharmaceutical University,   shenyang  110016, People’s   Republic of China   Tel +86 24 2398 6258  Fax +86 24 2398 6293  email li_sanming@126.co mAbstract:  Ion-exchange fibers were different from conventional ion-exchange resins in their  non-cross-linked structure.",Non-OADS,/arxiv_data1/oa_pdf/1a/ce/dddt-8-945.PMC4109635.pdf
"Atenolol, diltiazem hydrochloride, sinomenine  hydrochloride, tramadol hydrochloride, and venlafaxine hydro - chloride were obtained from Wuhan Y uancheng Science and  Technology Development Co, Ltd, (Hubei, People’ s Republic  of China), Chengdu Geleixiya Chemical Technology Co, Ltd,  (Sichuan, People’ s Republic of China), Shanghai Boshikai  Chemical Science Co, Ltd, (Shanghai, People’ s Republic of  China), Wuhan Yuancheng Science and Technology Develop - ment Co, Ltd., (Hubei, People’ s Republic of China), and Kerui- Framework Exchange group Figure 1 The distinction in structure between fiber (left) and resin (right).Table  1 The structures, molecular weights, and physicochemical  data of the model drugs Drug (Mw) Structural formula pKaalogP atenolol   (266.34) HNHO O ONH29.43±0.10 0.335±0.27a/  0.5b/0.16c Tramadol   (263.38) NOH O9.61±0.28 2.316±0.27a/  2.4b/3.01c Venlafaxine   (277.40) OOHN9.26±0.28 2.475±0.26a/  2.8b/3.28c sinomenine   (329.40) O OHN OOH7.76±0.40 1.834±0.54a/  1.05c Diltiazem   (414.53) N NOO OOSHH8.94±0.28 4.727±0.76a  2.8b/2.79c Notes:  aData from https://scifinder.cas.org /; bdata from http://www.drugbank.ca /;  cdata from http://www.syrres.com/what-we-do/databaseforms.aspx?id= 386.",OADS,/arxiv_data1/oa_pdf/1a/ce/dddt-8-945.PMC4109635.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/1a/ce/dddt-8-945.PMC4109635.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/ce/dddt-8-945.PMC4109635.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b1/45/ijnrd-7-297.PMC4109637.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nephrology and Renovascular Disease 2014:7 297–302International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  297RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S3760 3Improving the prognosis of nephropathic  cystinosis Martine TP Besouw1,2 elena N Levtchenko1,2 1Department of Pediatric Nephrology,   University Hospitals Leuven, Belgium;   2Laboratory of Pediatrics, Catholic  University Leuven, Leuven, Belgium Correspondence: Martine TP Besouw   Department of Pediatric Nephrology,  University Hospitals Leuven, Herestraat   49, 3000 Leuven, Belgium   Tel +32 1634 3840  Fax +32 1634 3842  email martine.besouw@uzleuven.b eAbstract:  Cystinosis is an autosomal recessive inherited lysosomal storage disease.",Non-OADS,/arxiv_data1/oa_pdf/b1/45/ijnrd-7-297.PMC4109637.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/b1/45/ijnrd-7-297.PMC4109637.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/45/ijnrd-7-297.PMC4109637.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/56/29/opth-8-1345.PMC4109638.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1345–1349Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1345Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S6148 3Grader agreement, and sensitivity and specificity  of digital photography in a community optometry- based diabetic eye screening program luckni sellahewa1,2 Craig simpson2 Prema Maharajan2 John Duffy2 iskandar idris3 1Diabetic Medicine Department,   nottingham University hospitals,   2north nottinghamshire eye   screening service, sherwood Forest  hospitals Foundation Trust,    3Division of Medical sciences and  graduate entry Medicine, school   of Medicine, University of  nottingham, nottingham, UK Correspondence: iskandar idris   Division of Medical sciences and  graduate entry Medicine, school   of Medicine, University of nottingham,   royal Derby hospital, Uttoxeter road,  De22 3ne, UK   T el +44 1332 724 668   Fax +44 1332 724 697   email iskandar.idris@nottingham.ac.u kBackground:  Digital retinal photography with mydriasis is the preferred modality for diabetes  eye screening.",Non-OADS,/arxiv_data1/oa_pdf/56/29/opth-8-1345.PMC4109638.pdf
"As a result, the current  National Health Service (NHS) Diabetic Eye Screening Programme is in place.11 Journal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Sellahewa et al Running head recto: Optometry-based screening program DOI: http://dx.doi.org/10.2147/OPTH.S61483",Non-OADS,/arxiv_data1/oa_pdf/56/29/opth-8-1345.PMC4109638.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/56/29/opth-8-1345.PMC4109638.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1349Optometry-based screening program safety and effectiveness of an optometry community-based  retinopathy screening program.,Non-OADS,/arxiv_data1/oa_pdf/56/29/opth-8-1345.PMC4109638.pdf
Available from: http://www.screen - ing.nhs.uk.,Non-OADS,/arxiv_data1/oa_pdf/56/29/opth-8-1345.PMC4109638.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f3/0d/opth-8-1355.PMC4109639.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1355–1359Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1355Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S6175 6Learning curve of sutureless transconjunctival   20-gauge vitrectomy Gilbert Ws simanjuntak1,2 arief s Kartasasmita3,4 ilias Georgalas5 eustratios V Gotzaridis6 1Department of Ophthalmology,   Faculty of Medicine, Christian  University of indonesia, Jakarta,   2Cikini eye institute, Cikini CC i  Hospital, Jakarta, 3Department  of Ophthalmology, Padjadjaran  University, Jawa Barat, 4Cicendo  eye Hospital, Bandung, indonesia;   5Department of Ophthalmology,   G Gennimatas General Hospital,   University of athens, 6athens retina  institute, athens, GreeceBackground:  To report the learning curve of transition from 20-gauge (20 G) conventional  vitrectomy to a 20 G sutureless vitrectomy technique.",Non-OADS,/arxiv_data1/oa_pdf/f3/0d/opth-8-1355.PMC4109639.pdf
"These  inventions also involve higher cost in purchasing new equipment for performing   23 G, 25 G, and 27 G vitrectomy, since these procedures require additional specially  designed intraocular instruments other than the ones required for conventional 20 G  vitrectomy.Correspondence: Gilbert Ws simanjuntak Department of Ophthalmology, Christian  University of indonesia, Jalan sutoyo Ps  Cawang, Jakarta 13630, indonesia Tel +62 811 168 237 Fax +62 21 3899 7778 email retinaid@yahoo.co mJournal name: Clinical Ophthalmology Journal Designation: Case Series Y ear: 2014 Volume: 8 Running head verso: Simanjuntak et al Running head recto: Sutureless transconjunctival 20-gauge vitrectomy DOI: http://dx.doi.org/10.2147/OPTH.S61756",Non-OADS,/arxiv_data1/oa_pdf/f3/0d/opth-8-1355.PMC4109639.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f3/0d/opth-8-1355.PMC4109639.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1359sutureless transconjunctival 20-gauge vitrectomy and flow and aspiration of the vitreous cutter is comfort - able.,Non-OADS,/arxiv_data1/oa_pdf/f3/0d/opth-8-1355.PMC4109639.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4a/57/ott-7-1301.PMC4109640.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2014:7 1301–1310OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1301Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6506 7Prognostic significance of thymidylate synthase in  postoperative non-small cell lung cancer patients hong-Yun Zhao1,* guo-Wei Ma1,* Ben-Yan Zou1,* Mei li1 su-Xia lin1 li-Ping Zhao2 Ying guo1 Yan huang1 Ying Tian1 Dan Xie1 li Zhang1 1sun Yat-sen University cancer center,  State Key Laboratory of Oncology in  south china, collaborative innovation  Center for Cancer Medicine,  Guangzhou, People’s Republic of  china;  2Department of Medical  Oncology, Zhongshan Hospital of   sun Yat-sen University, Zhongshan  People’s city hospital, Zhongshan,  People’s Republic of China *The first three authors contributed  equally to this work correspondence: Dan Xie   State key Laboratory of Oncology   in south china, cancer center,   sun Yat-sen University,  651 Dongfeng  road east, guangzhou  510060,   People’s Republic of China   Tel +86 20 8734 3193  Fax +86 20 8734 3170  email xied@mail.sysu.edu.c n    li Zhang   Department of Medical Oncology,   sun Yat-sen University cancer center,   651 Dong Feng road east, guangzhou   510060, People’s Republic of China   Tel +86 20 3734 3458  Fax +86 20 8734 3365  email zhangli6@mail.sysu.edu.c n;  li-zhang@csco.org.c nAbstract:  The aim of the present study was to investigate the clinicopathologic/prognostic  significance of thymidylate synthase (TS), orotate phosphoribosyltransferase (OPRT), and  thymidine phosphorylase (TP) proteins in postoperative non-small cell lung cancer (NSCLC)  patients.",Non-OADS,/arxiv_data1/oa_pdf/4a/57/ott-7-1301.PMC4109640.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/4a/57/ott-7-1301.PMC4109640.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4a/57/ott-7-1301.PMC4109640.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d7/36/ppa-8-1007.PMC4109641.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 1007–1018Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1007OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S6459 3What puts heart failure patients at risk   for poor medication adherence?,Non-OADS,/arxiv_data1/oa_pdf/d7/36/ppa-8-1007.PMC4109641.pdf
"In a prior study, we developed an effective model of risk factors for Journal name: Patient Preference and Adherence Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Knafl and Riegel Running head recto: Risk factors for poor adherence DOI: http://dx.doi.org/10.2147/PPA.S64593",Non-OADS,/arxiv_data1/oa_pdf/d7/36/ppa-8-1007.PMC4109641.pdf
Available from: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb42.,OADS,/arxiv_data1/oa_pdf/d7/36/ppa-8-1007.PMC4109641.pdf
Available from:  http://www.adultmeducation.com/downloads/Adult_Med_Overview.,Non-OADS,/arxiv_data1/oa_pdf/d7/36/ppa-8-1007.PMC4109641.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/d7/36/ppa-8-1007.PMC4109641.pdf
"doi:10.1093/shm/hkt123 Advance Access published 25 February 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence(http://creativecommons.org/licenses/by-nc-nd/.0/),whichpermitsnon-commercialreproductionanddistributionof the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/a6/hkt123.PMC4109696.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/ba/main.PMC4109700.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/ba/main.PMC4109700.pdf
http://dx.doi.org/10.1016/j.nicl.2014.02.007 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/5e/ba/main.PMC4109700.pdf
"Supplementary Material Supplementary material associ ated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.nicl.",Non-OADS,/arxiv_data1/oa_pdf/5e/ba/main.PMC4109700.pdf
"Reading Research Quarterly 8, 40. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/5e/ba/main.PMC4109700.pdf
http://dx.doi.org/10.1016/j.neuroimage.2007.07.00717761438 .,OADS,/arxiv_data1/oa_pdf/5e/ba/main.PMC4109700.pdf
http://dx.doi.org/10.1056/NEJMoa080226818441371 .,Non-OADS,/arxiv_data1/oa_pdf/5e/ba/main.PMC4109700.pdf
http://dx.doi.org/10.1016/j.ophtha.2005.03.02716087239 .,OADS,/arxiv_data1/oa_pdf/5e/ba/main.PMC4109700.pdf
"Annals of the New York Academy of Sciences 1164, 282– 292. http://dx.doi.org/10.1111/j.1749-6632.",Non-OADS,/arxiv_data1/oa_pdf/5e/ba/main.PMC4109700.pdf
http://dx.doi.org/10.1523/JNEUROSCI.5258-08.,Non-OADS,/arxiv_data1/oa_pdf/5e/ba/main.PMC4109700.pdf
http://dx.doi.org/10.3758/ BF03198765 .,Non-OADS,/arxiv_data1/oa_pdf/5e/ba/main.PMC4109700.pdf
http://dx.doi.org/10.1080/713820103 .,Non-OADS,/arxiv_data1/oa_pdf/5e/ba/main.PMC4109700.pdf
http://dx.doi.org/10.1371/journal.pone.007944724260224 .,Non-OADS,/arxiv_data1/oa_pdf/5e/ba/main.PMC4109700.pdf
"http://dx.doi.org/10.1093/cercor/bhm25618250083 .M c M a h o n ,T .",Non-OADS,/arxiv_data1/oa_pdf/5e/ba/main.PMC4109700.pdf
http://dx.doi.org/10.1097/ 00006324-199306000-00010.,Non-OADS,/arxiv_data1/oa_pdf/5e/ba/main.PMC4109700.pdf
http://dx.doi.org/10.1167/iovs.,Non-OADS,/arxiv_data1/oa_pdf/5e/ba/main.PMC4109700.pdf
"Journal of Medical Investi- gation 59, 1 –11.http://dx.doi.org/10.2152/jmi.59.122449988 .",Non-OADS,/arxiv_data1/oa_pdf/5e/ba/main.PMC4109700.pdf
http://dx.doi.org/10.1152/jn.,Non-OADS,/arxiv_data1/oa_pdf/5e/ba/main.PMC4109700.pdf
"Current Opinion in Neurology 17, 17 –25.http://dx.doi.org/10.1097/ 00019052-200402000-00005 .",Non-OADS,/arxiv_data1/oa_pdf/5e/ba/main.PMC4109700.pdf
http://dx.doi.org/10.3758/BF03198797 .,Non-OADS,/arxiv_data1/oa_pdf/5e/ba/main.PMC4109700.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/5e/ba/main.PMC4109700.pdf
http://dx.doi.org/10.1167/iovs.10-613721296824 .,Non-OADS,/arxiv_data1/oa_pdf/5e/ba/main.PMC4109700.pdf
"Neuroimage 53, 718– 724. http://dx.doi.org/10.1016/j.neuroimage.2010.06.",OADS,/arxiv_data1/oa_pdf/5e/ba/main.PMC4109700.pdf
http://dx.doi.org/10.1038/eye.,Non-OADS,/arxiv_data1/oa_pdf/5e/ba/main.PMC4109700.pdf
http://dx.doi.org/10.1167/iovs.08-225819387076 .,Non-OADS,/arxiv_data1/oa_pdf/5e/ba/main.PMC4109700.pdf
http://dx.doi.org/10.1006/nimg.2001.097811771995 .,Non-OADS,/arxiv_data1/oa_pdf/5e/ba/main.PMC4109700.pdf
"http://dx.doi.org/10.1016/j.bjhh.2014.03.022 1516-8484/© 2014 Associac ¸ ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/4a/b6/main.PMC4109729.pdf
"5 In the ﬁeld of hematology, spirituality and religious- ness have been associated with several positive outcomes:better quality of life in hematopoietic stem cell trans-plant patients, 6in patients with multiple myeloma7and in patients with myelodysplastic syndromes8; slower passage of subjective time (which could be a sign of mental suf-fering) in patients with hematological malignancies 9;l o w e r DOI of original article: http://dx.doi.org/10.1016/j.bjhh.2014.03.012 .",Non-OADS,/arxiv_data1/oa_pdf/bc/25/main.PMC4109730.pdf
"They found no relationship between http://dx.doi.org/10.1016/j.bjhh.2014.03.016 1516-8484/© 2014 Associac ¸ ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",OADS,/arxiv_data1/oa_pdf/bc/25/main.PMC4109730.pdf
"2 http://dx.doi.org/10.1016/j.bjhh.2014.03.021 1516-8484/© 2014 Associac ¸ ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/53/a7/main.PMC4109731.pdf
"http://dx.doi.org/10.1016/j.bjhh.2014.03.012 1516-8484/© 2014 Associac ¸ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/ef/e1/main.PMC4109732.pdf
"Moreover,the study was carried out in the Gaza Strip of Palestine where DOI of original article: http://dx.doi.org/10.1016/j.bjhh.2014.03.005 .",Non-OADS,/arxiv_data1/oa_pdf/87/69/main.PMC4109733.pdf
"http://dx.doi.org/10.1016/j.bjhh.2014.03.013 1516-8484/© 2014 Associac ¸ ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/87/69/main.PMC4109733.pdf
"http://dx.doi.org/10.1016/j.bjhh.2014.03.007 1516-8484/© 2014 Associac ¸ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/60/f9/main.PMC4109734.pdf
http://dx.doi.org/10.1016/j.bjhh.2014.03.020,OADS,/arxiv_data1/oa_pdf/f6/0d/main.PMC4109735.pdf
"Only in Hb M Milwaukee-I, the valine residue is replaced by glutamic acid at position beta 67 [E11] (http://globin.bx.psu.edu/hbvar/).",Non-OADS,/arxiv_data1/oa_pdf/f6/0d/main.PMC4109735.pdf
"5,8,9  The amino acid substitution His>T yr was demonstrated  in 1964.10 The other names for Hb M Iwate as can be read at  HbVar site (http://globin.bx.psu.edu/hbvar/) are M-Kankakee,8  M-Oldenburg,11 and M-Sendai (no reference found).",Non-OADS,/arxiv_data1/oa_pdf/f6/0d/main.PMC4109735.pdf
"There was http://dx.doi.org/10.1016/j.bjhh.2014.03.003 1516-8484/© 2014 Associac ¸ ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",OADS,/arxiv_data1/oa_pdf/c2/4d/main.PMC4109736.pdf
"The models most commonlyused in prognostic score for MDS de novo , such as the Interna- tional Prognostic Scoring System (IPSS), the WHO PrognosticScoring System (WPSS), and the Revised International Progno-stic Scoring System (IPSS-R) basically use biological variables,obtained from the study of blood cell counts (cytopenias), per- DOI of original article: http://dx.doi.org/10.1016/j.bjhh.2014.03.007 .",Non-OADS,/arxiv_data1/oa_pdf/2d/4e/main.PMC4109737.pdf
"http://dx.doi.org/10.1016/j.bjhh.2014.03.009 1516-8484/© 2014 Associac ¸ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/2d/4e/main.PMC4109737.pdf
"2 http://dx.doi.org/10.1016/j.bjhh.2014.03.008 1516-8484/© 2014 Associac ¸ ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/53/e2/main.PMC4109738.pdf
Available from: http://portal.anvisa.,Non-OADS,/arxiv_data1/oa_pdf/53/e2/main.PMC4109738.pdf
Available from: http://bvsms.saude.,Non-OADS,/arxiv_data1/oa_pdf/53/e2/main.PMC4109738.pdf
"4,5 Salvadori et al.5in their article entitled, “Frequency of alleles and haplotypes of the human leukocyte antigen sys-tem in Bauru, São Paulo” published in the current editionof the Revista Brasileira de Hematologia e Hemoterapia , aimed to determine the genetic diversity of HLA class I and II DOI of original article: http://dx.doi.org/10.5581/1516-8484.20140026 .",Non-OADS,/arxiv_data1/oa_pdf/a5/03/main.PMC4109739.pdf
"This ﬁnding shows that although similarities http://dx.doi.org/10.1016/j.bjhh.2014.03.015 1516-8484/© 2014 Associac ¸ ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",OADS,/arxiv_data1/oa_pdf/a5/03/main.PMC4109739.pdf
"http://dx.doi.org/10.1016/j.bjhh.2014.03.002 1516-8484/© 2014 Associac ¸ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/4d/86/main.PMC4109740.pdf
Available from:http://genome.ucsc.edu/cgi-bin/hgBlat [cited 21.01.14].,OADS,/arxiv_data1/oa_pdf/4d/86/main.PMC4109740.pdf
Exposing the skin without sunscreen for half the DOI of original article: http://dx.doi.org/10.5581/1516-8484.20140029 .,Non-OADS,/arxiv_data1/oa_pdf/70/63/main.PMC4109742.pdf
"The active form, 1,25(OH) 2Vit D3, is recognized as an immune modulator: while it increases the ability of mono-cytes and macrophages to kill intracellular mycobacteria, it http://dx.doi.org/10.1016/j.bjhh.2014.03.017 1516-8484/© 2014 Associac ¸ ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/70/63/main.PMC4109742.pdf
Available from: http://www.who.int/influenza/human_animal_interface/influenza_h7n9/08_ReportWebH7N9Number.pdf  3.,Non-OADS,/arxiv_data1/oa_pdf/12/ce/main.PMC4109743.pdf
http://dx.doi.org/10.1016/j.bjhh.2014.03.019,OADS,/arxiv_data1/oa_pdf/12/ce/main.PMC4109743.pdf
This clone can subsequently acquire additional DOI of original article: http://dx.doi.org/10.1016/j.bjhh.2014.03.007 .,OADS,/arxiv_data1/oa_pdf/02/1d/main.PMC4109744.pdf
"Interpreting p53 mutation role in MDS is not a trivial task, however, since there are often complicating interactions http://dx.doi.org/10.1016/j.bjhh.2014.03.014 1516-8484/© 2014 Associac ¸ ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/02/1d/main.PMC4109744.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseDecember 2013 |  82  | e51060 | Page 1 of 8Video Article Analysis of Apoptosis in Zebrafish Embryos by Whole-mount Immunofluorescence to Detect Activated Caspase 3 Shelly Sorrells1, Cristhian Toruno1, Rodney A. Stewart1, Cicely Jette1 1Department of Oncological Sciences, University of Utah Correspondence to: Cicely Jette at Cicely.Jette@hci.utah.edu URL: http://www.jove.com/video/51060 DOI: doi:10.3791/51060 Keywords: Developmental Biology, Issue 82, zebrafish, embryo, apoptosis, Caspase 3, Immunofluorescence, whole-mount, cell death Date Published: 12/20/2013 Citation: Sorrells, S., Toruno, C., Stewart, R.A., Jette, C. Analysis of Apoptosis in Zebrafish Embryos by Whole-mount Immunofluorescence to Detect Activated Caspase 3.",Non-OADS,/arxiv_data1/oa_pdf/6f/6b/jove-82-51060.PMC4109746.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/51060/ Introduction Here we describe how to perform whole-mount immunofluorescence in early zebrafish embryos to detect cells with activated Caspase 3 (referred to hereafter as the Casp3 assay).,Non-OADS,/arxiv_data1/oa_pdf/6f/6b/jove-82-51060.PMC4109746.pdf
"http://dx.doi.org/10.1016/j.bjhh.2014.03.011 1516-8484/© 2014 Associac ¸ ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/2f/7a/main.PMC4109747.pdf
"1,2 Differently from embryonic SC, where there have been several reports of genetic abnormalities and tumor forma-tion in mice, 3–6adult human SC, especially mesenchymal http://dx.doi.org/10.1016/j.bjhh.2014.03.006 1516-8484/© 2014 Associac ¸ ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/cf/2d/main.PMC4109748.pdf
"http://dx.doi.org/10.1016/j.bjhh.2014.03.005 1516-8484/© 2014 Associac ¸ ão Brasileira de Hematologia, Hemoterapia e Terapia Celular.",Non-OADS,/arxiv_data1/oa_pdf/69/45/main.PMC4109749.pdf
Available from: http://edis.ifas.uﬂ.edu/pd005 [cited 04.10.13].,OADS,/arxiv_data1/oa_pdf/69/45/main.PMC4109749.pdf
Availablefrom: http://www.emro.who.int/palestine [cited 04.10.13].,Non-OADS,/arxiv_data1/oa_pdf/69/45/main.PMC4109749.pdf
"8 : 1069 -1074  August  2014   http://dx.doi.org/ 10.5713/ ajas.2013.13289   www.ajas.info   pISSN 1011 -2367  eISSN 1976 -5517     Selection and Crossbreeding in Relation to Plumage Color Inheritance  in   Three Chinese Egg Type Duck Breeds ( Anas Platyrhynchos )    R. L. Lin, H .",Non-OADS,/arxiv_data1/oa_pdf/65/6a/ajas-27-8-1069-1.PMC4109861.pdf
"(Key Words:  Egg-type Ducks, Plumage  Color Inheritance, Crossbreeding, Selection)     Copyright © 2014 by Asian -Australasian Journal of Animal Sciences   This is an open -access article distributed under the t erms of the Creative Commons Attribution Non -Commercial License ( http://creativecommons.org/licenses/by -nc/3.0/ ),   which permits unrestricted non -commercial use, distribution, and r eproduction in any medium, provided the original work is properly cited .",Non-OADS,/arxiv_data1/oa_pdf/65/6a/ajas-27-8-1069-1.PMC4109861.pdf
"8 : 1075 -1081  August  2014   http://dx.doi.org/ 10.5713/ ajas.2013.13587    www.ajas.info   pISSN 1011 -2367   eISSN 1976 -5517     Identification of SNPs in Cellular Retinol Binding Protein 1  and   Cellular Retinol Binding Protein 3 Genes and Their Associations with   Laying Performance Traits in Erlang Mountainous Chicken     Yan Wanga, Li-Hua Xiao1,a, Xiao -Ling Zhao, Yi -Ping Liu, and Qing Zhu *  Laboratory of Animal Genetic and Breeding, Institute of Anim al Genetics and Breeding,    Sichuan Agricultural University, Ya’an, Sichuan, 625014, China     ABSTRACT:  CRBP1 (cellular retinol binding protein 1) and CRBP3  (cellular retinol binding protein 3), are important components of  the retinoid signaling pathway and  take part in vitamin A absorption, transport and metabolism.",Non-OADS,/arxiv_data1/oa_pdf/42/34/ajas-27-8-1075-2.PMC4109862.pdf
"(Key  Words:  CRBP1 , CRBP3 , Laying Performance , Egg Quality , Gene Polymorphism , Erlang Mountainous Chicken )    Copyright © 2014 by Asian -Australasian Journal of Animal Sc iences   This is an open -access article distributed under the terms of the Creative Commons Attribution Non -Commercial License ( http://creativecommons.org/licenses/by -nc/3.0/ ),   which permits unrestricted non -commercial use, distribution, and reproduction in any medium, provided the original work is properly cited .",Non-OADS,/arxiv_data1/oa_pdf/42/34/ajas-27-8-1075-2.PMC4109862.pdf
"8 : 1082 -1087  August  2014   http://dx.doi.org/ 10.5713/ ajas.2013.13818    www.ajas.info   pISSN 1011 -2367   eISSN 1976 -5517     Effects of Dietary Selenium, Sulphur and Copper Levels on   Selenium  Concentration in the Serum and Liver of Lamb    Arlindo Saran Netto1,*, Marcus Antonio Zanetti1, Lisia Bertonha Correa1, Gustavo Ribeiro Del Claro1,   Márcia Saladini Vieira Salles2, and Flávio Garcia Vilela3  1 Department of Animal Science, Faculty of Animal  Science and Food Engineering,   University of São Paulo, Pirassununga -SP, 13635 -900, Brazil     ABSTRACT:  Thirty -two lambs were distributed in eight treatments under 2 ×2×2 factorial experiment to compare the effects of two  levels of selenium (0.2 to 5  mg/kg  dry matter [ DM]), sulphur (0.25 % and 0.37 %) and copper (8 and 25  mg/kg DM) levels on selenium  concentration in liver and serum of lambs.",Non-OADS,/arxiv_data1/oa_pdf/5e/e7/ajas-27-8-1082-3.PMC4109863.pdf
"(Key Words:  Selenium, Sulphur, Copper,   Nutrition, Sheep )    Copyright © 2014 by Asian -Australasian Journal of Animal Sciences   This is an open -access article distributed under the terms of the Creative Commons Attribution Non -Commercial License ( http://creativecommons.org/licenses/by -nc/3.0/ ),   which permits unrestricted non -commercial use, distribution, and reproduction in any medium, provided the original work is properly cited .",Non-OADS,/arxiv_data1/oa_pdf/5e/e7/ajas-27-8-1082-3.PMC4109863.pdf
"8 : 1088 -1097 August  2014   http://dx.doi.org/ 10.5713/ ajas.2013.13714   www.ajas.info   pISSN 1011 -2367   eISSN 1976 -5517     Effect of Gynosaponin on Rumen In vitro  Methanogenesis under   Differ ent Forage -Concentrate Ratios     Bakhetgul  Manatbay, Yanfen Cheng, Shengyong Mao, and Weiyun Zhu*  Laboratory of Gastrointestinal Microbiology, Nanjing Agricultural University , Nanjing 210095, China     ABSTRACT:  The study aimed to investigate the effects of g ynosaponin on in vitro  methanogenesis under different forage -concentrate  ratios (F:C ratios).",Non-OADS,/arxiv_data1/oa_pdf/88/31/ajas-27-8-1088-4.PMC4109864.pdf
"(Key Words:  Forage:Concentrate Ratios, Gynosaponin,  Methanogenesis , Microbiota, In vitro )    Copyright © 2014 by Asian -Australasian Journal of Animal Sciences   This is an open -access article distributed under the terms of the Creative Commons Attribution Non -Commercial License ( http://creativecommons.org/licenses/by -nc/3.0/ ),   which permits unrestricted non -commercial use, distribution, and reproduction in any medium, provided the original work is properly cited .",Non-OADS,/arxiv_data1/oa_pdf/88/31/ajas-27-8-1088-4.PMC4109864.pdf
"8 : 1098 -1103  August  2014   http://dx.doi.org/ 10.5713/ ajas.2013.13746   www.ajas.info   pISSN 1011 -2367   eISSN 1976 -5517     Effect of Sodium Bicarbonate Supplementation on   Carcass Characteris tics of Lambs Fed Concentrate Diets at   Different Ambient Temperature Levels     Demba B. Jallow and Liang  Chou Hsia *  Department of Tropical Agriculture and International Cooperation,   National Pingtung University of Science and Technology, Pingtung 91201, Ta iwan    ABSTRACT:  The objective of this study was to investigate the inﬂuence of ambient temperatures on carcass characteristics of lambs  fed concentrate diets with or without NaHCO 3 supplementation.",Non-OADS,/arxiv_data1/oa_pdf/73/c2/ajas-27-8-1098-5.PMC4109865.pdf
"(Key Words:  Ambient Temperature, Sodium  Bicarbonate, Carcass, Lambs )    Copyright © 2014 by Asian -Australasian Journal of Animal Sciences   This is an open -access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by -nc/3.0/ ),   which permits unrestricted non -commercial use, distribution, and reproduction in any medium, provided the o riginal work is properly cited .",Non-OADS,/arxiv_data1/oa_pdf/73/c2/ajas-27-8-1098-5.PMC4109865.pdf
8 : 1104 -1113 August  2014   http://dx.doi.org/ 10.5713/ ajas.2013.13836   www.ajas.info   pISSN 1011 -2367   eISSN 1976 -5517     Citrus Pulp as a Dietary Source of Antioxidants for Lactating Holste in Cows   Fed Highly Polyunsaturated Fatty Acid Diets     G .,Non-OADS,/arxiv_data1/oa_pdf/83/8c/ajas-27-8-1104-6.PMC4109866.pdf
"(Key Words:  Flavonoids, Polyphenols, Ferric  Reducing Antioxidant Power )    Copyright © 2014 by Asian -Australasian Journal of Animal Sciences   This is an open -access article distributed under the terms of the Creative Commons Attribution Non -Commercial License ( http://creativecommons.or g/licenses/by -nc/3.0/ ),   which permits unrestricted non -commercial use, distribution, and reproduction in any medium, provided the original work is properly cited .",Non-OADS,/arxiv_data1/oa_pdf/83/8c/ajas-27-8-1104-6.PMC4109866.pdf
"8 : 1114-1123  August  2014   http://dx.doi.org/ 10.5713/ ajas.2014.14072   www.ajas.info   pISSN 1011 -2367   eISSN 1976 -5517     Seamustard ( Undaria pinnatifida ) Improves Growth, Immunity,   Fatty A cid Profile and Reduces Cholesterol in Hanwoo Steers     J.",Non-OADS,/arxiv_data1/oa_pdf/25/c1/ajas-27-8-1114-7.PMC4109867.pdf
"(Key  Words:  Seaweed, Immunity, Carcass Quality, Cholesterol, Fatty Acid, Hanwoo Steer )    Copyright © 2014 by Asian -Austral asian Journal of Animal Sciences   This is an open -access article distributed under the terms of the Creative Commons Attribution Non -Commercial License ( http://creativecommons.org/li censes/by -nc/3.0/ ),   which permits unrestricted non -commercial use, distribution, and reproduction in any medium, provided the original work is properly cited .",Non-OADS,/arxiv_data1/oa_pdf/25/c1/ajas-27-8-1114-7.PMC4109867.pdf
"http://www.ekape.or.kr/view/eng/   system/beef.asp  Accessed  May 15, 2012.",Non-OADS,/arxiv_data1/oa_pdf/25/c1/ajas-27-8-1114-7.PMC4109867.pdf
http://news.naver.com/main/read.nhn?,Non-OADS,/arxiv_data1/oa_pdf/25/c1/ajas-27-8-1114-7.PMC4109867.pdf
"mode=LSD&mid=sec&sid1=102&oid=003&aid=0005009404   (Korean), http://ofsi.jeonnam.go.kr/?pid=B  (English).",Non-OADS,/arxiv_data1/oa_pdf/25/c1/ajas-27-8-1114-7.PMC4109867.pdf
"8 : 1124 -1130  August  2014   http://dx.doi.org/ 10.5713/ ajas.2014.14232   www.ajas.info   pISSN 1011 -2367   eISSN 1976 -5517     Ileal Endogenous Amino Acid Flow Response to Nitrogen -free Diets wi th  Differing Ratios of Corn Starch to Dextrose in Pigs     C. Kong , D. Ragland1, and O. Adeola *  Department of Animal Sciences, Purdue University , West Lafayette, IN 47907 -2054 , USA     ABSTRACT:  The objective of this study was to determine the responses in the  digestibility of dry matter (DM) and amino acid    (AA) composition of ileal endogenous flow (IEF) of pigs (initial body weight , 69.1±6.46 kg)  fed N-free diets (NFD) formulated with  different ratios of corn starch to dextrose.",Non-OADS,/arxiv_data1/oa_pdf/91/fc/ajas-27-8-1124-8.PMC4109868.pdf
"(Key Words:  Ileal Digestibility, Basal  Endogenous  Amino Acid Loss, Swine )    Copyright © 2014 by Asian -Australasian Journal of Animal Sciences   This is an open -access article distributed under the terms of the Creative Commons Attribution Non -Commercial License ( http://creativecommons.org/licenses/by -nc/3.0/ ),   which permits unrestricted non -commercial use, distribution, and reproduction in any medium, provided the original work is properly cited .",Non-OADS,/arxiv_data1/oa_pdf/91/fc/ajas-27-8-1124-8.PMC4109868.pdf
http://www.corn.org/wp -content/uploads/2013/12/StarchBook   let2013.pdf .,Non-OADS,/arxiv_data1/oa_pdf/91/fc/ajas-27-8-1124-8.PMC4109868.pdf
"8 : 1131 -1140  August  2014   http://dx.doi.org/ 10.5713/ ajas.2013.13737   www.ajas.info   pISSN 1011 -2367   eISSN 1976 -5517     Effects of Bacillus subtilis  KN-42 on Growth Performance, Diarrhea a nd   Faecal Bacterial Flora of Weaned Piglets     Yuanliang Hu1,2, Yaohao Dun1, Shenao Li1, Shumiao Zhao1, Nan Peng1, and Yunxiang Liang1,*  1 State Key Laboratory of Agricultural Microbiology, College of Life Science and Technology,   Huazhong Agricultural Univ ersity, Wuhan 430070, China     ABSTRACT:  This research focused on the effects of different doses of Bacillus subtilis  KN-42 on the growth performance, diarrhea   incidence , faecal bacterial flora, and the relative number of Lactobacillus  and Escherichia coli  in faeces of weaned piglets to determine  whether the strain can serve as a candidate antimicrobial growth promoter.",Non-OADS,/arxiv_data1/oa_pdf/89/57/ajas-27-8-1131-9.PMC4109869.pdf
"(Key Words:  Bacillus subtilis , Bacterial  Community, Diarrhea,  Growth Performance, Lactobacillus , Weaned Piglets )    Copyright © 2014 by Asian -Australasian Journal of Animal Sciences   This is an open -access a rticle distributed under the terms of the Creative Commons Attribution Non -Commercial License ( http://creativecommons.org/licenses/by -nc/3.0/ ),   which permits unrestricted non -comme rcial use, distribution, and reproduction in any medium, provided the original work is properly cited .",Non-OADS,/arxiv_data1/oa_pdf/89/57/ajas-27-8-1131-9.PMC4109869.pdf
"8 : 1141 -1149  August  2014   http://dx.doi.org/ 10.5713/ ajas.2014.14079   www.ajas.info   pISSN 1011 -2367   eISSN 1976 -5517     Effects of Dietary Supplementation of Magnesium Hydrogen Phosphate  (MgHPO 4) as an Alternative Phosphorus Source on Growth and   Feed Utilization of Juvenile Far Eastern Catfish ( Silurus asotus )    Tae-Hyun Yoon, Dong -Hoon Lee1, Seung -Gun Won, Chang -Six Ra, and Jeong -Dae Kim *  College of Animal Life Sciences, Kangwon National U niversity, Chuncheon 200 -701, Korea     ABSTRACT:  The present study was conducted to investigate a supplemental effect of magnesium hydrogen phosphate (MHP,  MgHPO 4) as an alternative phosphorus (P)  source on growth and feed utilization of juvenile far easte rn catfish (Silurus asotus ) in  comparison with three conventional P additives (monocalcium phosphate (MCP), dicalcium phosphate (DCP) and tricalcium phosphate  [TCP])  as positive controls.",Non-OADS,/arxiv_data1/oa_pdf/c4/f5/ajas-27-8-1141-10.PMC4109870.pdf
"(Key Words:  Silurus asotus , Weight Gain, Feed E fficiency , Phosphorus Availability,  Alternative Phosph orus, Plasma P hosphorus )    Copyright © 2014 by Asian -Australasian Journal of Animal Sciences   This is an open -access article distributed under the terms of the Creative Commons Attribution Non -Commercial License ( http://creativecommons.org/licenses/by -nc/3.0/ ),   which permits unrestricted non -commercial use, distribution, and reproduction in any medium, provided the original work is properly cited .",Non-OADS,/arxiv_data1/oa_pdf/c4/f5/ajas-27-8-1141-10.PMC4109870.pdf
"http://kostat.go.kr  Accessed February  16, 2012 .",Non-OADS,/arxiv_data1/oa_pdf/c4/f5/ajas-27-8-1141-10.PMC4109870.pdf
"Acid  digestion of sediments, sludge, and solids, Me thod 3050B,  Revision 2. http://www.epa.gov/epaoswer/hazwaste/test/3050b.pdf    Accessed December , 1996 .",OADS,/arxiv_data1/oa_pdf/c4/f5/ajas-27-8-1141-10.PMC4109870.pdf
http://minerals.usgs.gov/   minerals/pubs/mcs/2013/mcs2013.pdf .,OADS,/arxiv_data1/oa_pdf/c4/f5/ajas-27-8-1141-10.PMC4109870.pdf
"8 : 1150 -1156 August  2014   http://dx.doi.org/ 10.5713/ ajas.2013.13828   www.ajas.info   pISSN 1011 -2367  eISSN 1976 -5517     Effects of L -proline on the Growth Performance, and   Blood Parameter s in Weaned Lipopolysaccharide  (LPS)-challenged Pigs    Ping  Kang1, Lili Zhang1, Yongqing Hou1,*, Binying  Ding1, Dan Yi1, Lei Wang1,   Huiling  Zhu1, Yulan  Liu1, Yulong  Yin1,2, and Guoyao Wu3  1 Hubei key Laboratory of Animal Nutrition and Feed Science, Wuhan P olytechnic University, Wuhan 430023, China     ABSTRACT:  This trail was conducted to study the effect of L -proline on the growth performance, and blood parameter  in the weaned  lipopolysaccharide ( LPS) -challenged pigs.",Non-OADS,/arxiv_data1/oa_pdf/04/82/ajas-27-8-1150-11.PMC4109871.pdf
"(Key Words:  L-proline, Growth  Performance, Blood Parameters, Gastroin testinal Tract Digestibility, Early Weaned Pigs, Lipopolysaccharide )    Copyright © 2014 by Asian -Australasian Journal of Animal Sciences   This is an open -access article distributed under the terms of the Creative Commons Attribution Non -Commer cial License ( http://creativecommons.org/licenses/by -nc/3.0/ ),   which permits unrestricted non -commercial use, distribution, and reproduction in any medium, provided the original wo rk is properly cited .",Non-OADS,/arxiv_data1/oa_pdf/04/82/ajas-27-8-1150-11.PMC4109871.pdf
"8 : 1157 -1163  August  2014   http://dx.doi.org/ 10.5713/ ajas.2013.13768   www.ajas.info   pISSN 1011 -2367   eISSN 1976 -5517     Effects of Gas Composition in the Modified Atmosphere Packaging on t he  Shelf -life of Longissimus dorsi  of Korean Native Black Pigs -Duroc Crossbred  during Refrigerated Storage     Muhlisin1,2, Panjono2, Dong Soo Kim1, Yeong Rae Song1, Sung -Jin Lee3, Jeong Koo Lee4, and Sung Ki Lee1,*  1 Department of Animal Products and Food Sc ience, Kangwon National University, Chuncheon  200-701, Korea     ABSTRACT:  This study was conducted to observe the effects of gas composition in modified atmosphere packaging (MAP) on the  shelf -life of Longissimus dorsi  of Korean Native Black Pigs -Duroc Cro ssbred (KNP ×D) during refrigerated storage.",Non-OADS,/arxiv_data1/oa_pdf/27/97/ajas-27-8-1157-12.PMC4109872.pdf
"(Key Words:  Modified  Atmosphere Packaging (MAP), Korean Native Black Pigs Crossbred with Duroc, S torage Time, Meat Quality )    Copyright © 2014 by Asian -Australasian Journal of Animal Sciences   This is an open -access article distributed under the terms of the Creative Commons Attribution Non -Commercial License ( http://creativecommons.org/licenses/by -nc/3.0/ ),   which permits unrestricted non -commercial use, distribution, and reproduction in any medium, provided the original work is properly cited .",Non-OADS,/arxiv_data1/oa_pdf/27/97/ajas-27-8-1157-12.PMC4109872.pdf
"8 : 1164 -1173  August  2014   http://dx.doi.org/ 10.5713/ ajas.2013.13770  www.ajas.info   pISSN 1011 -2367   eISSN 1976 -5517     Effect of Particular Breed on the Chemical Composition,   Texture, Color, and Sensorial Characteristics of Dry-cured Ham    Pil Nam S eong, Kuyng Mi P ark, Sun Moon K ang, Geun Ho K ang, Soo Hyun C ho,   Beom Young P ark, and Hoa Van B a*  Animal Products and Processing Division, National Institute  of Animal Science , Suwon  441-706, Ko rea    ABSTRACT:  The present study demonstrates  the impact of specific breed on the characteristics of dry -cured ham.",Non-OADS,/arxiv_data1/oa_pdf/ef/64/ajas-27-8-1164-13.PMC4109873.pdf
"These data could be useful for meat processors to select  the suitable breed s for economical manufacturing of high quality dry -cured ham s. (Key Words:  Breed, Dry-cured Ham, Texture , Color,  Sensory )    Copyright © 2014 by Asian -Australasian  Journal of Animal Sciences   This is an open -access article distributed under the terms of the Creative Commons Attribution Non -Commercial License ( http://creativecommons.org/license s/by-nc/3.0/ ),   which permits unrestricted non -commercial use, distribution, and reproduction in any medium, provided the original work is properly cited .",Non-OADS,/arxiv_data1/oa_pdf/ef/64/ajas-27-8-1164-13.PMC4109873.pdf
"8 : 1174 -1180  August  2014   http://dx.doi.org/ 10.5713/ ajas.2013.13853   www.ajas.info   pISSN 1011 -2367   eISSN 1976 -5517     Effect of  Curing Time on the Physicochemical and Sensory Properties of   Beef Jerky Replaced Salt with Soy Sauce, Red Pepper Paste and   Soybean Paste     H. J. Lim, G .",Non-OADS,/arxiv_data1/oa_pdf/d4/ff/ajas-27-8-1174-14.PMC4109874.pdf
"(Key Words:  Beef Jerky,  Replaced Salt, Soy Sauce, Red Pepper Paste, Soybean Paste)    Copyright © 2014 by Asian -Australasian Journal of Animal Sciences   This is an open -access article distributed under the terms of the Creative Commons Attribution Non -Commercial License ( http://creativecommons.org/licenses/by -nc/3.0/ ),   which permits unrestricted non -commercial use, distribution, and reproduction in any medium, provided the original work is properly cited .",Non-OADS,/arxiv_data1/oa_pdf/d4/ff/ajas-27-8-1174-14.PMC4109874.pdf
"8 : 1181 -1188  August  2014   http://dx.doi.org/ 10.5713/ ajas.2013.13729   www.ajas.info   pISSN 1011 -2367   eISSN 1976 -5517     Identification of Differentially Expressed Proteins in Liver in   Response to Subacute Ruminal Acidosis (SARA) Induced by   High -concentrate Diet    X. Y. Jiang, Y. D. Ni, S. K. Zhang, Y. S. Zhang *, and X.",Non-OADS,/arxiv_data1/oa_pdf/5d/f5/ajas-27-8-1181-15.PMC4109875.pdf
"(Key Words:  Liver, M etabolism , High-concentrate , Subacute Ruminal Acidosi s  [SARA ])    Copyright © 2014 by Asian -Australasian Journal of Animal Sciences   This is an open -access article distributed under the terms of the Creative Commons Attribution Non -Commercial License ( http://creativecommons.org/licenses/by -nc/3.0/ ),   which permits unrestricted non -commercial use, distribution, and reproduction in any medium, provided the original work is properly cited .",Non-OADS,/arxiv_data1/oa_pdf/5d/f5/ajas-27-8-1181-15.PMC4109875.pdf
"8 : 1189 -1195  August  2014   http://dx.doi.org/ 10.5713/ ajas.2014.14017   www.ajas.info   pISSN 1011 -2367   eISSN 1976 -5517     Polymorphism, Expression of Natural Resistance -associated   Macrophag e Protein 1 Encoding Gene ( NRAMP1 ) and   Its Association with Immune Traits in Pigs    Xiaoling Dinga, Xiaodong Zhanga, Yong Yang1, Yueyun Ding, Weiwei Xue, Yun Meng,   Weihua Zhu, and Zongjun Yin *  College of Animal Science and Technology, Anhui Agricultural U niversity, 230036 Hefei, China     ABSTRACT:  Natural resistance -associated macrophage protein 1 encoding gene ( NRAMP1 ) plays an important role in immune  response against intracellular pathogens.",Non-OADS,/arxiv_data1/oa_pdf/19/c6/ajas-27-8-1189-16.PMC4109876.pdf
"These results indicate that the NRAMP1  gene can be regarded as a molecular marker for genetic selection of disease susceptibility in pig  breedin g. (Key Words:  Pig, Natural Resistance -associated Macrophage Protein 1  (NRAMP1 ), Polymorphism , Expression , Association )    Copyright © 2014 by Asian -Australasian Journal of Animal Sciences   This is an open -access article distributed under the t erms of the Creative Commons Attribution Non -Commercial License ( http://creativecommons.org/licenses/by -nc/3.0/ ),   which permits unrestricted non -commercial use, distribution, and r eproduction in any medium, provided the original work is properly cited .",Non-OADS,/arxiv_data1/oa_pdf/19/c6/ajas-27-8-1189-16.PMC4109876.pdf
"8 : 1196 -1203  August  2014   http://dx.doi.org/ 10.5713/ ajas.2013.13394   www.ajas.info   pISSN 1011 -2367   eISSN 1976 -5517     Comparison of Aviary, Barn and Conventional Cage Raising of   Chicken s on Laying Performance and Egg Quality     M. Ahammed , B. J. Chae , J. Lohakare, B. Keohavong, M. H. Lee, S. J.  Lee,   D. M. Kim, J. Y. Lee1, and S. J. Ohh *  College of Animal Life Sciences, Kangwon National University, Chuncheon 200 -701, Korea     ABSTRACT:  This study intended to compare the productive performance of three different layer raising systems; conventional cage  (CC), barn (BR) and aviary (A V).",Non-OADS,/arxiv_data1/oa_pdf/27/f4/ajas-27-8-1196-17.PMC4109877.pdf
"The study  implied that the facility depreciation cost for A V and cost for increased feed intake in A V compare d to CC are believed to be critical to  evaluate the cost effectiveness of egg production in A V.  (Key Words:  Chicken Welfare, Aviary System, Poultry Housing, Productive  Performance, Egg Traits)    Copyright © 2014 by Asian -Australasian Journal o f Animal Sciences   This is an open -access article distributed under the terms of the Creative Commons Attribution Non -Commercial License ( http://creativecommons.org/licenses/by -nc/3.",Non-OADS,/arxiv_data1/oa_pdf/27/f4/ajas-27-8-1196-17.PMC4109877.pdf
8 : 1204 -1210  August  2014   http://dx.doi.org/ 10.5713/ ajas.2013.13774   www.ajas.info   pISSN 1011 -2367   eISSN 1976 -5517     Growth Performance and Behaviour in Grouped Pigs Fed Fibrous Diet    A. G .,Non-OADS,/arxiv_data1/oa_pdf/61/a9/ajas-27-8-1204-18.PMC4109878.pdf
"(Key Words:  Aggress ive Behaviour , Fibrous Diet, Pigs, Skin Lesions )    Copyright © 2014 by Asian -Australasian Journal of Animal Sciences   This is an open -access article distributed under the terms of the Creative Commons Attribution Non -Commercial License ( http://creativecommons.org/licenses/by -nc/3.0/ ),   which permits unrestricted non -commercial use, distribution, and reproduction in any medium, provided the original work is properly cited .",Non-OADS,/arxiv_data1/oa_pdf/61/a9/ajas-27-8-1204-18.PMC4109878.pdf
"8 : 1211 -1218  August  2014   http://dx.doi.org/ 10.5713/ ajas.2014.14099   www.ajas.info   pISSN 1011 -2367   eISSN 1976 -5517     Ammonia and Carbon Dioxide Concentrations in a Layer House     Ilker Ki lic* and Erkan Yaslioglu   Biosystems Engineering Department,  Agricultur e Faculty,  Uludag  University, Bursa, 16059, Turkey     ABSTRACT:  Higher concentrations of ammonia (NH 3) and carbon dioxide (CO 2) in animal barns can negatively affect production  and healt h of animals and workers.",Non-OADS,/arxiv_data1/oa_pdf/16/22/ajas-27-8-1211-19.PMC4109879.pdf
"(Key Words:   Ammonia, Carbon Dioxide, Concentration, Diurnal Pattern, Laying Hens Houses )    Copyright © 2014 by Asian -Australasian Journal of  Animal Sciences   This is an open -access article distributed under the terms of the Creative Commons Attribution Non -Commercial License ( http://creativecommons.org/licenses/by -nc/3.0 /),   which permits unrestricted non -commercial use, distribution, and reproduction in any medium, provided the original work is properly cited .",Non-OADS,/arxiv_data1/oa_pdf/16/22/ajas-27-8-1211-19.PMC4109879.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License ( http://creativecommons.org/licenses/by-nc/3.0/ ), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/33/1d/nihms558321.PMC4109987.pdf
"Improvements through  Tempering  pp 212–4 Lipocryolysis (a localized fat reduc - tion treatment) combines a vacuum with  Correspondence to: Azaam M Samad; Email: asamad@sdbri.org Submitted: 07/18/2014; Accepted: 07/18/2014; Published Online: 07/18/2014http://dx.doi.org/10.4161/adip.30000In this issue of Adipocyte Azaam M Samad San d iego Biomedical r esearch i nstitute; San d iego, CA USA Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/93/52/adip-3-167.PMC4110092.pdf
"6,17,18 Recent studies  *Correspondence to: Ella Atlas; Email: ella.atlas@hc-sc.gc.ca Submitted: 01/13/2014; Revised: 03/03/2014; Accepted: 03/04/2014; Published Online: 03/11/2014http://dx.doi.org/10.4161/adip.28436Bisphenol A increases aP2 expression in 3T3L1   by enhancing the transcriptional activity   of nuclear receptors at the promoter ella Atlas*, Louise Pope, Mike G Wade, Alice Kawata, Adele Boudreau, and Jonathan G Boucher health c anada; e nvironmental h ealth Science and Research Bureau; Ottawa, ON c anada Keywords:  C/EBP δ, adipogenesis, differentiation, GR, bisphenol A, adipocyte differentiation, glucocorticoid receptor, aP2,  transcription environmental pollutants, such as bisphenol A (BPA), have the potential to affect the differentiation processes and the  biology of the adipose tissue.",Non-OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
JAMA  2006; 295:1549-55;  PMID:16595758 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
Mol Cell Endocrinol 2009; 304:90-6; PMID:19433253 ;  http://dx.doi.org/10.1016/j.mce.2009.02.025 3.,OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
Endocr Rev 2012; 33:378-455;  PMID:22419778 ; http://dx.doi.org/10.1210/ er.2011-1050 4.,Non-OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
Environ Health Perspect  1995; 103:608-12;  PMID:7556016 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
Toxicol Sci  2005; 84:319-27;  PMID:15659569 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
Environ Health Perspect 2009; 117:1549-55;  PMID:20019905 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
Environ Health  Perspect 2010; 118:1243-50; PMID:20488778 ;  http://dx.doi.org/10.1289/ehp.1001993 10.,Non-OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
Mol  Cell Endocrinol 1998; 142:203-14; PMID:9783916 ;  http://dx.doi.org/10.1016/S0303-7207(98)00084-711.,OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
Mol Cell Endocrinol 2009; 304:49- 54; PMID:19433247 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
Environ Health Perspect 2005; 113:969- 77; PMID:16079065 ; http://dx.doi.org/10.1289/ ehp.8002 13.,Non-OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
J Lipid Res  2012; 53:227-46;  PMID:22140268 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
Physiologically based pharmacokinetics of  bisphenol A. J Toxicol Environ Health A 2004; 67:1971-85;  PMID :15513896 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
Chemosphere 2001; 42:917-22;  PMID:11272914 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
Environ Health Perspect 2012; 120:984-9; PMID:22763116 ; http://dx.doi.org/10.1289/ ehp.1205063 18.,Non-OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
Obesity (Silver Spring) 2010; 18:1283-8;  PMID:19927138 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
Nat Rev Mol Cell Biol 2006; 7:885-96;  PMID:17139329 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
Endocrinology 2013; 154:1454-64; PMID:23456364 ; http://dx.doi.org/10.1210/ en.2012-2061 22.,Non-OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
Proc Natl Acad Sci U S A 2004; 101:9607- 11; PMID:15210946 ; http://dx.doi.org/10.1073/ pnas.0403100101 23.,OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
J Biol Chem 2011; 286:21488-99; PMID:21521687 ;  http://dx.doi.org/10.1074/jbc.M110.211540 24.,OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
EMBO J 2003; 22:2135-45; PMID:12727880 ;  http://dx.doi.org/10.1093/emboj/cdg218 25.,OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
Curr Opin Nephrol Hypertens  2004; 13:451-8;  PMID :15199296 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
Ann  Biomed Eng 2012; 40:1508-19;  PMID:22227972 ;  http://dx.doi.org/10.1007/s10439-011-0499-7 28.,Non-OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
Science 1996; 274:1377-9; PMID:8910278 ;  http://dx.doi.org/10.1126/science.274.5291.1377 30.,Non-OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
Mol Cell 1999; 3:151- 8; PMID:10078198 ; http://dx.doi.org/10.1016/ S1097-2765(00)80306-8 31.,OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
Reprod Toxicol 2007; 24:139-77; PMID:17825522 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
Chem Res Toxicol 2001; 14:149-57;  PMID:11258963 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
Critical evaluation of key  evidence on the human health hazards of exposure  to bisphenol A. Crit Rev Toxicol 2011; 41:263-91;  PMID:21438738 ; http://dx.doi.org/10.3109/10408 444.2011.558487 34.,Non-OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
"Vandenberg LN, Chahoud I, Heindel JJ, Padmanabhan V, Paumgartten FJ, Schoenfelder G. Urinary, circulating, and tissue biomonitoring  studies indicate widespread exposure to bisphe - nol A. Environ Health Perspect 2010; 118:1055-70; PMID:20338858 ; http://dx.doi.org/10.1289/ ehp.0901716 35.",Non-OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
Endocrinology 2006; 147:5284-93;  PMID:16873539 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/85/adip-3-170.PMC4110093.pdf
